cancer.type	eQTL.type	tagSNP	LD	SNP.ID	SNP.position.hg19	Gene.symbol	Gene.position.hg19	Beta	t-stat	P-value	GWAS-Traits	
PCPG	cis	1	rs1001530	chr5:176985515	HK3	chr5:176307871-176326333:-	-0.54	-4.29	3.16E-5	Alzheimer disease and age of onset	
PCPG	cis	1	rs1003719	chr21:38491095	PIGP	chr21:38437664-38445458:-	-0.4	-4.49	1.41E-5	Eye color traits	
PCPG	cis	1	rs10051747	chr5:56083289	C5orf35	chr5:56205103-56213010:+	0.9	7.79	9.3E-13	Type 2 diabetes	
PCPG	cis	1	rs10078	chr5:438102	C5orf55	chr5:441645-443258:-	0.39	4.73	5.03E-6	Fat distribution (HIV)	
PCPG	cis	1	rs10088139	chr8:27740661	CCDC25	chr8:27590835-27630170:-	-0.37	-4.17	5.04E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
PCPG	cis	1	rs10088835	chr8:27740523	CCDC25	chr8:27590835-27630170:-	-0.37	-4.17	5.04E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
PCPG	cis	1	rs10103507	chr8:27740693	CCDC25	chr8:27590835-27630170:-	-0.37	-4.17	5.04E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
PCPG	cis	1	rs10117059	chr9:123653477	LOC253039	chr9:123605320-123616644:+	-0.56	-5.43	2.15E-7	Rheumatoid arthritis	
PCPG	cis	1	rs10140433	chr14:74659989	LIN52	chr14:74551656-74667117:+	-0.32	-5.98	1.48E-8	Common traits (Other)	
PCPG	cis	1	rs10143866	chr14:52884355	TXNDC16	chr14:52897309-53019301:-	-0.41	-4.1	6.69E-5	Smooth-surface caries	
PCPG	cis	1	rs10144220	chr14:74647904	LIN52	chr14:74551656-74667117:+	-0.31	-5.74	4.9E-8	Common traits (Other)	
PCPG	cis	1	rs10150201	chr14:74649157	LIN52	chr14:74551656-74667117:+	-0.31	-5.86	2.7E-8	Common traits (Other)	
PCPG	cis	1	rs10157597	chr1:45990278	CCDC163P	chr1:45960581-45965646:-	-0.6	-9.63	1.84E-17	Homocysteine levels	
PCPG	cis	1	rs10165485	chr2:54481636	C2orf73	chr2:54558071-54588714:+	0.57	4.26	3.5E-5	Telomere length	
PCPG	cis	1	rs1016669	chr3:41894440	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs10169714	chr2:73808773	ALMS1P	chr2:73872046-73912692:+	0.61	5.88	2.48E-8	Metabolite levels	
PCPG	cis	1	rs10175180	chr2:73673123	ALMS1P	chr2:73872046-73912692:+	0.59	5.83	3.16E-8	Metabolite levels	
PCPG	cis	1	rs10178409	chr2:73855507	ALMS1P	chr2:73872046-73912692:+	0.62	6.09	8.44E-9	Urinary metabolites	
PCPG	cis	1	rs10179134	chr2:73637519	ALMS1P	chr2:73872046-73912692:+	0.62	5.87	2.54E-8	Metabolite levels	
PCPG	cis	1	rs1018184	chr6:86648475	SNHG5	chr6:86386726-86388451:-	0.51	6.64	5.15E-10	Response to antipsychotic treatment	
PCPG	cis	1	rs10184268	chr2:73627044	ALMS1P	chr2:73872046-73912692:+	0.62	6.13	7.15E-9	Metabolite levels	
PCPG	cis	1	rs10186501	chr2:73697844	ALMS1P	chr2:73872046-73912692:+	0.6	5.92	2.0E-8	Metabolite levels	
PCPG	cis	1	rs10187192	chr2:73713500	ALMS1P	chr2:73872046-73912692:+	0.61	5.55	1.2E-7	Metabolite levels	
PCPG	cis	1	rs10187416	chr2:73713741	ALMS1P	chr2:73872046-73912692:+	0.57	5.61	9.13E-8	Metabolite levels	
PCPG	cis	1	rs10189574	chr2:73698518	ALMS1P	chr2:73872046-73912692:+	0.6	5.92	2.0E-8	Metabolite levels	
PCPG	cis	1	rs10190219	chr2:73658331	ALMS1P	chr2:73872046-73912692:+	0.6	5.71	5.68E-8	Metabolite levels	
PCPG	cis	1	rs10193972	chr2:73717656	ALMS1P	chr2:73872046-73912692:+	0.6	5.9	2.19E-8	Metabolite levels	
PCPG	cis	1	rs10207220	chr2:73785046	ALMS1P	chr2:73872046-73912692:+	0.61	5.82	3.31E-8	Metabolite levels	
PCPG	cis	1	rs10209928	chr2:108863898	SULT1C2	chr2:108905095-108926370:+	0.55	5.41	2.41E-7	Blood pressure	
PCPG	cis	1	rs10212536	chr3:41827026	ULK4	chr3:41288091-42003660:-	0.71	10.09	1.09E-18	Diastolic blood pressure	
PCPG	cis	1	rs10218795	chr1:145416056	NOTCH2NL	chr1:145209111-145295525:+	0.71	5.7	5.81E-8	Coronary heart disease	
PCPG	cis	1	rs10234309	chr7:135311167	PL-5283	chr7:135347221-135378160:+	0.45	4.62	8.2E-6	Paget's disease	
PCPG	cis	1	rs10234309	chr7:135311167	SLC13A4	chr7:135365993-135412933:-	-0.68	-6.1	8.17E-9	Paget's disease	
PCPG	cis	1	rs10238070	chr7:23909791	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs10245161	chr7:23907692	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs1025646	chr3:41754422	ULK4	chr3:41288091-42003660:-	0.72	9.66	1.53E-17	Diastolic blood pressure	
PCPG	cis	1	rs10257777	chr7:23910981	C7orf46	chr7:23719749-23742268:+	0.44	5.63	8.16E-8	Schizophrenia	
PCPG	cis	1	rs10262624	chr7:23915676	C7orf46	chr7:23719749-23742268:+	0.44	5.73	5.01E-8	Schizophrenia	
PCPG	cis	1	rs1035142	chr2:202153078	ALS2CR12	chr2:202153148-202222101:-	-0.41	-4.85	3.01E-6	Melanoma;Esophageal squamous cell carcinoma	
PCPG	cis	1	rs1040558	chr6:20713706	CDKAL1	chr6:20534688-21232632:+	0.41	4.19	4.64E-5	Type 2 diabetes	
PCPG	cis	1	rs10406920	chr19:17389648	MRPL34	chr19:17416477-17417652:+	-0.41	-4.35	2.47E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PCPG	cis	1	rs10416218	chr19:33599127	GPATCH1	chr19:33571786-33621318:+	0.39	5.17	7.12E-7	Bone properties (heel)	
PCPG	cis	1	rs10423531	chr19:33600140	GPATCH1	chr19:33571786-33621318:+	0.39	5.17	7.12E-7	Bone properties (heel)	
PCPG	cis	1	rs10424178	chr19:17379558	MRPL34	chr19:17416477-17417652:+	-0.36	-4.22	4.21E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PCPG	cis	1	rs10425939	chr19:17397244	MRPL34	chr19:17416477-17417652:+	-0.44	-4.58	9.7E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PCPG	cis	1	rs1042658	chr17:38173902	GSDMA	chr17:38119226-38134019:+	-0.67	-8.35	3.61E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs10431505	chr12:58178589	FAM119B	chr12:58166383-58176323:+	0.57	5.45	1.97E-7	Multiple sclerosis	
PCPG	cis	1	rs10431505	chr12:58178589	TSFM	chr12:58176536-58191367:+	-0.6	-7.37	9.5E-12	Multiple sclerosis	
PCPG	cis	1	rs10431765	chr15:66044551	DPP8	chr15:65737999-65810035:-	-0.19	-4.65	7.23E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs10445300	chr17:2114587	SRR	chr17:2207248-2228553:+	-0.59	-6.31	2.82E-9	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs1044717	chr1:45976587	CCDC163P	chr1:45960581-45965646:-	-0.57	-9.54	3.03E-17	Homocysteine levels	
PCPG	cis	1	rs10455158	chr6:86672825	SNHG5	chr6:86386726-86388451:-	-0.48	-6.09	8.47E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs10455449	chr6:86592226	SNHG5	chr6:86386726-86388451:-	-0.51	-6.14	6.88E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs10455455	chr6:86670214	SNHG5	chr6:86386726-86388451:-	-0.51	-6.24	3.99E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs10455456	chr6:86670322	SNHG5	chr6:86386726-86388451:-	-0.49	-6.23	4.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs10456078	chr6:35118075	UHRF1BP1	chr6:34759794-34853117:+	-0.32	-4.6	8.86E-6	Airway responsiveness in chronic obstructive pulmonary disease	
PCPG	cis	1	rs10456362	chr6:28221816	ZNF187	chr6:28234788-28245978:+	0.3	4.1	6.64E-5	Depression	
PCPG	cis	1	rs1046073	chr20:25281333	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1046073	chr20:25281333	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs10461617	chr5:56104308	C5orf35	chr5:56205103-56213010:+	0.9	8.23	7.32E-14	Type 2 diabetes	
PCPG	cis	1	rs1046875	chr17:80685426	FN3KRP	chr17:80674582-80685889:+	0.51	5.15	7.79E-7	Glycated hemoglobin levels	
PCPG	cis	1	rs1046896	chr17:80685533	FN3KRP	chr17:80674582-80685889:+	0.51	5.14	8.22E-7	Glycated hemoglobin levels	
PCPG	cis	1	rs1046917	chr17:80685655	FN3KRP	chr17:80674582-80685889:+	0.51	5.15	7.79E-7	Glycated hemoglobin levels	
PCPG	cis	1	rs10470686	chr3:48449956	TREX1	chr3:48501186-48509043:+	-0.28	-4.17	5.06E-5	Longevity	
PCPG	cis	1	rs1047171	chr20:25428786	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1047171	chr20:25428786	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs10496191	chr2:73673798	ALMS1P	chr2:73872046-73912692:+	0.59	5.83	3.16E-8	Metabolite levels	
PCPG	cis	1	rs10496193	chr2:73773503	ALMS1P	chr2:73872046-73912692:+	0.62	6.06	1.02E-8	Metabolite levels	
PCPG	cis	1	rs10498958	chr6:86649705	SNHG5	chr6:86386726-86388451:-	0.55	6.6	6.39E-10	Response to antipsychotic treatment	
PCPG	cis	1	rs10500303	chr19:50512033	SIGLEC16	chr19:50472912-50479075:+	0.78	5.08	1.09E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs10510110	chr10:124192430	PLEKHA1	chr10:124134220-124191866:+	-0.34	-4.92	2.16E-6	Height	
PCPG	cis	1	rs1052501	chr3:41925398	ULK4	chr3:41288091-42003660:-	-0.79	-11.1	2.04E-21	Diastolic blood pressure	
PCPG	cis	1	rs10736426	chr1:45984353	CCDC163P	chr1:45960581-45965646:-	0.53	8.51	1.46E-14	Homocysteine levels	
PCPG	cis	1	rs10739388	chr9:115977175	CDC26	chr9:116029290-116037869:-	-0.49	-6.29	3.1E-9	Hematology traits	
PCPG	cis	1	rs10747783	chr12:58176614	FAM119B	chr12:58166383-58176323:+	0.56	5.39	2.65E-7	Multiple sclerosis	
PCPG	cis	1	rs10747783	chr12:58176614	TSFM	chr12:58176536-58191367:+	-0.59	-7.38	9.04E-12	Multiple sclerosis	
PCPG	cis	1	rs10749860	chr1:46328210	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.97E-7	Body mass index	
PCPG	cis	1	rs10754323	chr1:89119492	CCBL2	chr1:89401456-89458643:-	0.49	6.38	2.01E-9	Height	
PCPG	cis	1	rs10759636	chr9:116018777	CDC26	chr9:116029290-116037869:-	-0.47	-6.19	5.3E-9	Hematology traits	
PCPG	cis	1	rs10760118	chr9:123641616	LOC253039	chr9:123605320-123616644:+	-0.52	-5.12	8.81E-7	Rheumatoid arthritis	
PCPG	cis	1	rs10760121	chr9:123647915	LOC253039	chr9:123605320-123616644:+	-0.56	-5.43	2.15E-7	Rheumatoid arthritis	
PCPG	cis	1	rs1077889	chr20:25267893	ENTPD6	chr20:25176339-25207360:+	-0.35	-4.39	2.13E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1077889	chr20:25267893	FAM182A	chr20:26035250-26067552:+	-0.49	-5.94	1.86E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs10783847	chr12:58196447	FAM119B	chr12:58166383-58176323:+	0.57	5.45	1.97E-7	Multiple sclerosis	
PCPG	cis	1	rs10783847	chr12:58196447	TSFM	chr12:58176536-58191367:+	-0.6	-7.37	9.5E-12	Multiple sclerosis	
PCPG	cis	1	rs10783848	chr12:58196528	FAM119B	chr12:58166383-58176323:+	0.57	5.45	1.97E-7	Multiple sclerosis	
PCPG	cis	1	rs10783848	chr12:58196528	TSFM	chr12:58176536-58191367:+	-0.6	-7.37	9.5E-12	Multiple sclerosis	
PCPG	cis	1	rs10789475	chr1:46304177	CCDC163P	chr1:45960581-45965646:-	-0.36	-5.46	1.86E-7	Body mass index	
PCPG	cis	1	rs10789481	chr1:46383583	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.4	2.45E-7	Body mass index	
PCPG	cis	1	rs10789487	chr1:46420221	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.7	5.81E-8	Body mass index	
PCPG	cis	1	rs10804111	chr2:202145612	ALS2CR12	chr2:202153148-202222101:-	-0.42	-4.88	2.61E-6	Melanoma;Esophageal squamous cell carcinoma	
PCPG	cis	1	rs10804632	chr3:134294501	ANAPC13	chr3:134196547-134204865:-	0.36	4.86	2.81E-6	Height	
PCPG	cis	1	rs10818480	chr9:123643170	LOC253039	chr9:123605320-123616644:+	-0.56	-5.45	1.95E-7	Rheumatoid arthritis	
PCPG	cis	1	rs10829439	chr10:128782323	DOCK1	chr10:128594023-129250781:+	0.17	4.03	8.73E-5	Apolipoprotein Levels	
PCPG	cis	1	rs10849605	chr12:1064438	RAD52	chr12:1021255-1099219:-	-0.33	-5.15	8.03E-7	Lung cancer	
PCPG	cis	1	rs1085243	chr1:46544768	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.76	4.52E-8	Body mass index	
PCPG	cis	1	rs1085244	chr1:46563680	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.64	7.77E-8	Body mass index	
PCPG	cis	1	rs10853057	chr17:62998023	AMZ2P1	chr17:62962668-62971703:-	0.58	4.25	3.63E-5	White matter microstructure (global fractional anisotropy)	
PCPG	cis	1	rs10857712	chr10:135225666	MTG1	chr10:135207621-135234173:+	0.52	7.24	2.02E-11	Systemic lupus erythematosus	
PCPG	cis	1	rs10865914	chr3:41919499	ULK4	chr3:41288091-42003660:-	-0.77	-11	3.91E-21	Diastolic blood pressure	
PCPG	cis	1	rs10874656	chr1:92947024	EVI5	chr1:92974255-93257961:-	-0.28	-4.09	7.0E-5	Cholesterol, total	
PCPG	cis	1	rs10877012	chr12:58162085	FAM119B	chr12:58166383-58176323:+	0.48	4.53	1.19E-5	Multiple sclerosis	
PCPG	cis	1	rs10877012	chr12:58162085	TSFM	chr12:58176536-58191367:+	-0.59	-7.28	1.63E-11	Multiple sclerosis	
PCPG	cis	1	rs10877013	chr12:58165085	FAM119B	chr12:58166383-58176323:+	0.49	4.58	9.69E-6	Multiple sclerosis	
PCPG	cis	1	rs10877013	chr12:58165085	TSFM	chr12:58176536-58191367:+	-0.56	-6.84	1.78E-10	Multiple sclerosis	
PCPG	cis	1	rs10877014	chr12:58167661	FAM119B	chr12:58166383-58176323:+	0.5	4.83	3.23E-6	Multiple sclerosis	
PCPG	cis	1	rs10877014	chr12:58167661	TSFM	chr12:58176536-58191367:+	-0.55	-6.9	1.26E-10	Multiple sclerosis	
PCPG	cis	1	rs10877015	chr12:58167788	FAM119B	chr12:58166383-58176323:+	0.49	4.64	7.39E-6	Multiple sclerosis	
PCPG	cis	1	rs10877015	chr12:58167788	TSFM	chr12:58176536-58191367:+	-0.58	-7.21	2.36E-11	Multiple sclerosis	
PCPG	cis	1	rs10877019	chr12:58172929	FAM119B	chr12:58166383-58176323:+	-0.54	-5.23	5.39E-7	Multiple sclerosis	
PCPG	cis	1	rs10877019	chr12:58172929	TSFM	chr12:58176536-58191367:+	0.6	7.6	2.78E-12	Multiple sclerosis	
PCPG	cis	1	rs10887150	chr10:124180578	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.36	2.33E-5	Height	
PCPG	cis	1	rs10890352	chr1:46283628	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.4	2.43E-7	Body mass index	
PCPG	cis	1	rs10890354	chr1:46305347	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.49	1.61E-7	Body mass index	
PCPG	cis	1	rs10890361	chr1:46346234	CCDC163P	chr1:45960581-45965646:-	-0.36	-5.25	5.01E-7	Body mass index	
PCPG	cis	1	rs10890363	chr1:46356148	CCDC163P	chr1:45960581-45965646:-	0.4	6.05	1.06E-8	Body mass index	
PCPG	cis	1	rs10935120	chr3:134233092	ANAPC13	chr3:134196547-134204865:-	-0.36	-5.37	2.81E-7	Height	
PCPG	cis	1	rs10936601	chr3:169528449	LRRIQ4	chr3:169539710-169555558:+	-0.37	-4.08	7.22E-5	Multiple myeloma and monoclonal gammopathy;Interstitial lung disease	
PCPG	cis	1	rs10944161	chr6:86630376	SNHG5	chr6:86386726-86388451:-	-0.49	-6.23	4.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs10944163	chr6:86658693	SNHG5	chr6:86386726-86388451:-	-0.52	-6.31	2.76E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs10944169	chr6:86683036	SNHG5	chr6:86386726-86388451:-	-0.51	-6.53	8.9E-10	Response to antipsychotic treatment	
PCPG	cis	1	rs10944170	chr6:86685469	SNHG5	chr6:86386726-86388451:-	-0.48	-6.04	1.09E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs10946403	chr6:20717404	CDKAL1	chr6:20534688-21232632:+	-0.39	-4.13	5.83E-5	Type 2 diabetes	
PCPG	cis	1	rs10947673	chr6:37445079	C6orf129	chr6:37450699-37467700:-	0.29	4.33	2.65E-5	Cognitive performance	
PCPG	cis	1	rs10950973	chr7:23917277	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs10950974	chr7:23917280	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs10950975	chr7:23917480	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs10966	chr20:25282944	ENTPD6	chr20:25176339-25207360:+	-0.32	-4.06	7.89E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs10966	chr20:25282944	FAM182A	chr20:26035250-26067552:+	-0.51	-6.35	2.33E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs10988125	chr9:131572903	ENDOG	chr9:131580779-131584954:+	0.23	4.17	5.09E-5	Blood metabolite levels	
PCPG	cis	1	rs11049516	chr12:28452582	CCDC91	chr12:28332210-28703098:+	0.43	5.04	1.32E-6	Height	
PCPG	cis	1	rs11049532	chr12:28476912	CCDC91	chr12:28332210-28703098:+	0.41	4.81	3.49E-6	Height	
PCPG	cis	1	rs1106287	chr1:113242122	ST7L	chr1:113066142-113162405:-	0.47	4.4	1.98E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs11070798	chr15:50883263	SPPL2A	chr15:50999739-51057910:-	0.36	5.34	3.32E-7	QT interval	
PCPG	cis	1	rs11070800	chr15:50907347	SPPL2A	chr15:50999739-51057910:-	0.34	4.88	2.6E-6	QT interval	
PCPG	cis	1	rs11070805	chr15:50964192	SPPL2A	chr15:50999739-51057910:-	0.32	4.72	5.21E-6	QT interval	
PCPG	cis	1	rs11070807	chr15:50974505	SPPL2A	chr15:50999739-51057910:-	0.33	4.82	3.47E-6	QT interval	
PCPG	cis	1	rs11071846	chr15:65792839	DPP8	chr15:65737999-65810035:-	0.18	4.29	3.1E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs11087520	chr20:25436827	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.08	7.2E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs11087520	chr20:25436827	FAM182A	chr20:26035250-26067552:+	-0.48	-5.82	3.36E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs11087521	chr20:25440648	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.15	5.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs11087521	chr20:25440648	FAM182A	chr20:26035250-26067552:+	-0.51	-6.02	1.24E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1110042	chr1:113236534	ST7L	chr1:113066142-113162405:-	0.46	4.28	3.28E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs11100	chr20:25281184	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs11100	chr20:25281184	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1112137	chr1:247215375	ZNF670	chr1:247200087-247242069:-	-0.46	-6.03	1.16E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs11125529	chr2:54475866	C2orf73	chr2:54558071-54588714:+	-0.57	-4.32	2.83E-5	Telomere length	
PCPG	cis	1	rs11127188	chr2:28972852	TRMT61B	chr2:29072690-29093175:-	-0.52	-5.32	3.62E-7	Body mass index	
PCPG	cis	1	rs11130170	chr3:48449897	TREX1	chr3:48501186-48509043:+	-0.28	-4.17	5.06E-5	Longevity	
PCPG	cis	1	rs111315781	chr2:201738724	PPIL3	chr2:201735680-201753999:-	-0.98	-8.97	9.59E-16	Triptolide cytotoxicity	
PCPG	cis	1	rs1114380	chr2:73804708	ALMS1P	chr2:73872046-73912692:+	0.61	5.88	2.48E-8	Metabolite levels	
PCPG	cis	1	rs11148252	chr13:53009048	CKAP2	chr13:53029495-53050763:+	-0.46	-7.13	3.57E-11	Lewy body disease	
PCPG	cis	1	rs11159067	chr14:74637444	LIN52	chr14:74551656-74667117:+	0.27	4.99	1.61E-6	Common traits (Other)	
PCPG	cis	1	rs11164654	chr1:92968312	EVI5	chr1:92974255-93257961:-	-0.3	-4.13	5.87E-5	Cholesterol, total;LDL cholesterol	
PCPG	cis	1	rs11172333	chr12:58170335	FAM119B	chr12:58166383-58176323:+	0.56	5.49	1.66E-7	Multiple sclerosis	
PCPG	cis	1	rs11172333	chr12:58170335	TSFM	chr12:58176536-58191367:+	-0.54	-6.55	8.32E-10	Multiple sclerosis	
PCPG	cis	1	rs11172335	chr12:58175201	FAM119B	chr12:58166383-58176323:+	0.56	5.26	4.78E-7	Multiple sclerosis	
PCPG	cis	1	rs11172335	chr12:58175201	TSFM	chr12:58176536-58191367:+	-0.62	-7.67	1.83E-12	Multiple sclerosis	
PCPG	cis	1	rs11172342	chr12:58187758	FAM119B	chr12:58166383-58176323:+	0.56	5.26	4.78E-7	Multiple sclerosis	
PCPG	cis	1	rs11172342	chr12:58187758	TSFM	chr12:58176536-58191367:+	-0.62	-7.67	1.83E-12	Multiple sclerosis	
PCPG	cis	1	rs11172343	chr12:58188157	FAM119B	chr12:58166383-58176323:+	0.56	5.26	4.78E-7	Multiple sclerosis	
PCPG	cis	1	rs11172343	chr12:58188157	TSFM	chr12:58176536-58191367:+	-0.62	-7.67	1.83E-12	Multiple sclerosis	
PCPG	cis	1	rs11172344	chr12:58193448	FAM119B	chr12:58166383-58176323:+	0.57	5.45	1.97E-7	Multiple sclerosis	
PCPG	cis	1	rs11172344	chr12:58193448	TSFM	chr12:58176536-58191367:+	-0.6	-7.37	9.5E-12	Multiple sclerosis	
PCPG	cis	1	rs11172349	chr12:58212528	FAM119B	chr12:58166383-58176323:+	0.56	5.39	2.57E-7	Multiple sclerosis	
PCPG	cis	1	rs11172349	chr12:58212528	TSFM	chr12:58176536-58191367:+	-0.59	-7.3	1.4E-11	Multiple sclerosis	
PCPG	cis	1	rs11172351	chr12:58213485	FAM119B	chr12:58166383-58176323:+	0.56	5.24	5.23E-7	Multiple sclerosis	
PCPG	cis	1	rs11172351	chr12:58213485	TSFM	chr12:58176536-58191367:+	-0.6	-7.28	1.63E-11	Multiple sclerosis	
PCPG	cis	1	rs11180559	chr12:75920285	GLIPR1L2	chr12:75784889-75825591:+	0.52	4.24	3.87E-5	Daytime sleep phenotypes	
PCPG	cis	1	rs111902838	chr19:50496614	SIGLEC16	chr19:50472912-50479075:+	0.77	5.08	1.07E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs11191419	chr10:104612335	AS3MT	chr10:104613967-104661653:+	-0.37	-7.17	3.01E-11	Schizophrenia	
PCPG	cis	1	rs11191419	chr10:104612335	C10orf32	chr10:104613967-104624718:+	-0.45	-5.89	2.34E-8	Schizophrenia	
PCPG	cis	1	rs11200595	chr10:124142629	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.36	2.38E-5	Height	
PCPG	cis	1	rs11200606	chr10:124148765	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.38	2.16E-5	Height	
PCPG	cis	1	rs11200608	chr10:124157821	PLEKHA1	chr10:124134220-124191866:+	-0.32	-4.47	1.53E-5	Height	
PCPG	cis	1	rs11200609	chr10:124157858	PLEKHA1	chr10:124134220-124191866:+	-0.32	-4.47	1.53E-5	Height	
PCPG	cis	1	rs11200629	chr10:124198585	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.41	1.96E-5	Height	
PCPG	cis	1	rs11201297	chr10:81793749	LOC219347	chr10:81805991-81838949:-	1.01	8.38	3.14E-14	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs11201298	chr10:81793751	LOC219347	chr10:81805991-81838949:-	1.01	8.38	3.14E-14	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs11201312	chr10:81795778	LOC219347	chr10:81805991-81838949:-	1.06	9	7.98E-16	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs11201660	chr10:81854531	LOC219347	chr10:81805991-81838949:-	-0.79	-6.83	1.82E-10	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs11201799	chr10:81881954	LOC219347	chr10:81805991-81838949:-	-0.59	-5	1.55E-6	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs11211132	chr1:45990516	CCDC163P	chr1:45960581-45965646:-	-0.6	-9.63	1.84E-17	Homocysteine levels	
PCPG	cis	1	rs11211199	chr1:46287869	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.53	1.34E-7	Body mass index	
PCPG	cis	1	rs11211208	chr1:46334256	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.97E-7	Body mass index	
PCPG	cis	1	rs11211230	chr1:46406767	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.55	1.23E-7	Body mass index	
PCPG	cis	1	rs11211241	chr1:46452683	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.85	2.91E-8	Body mass index	
PCPG	cis	1	rs1125203	chr3:41760895	ULK4	chr3:41288091-42003660:-	0.72	10.39	1.75E-19	Diastolic blood pressure	
PCPG	cis	1	rs1127489	chr6:170107702	WDR27	chr6:169857307-170102159:-	-0.5	-5.38	2.75E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs113143821	chr5:127893353	FBN2	chr5:127593602-127873916:-	0.47	4.97	1.79E-6	Multiple system atrophy	
PCPG	cis	1	rs113333037	chr17:2200106	SRR	chr17:2207248-2228553:+	-0.59	-6.42	1.59E-9	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs113638727	chr15:40706101	C15orf23	chr15:40674922-40686488:+	1.2	10.71	2.32E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs1138273	chr3:134261437	ANAPC13	chr3:134196547-134204865:-	0.37	5	1.56E-6	Height	
PCPG	cis	1	rs1148000	chr12:75936301	GLIPR1L2	chr12:75784889-75825591:+	-0.4	-4.06	7.88E-5	Polycystic ovary syndrome	
PCPG	cis	1	rs1148004	chr12:75978677	GLIPR1L2	chr12:75784889-75825591:+	-0.44	-4.03	8.61E-5	Polycystic ovary syndrome	
PCPG	cis	1	rs114955529	chr16:82446444	PLCG2	chr16:81812930-81991898:+	0.49	4.24	3.81E-5	Non-word repetition	
PCPG	cis	1	rs114960066	chr3:41882323	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs11532322	chr12:123731423	ABCB9	chr12:123413540-123459752:-	-0.44	-4.64	7.28E-6	Schizophrenia	
PCPG	cis	1	rs11541642	chr15:40683702	C15orf23	chr15:40674922-40686488:+	1.1	10.11	9.34E-19	Heschl's gyrus morphology	
PCPG	cis	1	rs11557072	chr15:40713374	C15orf23	chr15:40674922-40686488:+	1.2	10.66	3.18E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs11579634	chr1:46466391	CCDC163P	chr1:45960581-45965646:-	0.41	5.77	4.13E-8	Body mass index	
PCPG	cis	1	rs11585955	chr1:150043544	CDC42SE1	chr1:151023449-151032125:-	0.39	4.16	5.19E-5	Obesity in adult survivors of childhood cancer not exposed to cranial radiation	
PCPG	cis	1	rs11589562	chr1:46466721	CCDC163P	chr1:45960581-45965646:-	0.38	4.19	4.66E-5	Body mass index	
PCPG	cis	1	rs116139393	chr7:6771660	C7orf28B	chr7:6838572-6865861:-	-0.56	-4.55	1.07E-5	Alzheimer's disease (APOE e4 interaction)	
PCPG	cis	1	rs11628710	chr14:74649280	LIN52	chr14:74551656-74667117:+	0.32	6.16	6.15E-9	Common traits (Other)	
PCPG	cis	1	rs11632310	chr15:65882326	DPP8	chr15:65737999-65810035:-	-0.19	-4.47	1.48E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs11632465	chr15:85282045	WDR73	chr15:85186012-85197524:-	-0.42	-4.21	4.4E-5	Schizophrenia	
PCPG	cis	1	rs11634746	chr15:50941496	SPPL2A	chr15:50999739-51057910:-	0.31	4.34	2.6E-5	QT interval	
PCPG	cis	1	rs11636148	chr15:65796880	DPP8	chr15:65737999-65810035:-	0.18	4.29	3.1E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs11636964	chr15:50899616	SPPL2A	chr15:50999739-51057910:-	0.33	4.74	4.93E-6	QT interval	
PCPG	cis	1	rs11637142	chr15:85295927	WDR73	chr15:85186012-85197524:-	-0.42	-4.12	6.18E-5	Schizophrenia	
PCPG	cis	1	rs11637228	chr15:50899972	SPPL2A	chr15:50999739-51057910:-	0.33	4.74	4.93E-6	QT interval	
PCPG	cis	1	rs11637431	chr15:65882251	DPP8	chr15:65737999-65810035:-	-0.19	-4.47	1.48E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs11638290	chr15:85227636	WDR73	chr15:85186012-85197524:-	-0.45	-4.45	1.66E-5	Schizophrenia	
PCPG	cis	1	rs11650372	chr17:45721795	C17orf57	chr17:45401142-45518675:+	0.39	4.55	1.07E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs11651264	chr17:79576394	TSPAN10	chr17:79609349-79615778:+	-0.62	-8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs11652797	chr17:79574124	TSPAN10	chr17:79609349-79615778:+	0.62	8.38	3.09E-14	Eye color traits	
PCPG	cis	1	rs11658555	chr17:18817486	FOXO3B	chr17:18569236-18576494:-	0.36	4.04	8.36E-5	Pancreatic cancer	
PCPG	cis	1	rs11663558	chr18:21133937	NPC1	chr18:21108363-21166581:-	0.3	4.61	8.31E-6	Body mass index	
PCPG	cis	1	rs11674602	chr2:73723185	ALMS1P	chr2:73872046-73912692:+	0.6	5.7	5.91E-8	Metabolite levels	
PCPG	cis	1	rs1167827	chr7:75163169	PMS2L3	chr7:75137070-75157418:-	-0.51	-6.5	1.05E-9	Body mass index	
PCPG	cis	1	rs11688129	chr2:28952581	TRMT61B	chr2:29072690-29093175:-	0.5	4.84	3.17E-6	Body mass index	
PCPG	cis	1	rs11689392	chr2:73622026	ALMS1P	chr2:73872046-73912692:+	0.62	6.13	7.15E-9	Metabolite levels	
PCPG	cis	1	rs11690423	chr2:28951537	TRMT61B	chr2:29072690-29093175:-	0.5	4.84	3.17E-6	Body mass index	
PCPG	cis	1	rs11706117	chr3:134212526	ANAPC13	chr3:134196547-134204865:-	0.34	4.51	1.28E-5	Height	
PCPG	cis	1	rs1170612	chr2:124983056	CNTNAP5	chr2:124782864-125672861:+	0.36	4.22	4.18E-5	Schizophrenia	
PCPG	cis	1	rs11708531	chr3:134224902	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs11712561	chr3:48435272	TREX1	chr3:48501186-48509043:+	-0.28	-4.21	4.4E-5	Longevity	
PCPG	cis	1	rs11714406	chr3:121372513	IQCB1	chr3:121488610-121553926:-	0.5	5.67	6.84E-8	Cognitive performance	
PCPG	cis	1	rs11719458	chr3:121382005	IQCB1	chr3:121488610-121553926:-	0.52	5.87	2.59E-8	Cognitive performance	
PCPG	cis	1	rs11724031	chr4:77462778	C4orf26	chr4:76481258-76489927:+	-0.57	-4.36	2.36E-5	Gut microbiota (bacterial taxa)	
PCPG	cis	1	rs11733284	chr4:48028097	CNGA1	chr4:47937996-48018610:-	0.47	5.48	1.71E-7	Renal underexcretion gout;Gout	
PCPG	cis	1	rs11737481	chr4:159621250	ETFDH	chr4:159593277-159629839:+	-0.39	-4.98	1.66E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PCPG	cis	1	rs11739344	chr5:56111087	C5orf35	chr5:56205103-56213010:+	1	9.54	3.06E-17	Type 2 diabetes	
PCPG	cis	1	rs11746560	chr5:150185925	LOC134466	chr5:150310000-150326146:-	0.75	4.13	6.04E-5	Crohn's disease	
PCPG	cis	1	rs11748553	chr5:150184553	LOC134466	chr5:150310000-150326146:-	0.75	4.13	6.04E-5	Crohn's disease	
PCPG	cis	1	rs11753081	chr6:20705590	CDKAL1	chr6:20534688-21232632:+	-0.43	-4.4	2.02E-5	Type 2 diabetes	
PCPG	cis	1	rs11758849	chr6:86708262	SNHG5	chr6:86386726-86388451:-	-0.46	-5.64	7.85E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs11759855	chr6:86610841	SNHG5	chr6:86386726-86388451:-	-0.49	-6.11	7.63E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs11765006	chr7:108638163	PNPLA8	chr7:108112071-108168605:-	-0.58	-4.44	1.71E-5	Smoking behavior	
PCPG	cis	1	rs11767124	chr7:23919080	C7orf46	chr7:23719749-23742268:+	0.44	5.6	9.49E-8	Schizophrenia	
PCPG	cis	1	rs11774576	chr8:27740417	CCDC25	chr8:27590835-27630170:-	0.37	4.17	5.09E-5	Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin)	
PCPG	cis	1	rs117907570	chr6:86601283	SNHG5	chr6:86386726-86388451:-	-0.46	-6.07	9.56E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs11810993	chr1:46478793	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.9	2.18E-8	Body mass index	
PCPG	cis	1	rs118110670	chr10:81792242	LOC219347	chr10:81805991-81838949:-	1.01	8.33	4.19E-14	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs11835839	chr12:124431049	DNAH10	chr12:124247042-124420265:+	0.32	4.06	7.91E-5	Waist-to-hip ratio adjusted for body mass index	
PCPG	cis	1	rs1185260	chr12:122389248	PSMD9	chr12:122326646-122355770:+	-0.44	-4.07	7.36E-5	Urinary metabolites	
PCPG	cis	1	rs11856184	chr15:43919162	ADAL	chr15:43622872-43646094:+	-0.51	-4.93	2.07E-6	Tumor biomarkers	
PCPG	cis	1	rs11858714	chr15:40717447	C15orf23	chr15:40674922-40686488:+	1.2	10.62	4.07E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs11859274	chr16:31361059	ITGAX	chr16:31366509-31394318:+	0.22	4.31	2.91E-5	IgA nephropathy	
PCPG	cis	1	rs11870935	chr17:45732605	C17orf57	chr17:45401142-45518675:+	-0.4	-4.75	4.62E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs11882144	chr19:42072602	CEACAM21	chr19:42055886-42093196:+	0.62	9.15	3.21E-16	Schizophrenia	
PCPG	cis	1	rs11893832	chr2:88507537	THNSL2	chr2:88469835-88486145:+	-0.79	-4.84	3.2E-6	Plasma clusterin levels	
PCPG	cis	1	rs11893881	chr2:73824373	ALMS1P	chr2:73872046-73912692:+	0.62	6.01	1.31E-8	Metabolite levels	
PCPG	cis	1	rs11896604	chr2:54479199	C2orf73	chr2:54558071-54588714:+	-0.59	-4.53	1.16E-5	Telomere length	
PCPG	cis	1	rs11899740	chr2:73631212	ALMS1P	chr2:73872046-73912692:+	0.66	5.92	2.03E-8	Metabolite levels	
PCPG	cis	1	rs11899902	chr2:73631564	ALMS1P	chr2:73872046-73912692:+	0.65	6.13	7.01E-9	Metabolite levels	
PCPG	cis	1	rs11901272	chr2:73720444	ALMS1P	chr2:73872046-73912692:+	0.6	5.9	2.19E-8	Metabolite levels	
PCPG	cis	1	rs11903916	chr2:73815328	ALMS1P	chr2:73872046-73912692:+	0.59	5.84	3.06E-8	Metabolite levels	
PCPG	cis	1	rs11918291	chr3:99927994	LNP1	chr3:100120037-100175169:+	-0.3	-4.15	5.39E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
PCPG	cis	1	rs11919350	chr3:134235970	ANAPC13	chr3:134196547-134204865:-	-0.35	-4.61	8.34E-6	Height	
PCPG	cis	1	rs11923562	chr3:41760331	ULK4	chr3:41288091-42003660:-	0.68	8.89	1.51E-15	Diastolic blood pressure	
PCPG	cis	1	rs11927068	chr3:134266321	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs11928499	chr3:134232350	ANAPC13	chr3:134196547-134204865:-	-0.34	-4.52	1.24E-5	Height	
PCPG	cis	1	rs11928580	chr3:41885722	ULK4	chr3:41288091-42003660:-	0.79	11.08	2.43E-21	Diastolic blood pressure	
PCPG	cis	1	rs11961560	chr6:170130121	WDR27	chr6:169857307-170102159:-	-0.44	-4.46	1.6E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs11965538	chr6:28239915	ZNF187	chr6:28234788-28245978:+	-0.33	-4.5	1.35E-5	Depression	
PCPG	cis	1	rs11976020	chr7:72247800	TYW1B	chr7:72023729-72298813:-	0.98	14.46	1.74E-30	Educational attainment (years of education)	
PCPG	cis	1	rs11976180	chr7:143741580	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.04	8.27E-5	Obesity-related traits	
PCPG	cis	1	rs12021587	chr1:46472759	CCDC163P	chr1:45960581-45965646:-	-0.42	-6.11	7.91E-9	Body mass index	
PCPG	cis	1	rs1203156	chr6:88079694	C6orf162	chr6:88032306-88052043:+	-0.44	-5.07	1.14E-6	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs12040988	chr1:113173804	ST7L	chr1:113066142-113162405:-	0.47	4.38	2.19E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs12049588	chr1:46472422	CCDC163P	chr1:45960581-45965646:-	-0.42	-6.11	7.91E-9	Body mass index	
PCPG	cis	1	rs12088915	chr1:19708363	ALDH4A1	chr1:19197926-19229293:-	0.29	4.16	5.22E-5	Crohn's disease and psoriasis	
PCPG	cis	1	rs12091564	chr1:145395604	NOTCH2NL	chr1:145209111-145295525:+	-0.67	-5.59	1.03E-7	Coronary heart disease	
PCPG	cis	1	rs12101597	chr15:65935195	DPP8	chr15:65737999-65810035:-	-0.19	-4.79	3.93E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs12122290	chr1:247215810	ZNF670	chr1:247200087-247242069:-	-0.46	-6.07	9.76E-9	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs12123977	chr1:76209754	ACADM	chr1:76190043-76229353:+	-0.34	-4.35	2.5E-5	Blood metabolite levels;Acylcarnitine levels	
PCPG	cis	1	rs12130075	chr1:247218491	ZNF670	chr1:247200087-247242069:-	-0.44	-5.49	1.64E-7	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs12130219	chr1:152162106	FLG	chr1:152274651-152297679:-	0.55	5.84	2.93E-8	Inflammatory skin disease	
PCPG	cis	1	rs12130243	chr1:113169667	ST7L	chr1:113066142-113162405:-	0.46	4.31	2.91E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs12133583	chr1:113240790	ST7L	chr1:113066142-113162405:-	0.46	4.28	3.28E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs12139630	chr1:46350935	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.52	1.4E-7	Body mass index	
PCPG	cis	1	rs12139690	chr1:119491316	WARS2	chr1:119573841-119683295:-	0.47	4.05	8.05E-5	Waist-to-hip ratio adjusted for body mass index	
PCPG	cis	1	rs12141651	chr1:119492703	WARS2	chr1:119573841-119683295:-	0.46	4.03	8.64E-5	Waist-to-hip ratio adjusted for body mass index	
PCPG	cis	1	rs12144263	chr1:46352446	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.52	1.4E-7	Body mass index	
PCPG	cis	1	rs12154056	chr6:86634094	SNHG5	chr6:86386726-86388451:-	-0.49	-6.23	4.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12190598	chr6:86686074	SNHG5	chr6:86386726-86388451:-	-0.5	-6.02	1.24E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12190604	chr6:86716215	SNHG5	chr6:86386726-86388451:-	-0.5	-6.28	3.33E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12192992	chr6:86609915	SNHG5	chr6:86386726-86388451:-	-0.51	-6.28	3.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12196037	chr6:86694631	SNHG5	chr6:86386726-86388451:-	-0.52	-6.4	1.8E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12196411	chr6:86779762	SNHG5	chr6:86386726-86388451:-	-0.5	-5.96	1.69E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12197114	chr6:109735498	SMPD2	chr6:109761931-109765121:+	0.35	4.34	2.59E-5	Height	
PCPG	cis	1	rs12199516	chr6:86726221	SNHG5	chr6:86386726-86388451:-	-0.51	-6.34	2.36E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12199784	chr6:86726808	SNHG5	chr6:86386726-86388451:-	-0.5	-6.32	2.67E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12200330	chr6:86656653	SNHG5	chr6:86386726-86388451:-	-0.51	-6.28	3.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12201571	chr6:86609750	SNHG5	chr6:86386726-86388451:-	-0.49	-6.11	7.63E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12201735	chr6:86656939	SNHG5	chr6:86386726-86388451:-	-0.49	-6.23	4.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12201741	chr6:86602619	SNHG5	chr6:86386726-86388451:-	-0.5	-6.33	2.55E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12201880	chr6:86627007	SNHG5	chr6:86386726-86388451:-	-0.49	-6.23	4.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12203493	chr6:86758642	SNHG5	chr6:86386726-86388451:-	-0.49	-5.92	2.05E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12203924	chr6:86776412	SNHG5	chr6:86386726-86388451:-	-0.49	-5.92	2.05E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12204015	chr6:86598334	SNHG5	chr6:86386726-86388451:-	-0.45	-5.84	2.98E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12204365	chr6:86700532	SNHG5	chr6:86386726-86388451:-	-0.5	-6.33	2.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12205336	chr6:86722367	SNHG5	chr6:86386726-86388451:-	-0.51	-6.34	2.42E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12205548	chr6:86759770	SNHG5	chr6:86386726-86388451:-	-0.49	-5.88	2.43E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12207305	chr6:86723502	SNHG5	chr6:86386726-86388451:-	-0.5	-6.32	2.67E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12207610	chr6:86688016	SNHG5	chr6:86386726-86388451:-	-0.49	-6.16	6.01E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12208493	chr6:86662267	SNHG5	chr6:86386726-86388451:-	-0.51	-6.28	3.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12209127	chr6:86724427	SNHG5	chr6:86386726-86388451:-	-0.51	-6.34	2.42E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12212090	chr6:37431808	C6orf129	chr6:37450699-37467700:-	0.29	4.44	1.67E-5	Cognitive performance	
PCPG	cis	1	rs12212733	chr6:86726013	SNHG5	chr6:86386726-86388451:-	-0.49	-6.17	5.77E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12213149	chr6:86668644	SNHG5	chr6:86386726-86388451:-	-0.51	-6.28	3.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12213740	chr6:86656733	SNHG5	chr6:86386726-86388451:-	-0.5	-6.28	3.27E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12215037	chr6:86727631	SNHG5	chr6:86386726-86388451:-	-0.51	-6.31	2.86E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12215903	chr6:86675028	SNHG5	chr6:86386726-86388451:-	-0.47	-5.96	1.65E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12216203	chr6:86675301	SNHG5	chr6:86386726-86388451:-	-0.48	-5.97	1.59E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12216328	chr6:86703418	SNHG5	chr6:86386726-86388451:-	-0.49	-6.19	5.12E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12220777	chr10:81788104	LOC219347	chr10:81805991-81838949:-	-1	-8.06	1.96E-13	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs12301299	chr12:991710	RAD52	chr12:1021255-1099219:-	-0.45	-4.91	2.3E-6	Colorectal cancer	
PCPG	cis	1	rs12312603	chr12:988269	RAD52	chr12:1021255-1099219:-	-0.45	-5.01	1.47E-6	Colorectal cancer	
PCPG	cis	1	rs12405451	chr1:46384326	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.92E-7	Body mass index	
PCPG	cis	1	rs12409773	chr1:46358831	CCDC163P	chr1:45960581-45965646:-	-0.36	-5.25	5.07E-7	Body mass index	
PCPG	cis	1	rs12410071	chr1:46358886	CCDC163P	chr1:45960581-45965646:-	-0.36	-5.25	5.07E-7	Body mass index	
PCPG	cis	1	rs12411269	chr1:46271052	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.4	2.43E-7	Body mass index	
PCPG	cis	1	rs12414891	chr10:81690385	PLAC9	chr10:81892258-81904784:+	-0.37	-4.72	5.15E-6	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs12416687	chr10:104629011	AS3MT	chr10:104613967-104661653:+	-0.32	-5.12	8.91E-7	Arsenic metabolism	
PCPG	cis	1	rs12416687	chr10:104629011	C10orf32	chr10:104613967-104624718:+	-0.59	-7.18	2.8E-11	Arsenic metabolism	
PCPG	cis	1	rs12428	chr20:25433821	ENTPD6	chr20:25176339-25207360:+	0.33	4.17	5.15E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs12428	chr20:25433821	FAM182A	chr20:26035250-26067552:+	0.48	6	1.37E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs12428	chr20:25433821	FAM182B	chr20:25744102-25848786:-	-0.3	-4.07	7.48E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs12431682	chr14:101539999	PPP2R5C	chr14:102228135-102394326:+	0.35	4.03	8.88E-5	Corneal astigmatism	
PCPG	cis	1	rs12438181	chr15:78812098	CHRNA5	chr15:78857906-78886458:+	0.36	4.45	1.62E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs12438305	chr15:50912454	SPPL2A	chr15:50999739-51057910:-	0.37	5.32	3.61E-7	QT interval	
PCPG	cis	1	rs12438659	chr15:78824924	CHRNA5	chr15:78857906-78886458:+	0.36	4.58	9.45E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs12439744	chr15:50899211	SPPL2A	chr15:50999739-51057910:-	0.33	4.74	4.93E-6	QT interval	
PCPG	cis	1	rs12441354	chr15:78821016	CHRNA5	chr15:78857906-78886458:+	0.36	4.58	9.45E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs12441426	chr15:78812329	CHRNA5	chr15:78857906-78886458:+	0.37	4.59	9.25E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs12442510	chr15:66099113	DPP8	chr15:65737999-65810035:-	0.19	4.76	4.47E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs12442787	chr15:50918107	SPPL2A	chr15:50999739-51057910:-	0.34	4.88	2.6E-6	QT interval	
PCPG	cis	1	rs12443102	chr15:43932103	ADAL	chr15:43622872-43646094:+	-0.5	-4.79	3.87E-6	Tumor biomarkers	
PCPG	cis	1	rs12446632	chr16:19935389	C16orf88	chr16:19717676-19729492:-	0.51	4.38	2.19E-5	Body mass index;Menarche (age at onset);Childhood body mass index;Obesity	
PCPG	cis	1	rs12450191	chr17:80407948	C17orf62	chr17:80400520-80408694:-	-0.46	-4.15	5.49E-5	Protein quantitative trait loci	
PCPG	cis	1	rs12472278	chr2:108873433	SULT1C2	chr2:108905095-108926370:+	-0.54	-5.38	2.75E-7	Blood pressure	
PCPG	cis	1	rs12473740	chr2:88527647	THNSL2	chr2:88469835-88486145:+	-0.75	-4.66	6.67E-6	Plasma clusterin levels	
PCPG	cis	1	rs12477202	chr2:108867112	SULT1C2	chr2:108905095-108926370:+	0.57	5.65	7.55E-8	Blood pressure	
PCPG	cis	1	rs12483517	chr21:42691920	FAM3B	chr21:42676177-42729654:+	0.56	5.74	4.9E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PCPG	cis	1	rs12487542	chr3:48426076	TREX1	chr3:48501186-48509043:+	-0.28	-4.12	6.11E-5	Longevity	
PCPG	cis	1	rs12490835	chr3:134223730	ANAPC13	chr3:134196547-134204865:-	0.36	4.91	2.3E-6	Height	
PCPG	cis	1	rs12561806	chr1:46396776	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.52	1.42E-7	Body mass index	
PCPG	cis	1	rs12564541	chr1:46380237	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.92E-7	Body mass index	
PCPG	cis	1	rs12577464	chr11:43662440	HSD17B12	chr11:43702143-43878160:+	-0.4	-4.64	7.28E-6	Forced vital capacity	
PCPG	cis	1	rs12591751	chr15:50972497	SPPL2A	chr15:50999739-51057910:-	0.33	4.84	3.07E-6	QT interval	
PCPG	cis	1	rs12594061	chr15:66046429	DPP8	chr15:65737999-65810035:-	-0.18	-4.39	2.11E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs12600855	chr17:28279591	EFCAB5	chr17:28256874-28435469:+	0.43	4.28	3.34E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs12600993	chr17:28291222	EFCAB5	chr17:28256874-28435469:+	0.47	4.67	6.64E-6	Coffee consumption (cups per day)	
PCPG	cis	1	rs12615749	chr2:54475885	C2orf73	chr2:54558071-54588714:+	0.55	4.11	6.31E-5	Telomere length	
PCPG	cis	1	rs12616140	chr2:108867728	SULT1C2	chr2:108905095-108926370:+	0.55	5.41	2.41E-7	Blood pressure	
PCPG	cis	1	rs12619369	chr2:242282957	ANO7	chr2:242127924-242164791:+	0.37	4.04	8.44E-5	Prostate cancer	
PCPG	cis	1	rs12620050	chr2:108919798	SULT1C2	chr2:108905095-108926370:+	0.78	7.97	3.34E-13	Lobe size	
PCPG	cis	1	rs12637751	chr3:134266124	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs12639255	chr3:41861738	ULK4	chr3:41288091-42003660:-	0.8	10.9	7.1E-21	Diastolic blood pressure	
PCPG	cis	1	rs12661204	chr6:86678586	SNHG5	chr6:86386726-86388451:-	-0.51	-6.02	1.25E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12663651	chr6:86701655	SNHG5	chr6:86386726-86388451:-	-0.5	-6.33	2.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12663690	chr6:86640162	SNHG5	chr6:86386726-86388451:-	0.51	6.61	6.1E-10	Response to antipsychotic treatment	
PCPG	cis	1	rs12664335	chr6:86597774	SNHG5	chr6:86386726-86388451:-	0.48	6.09	8.69E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs12665321	chr6:86769289	SNHG5	chr6:86386726-86388451:-	-0.49	-5.88	2.43E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs12671584	chr7:23915422	C7orf46	chr7:23719749-23742268:+	0.44	5.73	5.01E-8	Schizophrenia	
PCPG	cis	1	rs12671624	chr7:23915413	C7orf46	chr7:23719749-23742268:+	0.44	5.73	5.01E-8	Schizophrenia	
PCPG	cis	1	rs12710454	chr21:40656919	PSMG1	chr21:40547390-40555440:-	-0.36	-4.31	2.86E-5	Cognitive function	
PCPG	cis	1	rs12733173	chr1:152173972	FLG	chr1:152274651-152297679:-	0.55	5.84	2.93E-8	Inflammatory skin disease	
PCPG	cis	1	rs1275468	chr12:75935157	GLIPR1L2	chr12:75784889-75825591:+	-0.49	-4.84	3.09E-6	Polycystic ovary syndrome	
PCPG	cis	1	rs12768613	chr10:81916566	PLAC9	chr10:81892258-81904784:+	-0.34	-5.14	8.11E-7	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs12899981	chr15:85302373	WDR73	chr15:85186012-85197524:-	-0.42	-4.12	6.18E-5	Schizophrenia	
PCPG	cis	1	rs12904436	chr15:65720706	DPP8	chr15:65737999-65810035:-	-0.17	-4.15	5.55E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs12905057	chr15:85210765	WDR73	chr15:85186012-85197524:-	-0.46	-4.53	1.18E-5	Schizophrenia	
PCPG	cis	1	rs12906032	chr15:24822388	PWRN1	chr15:24778839-24832924:+	0.45	5.73	5.25E-8	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
PCPG	cis	1	rs12906196	chr15:65884888	DPP8	chr15:65737999-65810035:-	-0.19	-4.47	1.48E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs12906542	chr15:78269472	LOC91450	chr15:78285576-78286567:-	-0.4	-4.54	1.15E-5	Breast cancer	
PCPG	cis	1	rs12908549	chr15:85322351	WDR73	chr15:85186012-85197524:-	-0.41	-4.03	8.8E-5	Schizophrenia	
PCPG	cis	1	rs12910012	chr15:85298662	WDR73	chr15:85186012-85197524:-	-0.42	-4.12	6.18E-5	Schizophrenia	
PCPG	cis	1	rs12911736	chr15:85240008	WDR73	chr15:85186012-85197524:-	-0.45	-4.45	1.66E-5	Schizophrenia	
PCPG	cis	1	rs12913259	chr15:51014716	SPPL2A	chr15:50999739-51057910:-	0.29	4.23	4.05E-5	Fibrinogen levels	
PCPG	cis	1	rs12923297	chr16:31360944	ITGAX	chr16:31366509-31394318:+	0.21	4.34	2.56E-5	IgA nephropathy	
PCPG	cis	1	rs12948099	chr17:79600799	TSPAN10	chr17:79609349-79615778:+	0.61	8.04	2.22E-13	Eye color traits	
PCPG	cis	1	rs13016963	chr2:202162811	ALS2CR12	chr2:202153148-202222101:-	-0.38	-4.36	2.4E-5	Melanoma;Esophageal squamous cell carcinoma	
PCPG	cis	1	rs13038834	chr20:25441433	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.15	5.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs13038834	chr20:25441433	FAM182A	chr20:26035250-26067552:+	-0.51	-6.02	1.24E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs13053175	chr22:37613309	PLA2G6	chr22:38507502-38577836:-	0.35	4.12	6.08E-5	Longevity	
PCPG	cis	1	rs13059720	chr3:134242021	ANAPC13	chr3:134196547-134204865:-	-0.37	-5	1.57E-6	Height	
PCPG	cis	1	rs13067306	chr3:94243713	STX19	chr3:93733215-93747454:-	0.54	5.55	1.22E-7	Blood pressure measurement (high sodium intervention)	
PCPG	cis	1	rs13071337	chr3:48438189	TREX1	chr3:48501186-48509043:+	-0.28	-4.21	4.4E-5	Longevity	
PCPG	cis	1	rs13071551	chr3:134310867	ANAPC13	chr3:134196547-134204865:-	-0.35	-4.81	3.58E-6	Height	
PCPG	cis	1	rs13081177	chr3:134289860	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.85E-6	Height	
PCPG	cis	1	rs13081688	chr3:134259954	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs13087299	chr3:94229344	STX19	chr3:93733215-93747454:-	0.52	5.15	7.93E-7	Blood pressure measurement (high sodium intervention)	
PCPG	cis	1	rs13087578	chr3:121369207	IQCB1	chr3:121488610-121553926:-	0.46	5.48	1.66E-7	Cognitive performance	
PCPG	cis	1	rs13087719	chr3:41951576	ULK4	chr3:41288091-42003660:-	-0.78	-11.39	3.55E-22	Diastolic blood pressure	
PCPG	cis	1	rs13087875	chr3:134261123	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs13089966	chr3:134279197	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs13090969	chr3:134307257	ANAPC13	chr3:134196547-134204865:-	-0.35	-4.81	3.58E-6	Height	
PCPG	cis	1	rs13096604	chr3:134250099	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.95	1.97E-6	Height	
PCPG	cis	1	rs13120847	chr4:48030036	CNGA1	chr4:47937996-48018610:-	0.47	5.53	1.37E-7	Renal underexcretion gout;Gout	
PCPG	cis	1	rs13122400	chr4:39713743	RPL9	chr4:39455747-39460568:-	-0.5	-4.94	2.0E-6	Plasma amyloid beta peptide concentrations (ABx-40)	
PCPG	cis	1	rs13125949	chr4:48026560	CNGA1	chr4:47937996-48018610:-	0.48	5.63	8.5E-8	Renal underexcretion gout;Gout	
PCPG	cis	1	rs13140968	chr4:48025095	CNGA1	chr4:47937996-48018610:-	0.46	5.27	4.57E-7	Renal underexcretion gout;Gout	
PCPG	cis	1	rs13142905	chr4:48025298	CNGA1	chr4:47937996-48018610:-	0.48	5.63	8.5E-8	Renal underexcretion gout;Gout	
PCPG	cis	1	rs13146880	chr4:48031499	CNGA1	chr4:47937996-48018610:-	0.47	5.59	1.02E-7	Renal underexcretion gout;Gout	
PCPG	cis	1	rs131801	chr22:50966634	TYMP	chr22:50964184-50968514:-	0.17	4.34	2.61E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs13194429	chr6:86646705	SNHG5	chr6:86386726-86388451:-	-0.49	-6.11	7.63E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs13195401	chr6:26463574	BTN3A2	chr6:26365398-26378546:+	-0.84	-5.14	8.41E-7	Schizophrenia	
PCPG	cis	1	rs13195402	chr6:26463575	BTN3A2	chr6:26365398-26378546:+	-0.84	-5.14	8.41E-7	Schizophrenia	
PCPG	cis	1	rs13196930	chr6:86652245	SNHG5	chr6:86386726-86388451:-	-0.51	-6.24	3.99E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs13199006	chr6:86608708	SNHG5	chr6:86386726-86388451:-	-0.47	-6.15	6.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs13200462	chr6:28218199	ZNF187	chr6:28234788-28245978:+	-0.35	-4.58	9.44E-6	Depression	
PCPG	cis	1	rs1320996	chr6:56100431	COL21A1	chr6:55921389-56258892:-	0.73	11.65	6.81E-23	Pulse pressure	
PCPG	cis	1	rs13217384	chr6:86720000	SNHG5	chr6:86386726-86388451:-	-0.49	-5.89	2.3E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs13220495	chr6:26441640	BTN3A2	chr6:26365398-26378546:+	-0.84	-5.14	8.41E-7	Schizophrenia	
PCPG	cis	1	rs13244265	chr7:23917903	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs13252719	chr8:71734569	XKR9	chr8:71581600-71648176:+	0.96	17.33	5.17E-38	Bone mineral density	
PCPG	cis	1	rs13253842	chr8:71625503	XKR9	chr8:71581600-71648176:+	0.95	16.95	5.06E-37	Bone mineral density	
PCPG	cis	1	rs13314659	chr3:48449149	TREX1	chr3:48501186-48509043:+	0.28	4.22	4.19E-5	Longevity	
PCPG	cis	1	rs13322305	chr3:134310791	ANAPC13	chr3:134196547-134204865:-	0.35	4.81	3.5E-6	Height	
PCPG	cis	1	rs13325965	chr3:41914942	ULK4	chr3:41288091-42003660:-	0.62	7.21	2.33E-11	Diastolic blood pressure	
PCPG	cis	1	rs13344413	chr19:39143289	LGALS7	chr19:39261608-39264157:-	-0.39	-4.4	2.02E-5	Heart rate	
PCPG	cis	1	rs1337844	chr6:86677273	SNHG5	chr6:86386726-86388451:-	-0.48	-6.03	1.15E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs1337850	chr6:86729103	SNHG5	chr6:86386726-86388451:-	-0.51	-6.34	2.42E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs13378547	chr13:47877760	SUCLA2	chr13:48516792-48612125:-	0.55	4.35	2.49E-5	Cannabis use (initiation)	
PCPG	cis	1	rs13383871	chr2:73631779	ALMS1P	chr2:73872046-73912692:+	0.63	5.87	2.64E-8	Metabolite levels	
PCPG	cis	1	rs13385191	chr2:20888265	C2orf43	chr2:20883803-21022827:-	-0.74	-9.15	3.21E-16	Prostate cancer	
PCPG	cis	1	rs13398075	chr2:202376269	PPIL3	chr2:201735680-201753999:-	0.79	6.61	5.95E-10	Rheumatoid arthritis	
PCPG	cis	1	rs13398956	chr2:73720258	ALMS1P	chr2:73872046-73912692:+	0.59	5.67	6.93E-8	Metabolite levels	
PCPG	cis	1	rs13405728	chr2:48978159	LHCGR	chr2:48913921-48982880:-	0.64	4.8	3.66E-6	Polycystic ovary syndrome	
PCPG	cis	1	rs13408294	chr2:202171573	PPIL3	chr2:201735680-201753999:-	-0.64	-5.91	2.17E-8	Rheumatoid arthritis	
PCPG	cis	1	rs13421462	chr2:73719875	ALMS1P	chr2:73872046-73912692:+	0.6	5.67	6.81E-8	Metabolite levels	
PCPG	cis	1	rs13428235	chr2:73633430	ALMS1P	chr2:73872046-73912692:+	0.65	6.13	7.01E-9	Metabolite levels	
PCPG	cis	1	rs13431267	chr2:73782200	ALMS1P	chr2:73872046-73912692:+	0.61	5.82	3.31E-8	Metabolite levels	
PCPG	cis	1	rs13432605	chr2:73810981	ALMS1P	chr2:73872046-73912692:+	0.61	5.93	1.93E-8	Metabolite levels	
PCPG	cis	1	rs134869	chr22:42652074	CYP2D6	chr22:42522502-42526883:-	-0.34	-4.68	6.37E-6	Cognitive function	
PCPG	cis	1	rs134873	chr22:42657566	CYP2D6	chr22:42522502-42526883:-	-0.33	-4.71	5.53E-6	Cognitive function	
PCPG	cis	1	rs134882	chr22:42670965	CYP2D6	chr22:42522502-42526883:-	-0.36	-5.43	2.14E-7	Cognitive function	
PCPG	cis	1	rs134900	chr22:42683343	CYP2D6	chr22:42522502-42526883:-	-0.37	-5.33	3.39E-7	Cognitive function	
PCPG	cis	1	rs134902	chr22:42683997	CYP2D6	chr22:42522502-42526883:-	-0.34	-4.93	2.14E-6	Cognitive function	
PCPG	cis	1	rs1357762	chr3:134264859	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs1369313	chr15:66084255	DPP8	chr15:65737999-65810035:-	-0.19	-4.65	7.18E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs1371135	chr15:90391270	AP3S2	chr15:90373832-90456222:-	-0.71	-8.2	9.01E-14	Type 2 diabetes	
PCPG	cis	1	rs1395297	chr15:50878509	SPPL2A	chr15:50999739-51057910:-	-0.35	-5.35	3.19E-7	QT interval	
PCPG	cis	1	rs1403284	chr2:73726662	ALMS1P	chr2:73872046-73912692:+	-0.59	-5.5	1.55E-7	Metabolite levels	
PCPG	cis	1	rs1406384	chr11:62083530	ASRGL1	chr11:62104774-62160885:+	0.4	4.48	1.44E-5	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs1406947	chr20:33969530	UQCC	chr20:33890383-33999833:-	0.38	4.78	4.02E-6	Height	
PCPG	cis	1	rs1408916	chr1:92992627	EVI5	chr1:92974255-93257961:-	-0.29	-4.03	8.73E-5	Cholesterol, total	
PCPG	cis	1	rs1409839	chr6:112115355	FYN	chr6:111982487-112194627:-	-0.33	-4.28	3.31E-5	Anger	
PCPG	cis	1	rs1415753	chr6:86753074	SNHG5	chr6:86386726-86388451:-	-0.49	-5.92	2.05E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs1417202	chr13:47896427	SUCLA2	chr13:48516792-48612125:-	0.55	4.31	2.91E-5	Cannabis use (initiation)	
PCPG	cis	1	rs1419183	chr6:28242794	ZNF187	chr6:28234788-28245978:+	-0.33	-4.53	1.19E-5	Depression	
PCPG	cis	1	rs1423620	chr5:56100996	C5orf35	chr5:56205103-56213010:+	0.92	9.43	6.16E-17	Type 2 diabetes	
PCPG	cis	1	rs1423621	chr5:56101035	C5orf35	chr5:56205103-56213010:+	0.87	8.66	5.83E-15	Type 2 diabetes	
PCPG	cis	1	rs144073979	chr22:18886814	DGCR6	chr22:18893541-18899600:+	-0.67	-5.23	5.44E-7	3-hydroxypropylmercapturic acid levels in smokers	
PCPG	cis	1	rs144447022	chr6:29244219	HCG2P7	chr6:29866808-29870429:+	0.75	4.11	6.36E-5	Schizophrenia	
PCPG	cis	1	rs144447022	chr6:29244219	ZFP57	chr6:29640171-29648887:-	1.05	6.15	6.33E-9	Schizophrenia	
PCPG	cis	1	rs1459242	chr3:48413537	TREX1	chr3:48501186-48509043:+	0.29	4.15	5.51E-5	Longevity	
PCPG	cis	1	rs1466211	chr2:108856412	SULT1C2	chr2:108905095-108926370:+	0.57	5.61	9.31E-8	Blood pressure	
PCPG	cis	1	rs1466212	chr2:108856532	SULT1C2	chr2:108905095-108926370:+	0.57	5.58	1.05E-7	Blood pressure	
PCPG	cis	1	rs1466213	chr2:108856607	SULT1C2	chr2:108905095-108926370:+	0.55	5.36	3.01E-7	Blood pressure	
PCPG	cis	1	rs1466389	chr17:2096384	SRR	chr17:2207248-2228553:+	-0.48	-5	1.51E-6	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs1474698	chr6:56064197	COL21A1	chr6:55921389-56258892:-	-0.75	-12.44	4.83E-25	Pulse pressure	
PCPG	cis	1	rs1498718	chr3:134205920	ANAPC13	chr3:134196547-134204865:-	0.33	4.57	9.76E-6	Height	
PCPG	cis	1	rs151964	chr5:96123666	ERAP1	chr5:96096515-96149837:-	-0.31	-4.65	7.06E-6	Ankylosing spondylitis	
PCPG	cis	1	rs151964	chr5:96123666	ERAP2	chr5:96211644-96255398:+	0.44	4.5	1.35E-5	Ankylosing spondylitis	
PCPG	cis	1	rs1533266	chr7:143766714	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.68E-5	Obesity-related traits	
PCPG	cis	1	rs1533267	chr7:143766440	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs1533268	chr7:143766358	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs1534025	chr3:134313304	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.94	2.04E-6	Height	
PCPG	cis	1	rs1534026	chr3:134284767	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.45E-6	Height	
PCPG	cis	1	rs1534471	chr2:73647508	ALMS1P	chr2:73872046-73912692:+	0.63	6.19	5.11E-9	Metabolite levels	
PCPG	cis	1	rs1538803	chr13:47896895	SUCLA2	chr13:48516792-48612125:-	0.55	4.31	2.91E-5	Cannabis use (initiation)	
PCPG	cis	1	rs1540894	chr7:143767676	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.22	4.22E-5	Obesity-related traits	
PCPG	cis	1	rs1540927	chr20:33931344	UQCC	chr20:33890383-33999833:-	0.42	5.41	2.42E-7	Height	
PCPG	cis	1	rs1542173	chr2:215657560	BARD1	chr2:215593275-215674428:-	0.32	4.47	1.49E-5	Neuroblastoma	
PCPG	cis	1	rs1552994	chr1:152171461	FLG	chr1:152274651-152297679:-	0.55	5.84	2.93E-8	Inflammatory skin disease	
PCPG	cis	1	rs1555569	chr17:2149425	SRR	chr17:2207248-2228553:+	-0.59	-6.46	1.31E-9	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs1559282	chr5:56099375	C5orf35	chr5:56205103-56213010:+	0.88	8.92	1.3E-15	Type 2 diabetes	
PCPG	cis	1	rs1563736	chr3:48436794	TREX1	chr3:48501186-48509043:+	-0.28	-4.21	4.4E-5	Longevity	
PCPG	cis	1	rs1564716	chr3:41862613	ULK4	chr3:41288091-42003660:-	0.8	10.9	7.1E-21	Diastolic blood pressure	
PCPG	cis	1	rs15676	chr9:131572027	ENDOG	chr9:131580779-131584954:+	-0.24	-4.15	5.47E-5	Blood metabolite levels	
PCPG	cis	1	rs1570004	chr20:33958253	UQCC	chr20:33890383-33999833:-	0.4	5.09	1.04E-6	Height	
PCPG	cis	1	rs1573897	chr1:247215054	ZNF670	chr1:247200087-247242069:-	-0.45	-6.03	1.14E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs1577917	chr6:86691940	SNHG5	chr6:86386726-86388451:-	-0.52	-6.4	1.8E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs1577919	chr6:86757296	SNHG5	chr6:86386726-86388451:-	-0.49	-5.92	2.05E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs1599932	chr12:58177943	FAM119B	chr12:58166383-58176323:+	0.56	5.26	4.78E-7	Multiple sclerosis	
PCPG	cis	1	rs1599932	chr12:58177943	TSFM	chr12:58176536-58191367:+	-0.62	-7.67	1.83E-12	Multiple sclerosis	
PCPG	cis	1	rs1607908	chr3:41905196	ULK4	chr3:41288091-42003660:-	0.76	10.98	4.54E-21	Diastolic blood pressure	
PCPG	cis	1	rs1609810	chr9:123642351	LOC253039	chr9:123605320-123616644:+	-0.56	-5.45	1.95E-7	Rheumatoid arthritis	
PCPG	cis	1	rs1612124	chr3:41967893	ULK4	chr3:41288091-42003660:-	-0.8	-11.66	6.5E-23	Diastolic blood pressure	
PCPG	cis	1	rs1613759	chr3:41906183	ULK4	chr3:41288091-42003660:-	0.76	10.86	9.25E-21	Diastolic blood pressure	
PCPG	cis	1	rs1615243	chr3:41965234	ULK4	chr3:41288091-42003660:-	-0.78	-11.6	9.07E-23	Diastolic blood pressure	
PCPG	cis	1	rs1615543	chr3:41906404	ULK4	chr3:41288091-42003660:-	0.76	10.86	9.25E-21	Diastolic blood pressure	
PCPG	cis	1	rs1628874	chr3:41955714	ULK4	chr3:41288091-42003660:-	-0.78	-11.6	9.07E-23	Diastolic blood pressure	
PCPG	cis	1	rs1629460	chr3:41927449	ULK4	chr3:41288091-42003660:-	-0.79	-11.1	2.04E-21	Diastolic blood pressure	
PCPG	cis	1	rs1633360	chr12:58108052	FAM119B	chr12:58166383-58176323:+	-0.42	-4.39	2.13E-5	Rheumatoid arthritis	
PCPG	cis	1	rs1633360	chr12:58108052	TSFM	chr12:58176536-58191367:+	0.34	4.3	3.05E-5	Rheumatoid arthritis	
PCPG	cis	1	rs1655841	chr15:65721043	DPP8	chr15:65737999-65810035:-	-0.17	-4.1	6.56E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs1655843	chr15:65721261	DPP8	chr15:65737999-65810035:-	-0.17	-4.1	6.56E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs166870	chr15:80069762	MTHFS	chr15:80137320-80189370:-	0.35	4.29	3.15E-5	Disease-free survival in breast cancer	
PCPG	cis	1	rs1679381	chr12:75946124	GLIPR1L2	chr12:75784889-75825591:+	-0.41	-4.13	5.86E-5	Polycystic ovary syndrome	
PCPG	cis	1	rs1679709	chr6:28228342	ZNF187	chr6:28234788-28245978:+	0.32	4.39	2.1E-5	Depression	
PCPG	cis	1	rs1679732	chr6:28221264	ZNF187	chr6:28234788-28245978:+	0.32	4.39	2.1E-5	Depression	
PCPG	cis	1	rs16826864	chr3:156580033	LEKR1	chr3:156544076-156763918:+	-0.48	-4.24	3.86E-5	Bone mineral density	
PCPG	cis	1	rs16837131	chr2:202173812	PPIL3	chr2:201735680-201753999:-	0.65	5.74	4.83E-8	Rheumatoid arthritis	
PCPG	cis	1	rs16876529	chr6:86591202	SNHG5	chr6:86386726-86388451:-	-0.45	-5.63	8.28E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs16936027	chr11:41884290	LRRC4C	chr11:40135753-41481323:-	-0.25	-4.16	5.35E-5	RR interval (heart rate)	
PCPG	cis	1	rs16952009	chr17:2102437	SRR	chr17:2207248-2228553:+	-0.52	-5.68	6.62E-8	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs17007017	chr4:142142729	ZNF330	chr4:142142049-142155848:+	-0.34	-4.02	9.13E-5	Conduct disorder	
PCPG	cis	1	rs17030613	chr1:113190807	ST7L	chr1:113066142-113162405:-	0.45	4.07	7.41E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs17036023	chr1:117129711	C1orf203	chr1:116935487-116961244:-	0.45	4.8	3.77E-6	Asthma (childhood onset)	
PCPG	cis	1	rs17061431	chr3:41792655	ULK4	chr3:41288091-42003660:-	0.72	10.29	3.18E-19	Diastolic blood pressure	
PCPG	cis	1	rs17062109	chr3:41810364	ULK4	chr3:41288091-42003660:-	0.74	10.91	6.66E-21	Diastolic blood pressure	
PCPG	cis	1	rs17063584	chr3:41861463	ULK4	chr3:41288091-42003660:-	0.79	10.68	2.87E-20	Diastolic blood pressure	
PCPG	cis	1	rs17063599	chr3:41861676	ULK4	chr3:41288091-42003660:-	0.8	10.9	7.1E-21	Diastolic blood pressure	
PCPG	cis	1	rs17063649	chr3:41863406	ULK4	chr3:41288091-42003660:-	0.8	10.9	7.1E-21	Diastolic blood pressure	
PCPG	cis	1	rs17064124	chr3:41890803	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs1707304	chr1:46598269	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.08	9.15E-9	Body mass index	
PCPG	cis	1	rs1707321	chr1:46505309	CCDC163P	chr1:45960581-45965646:-	-0.37	-5.54	1.25E-7	Body mass index	
PCPG	cis	1	rs1707335	chr1:46571921	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.64	7.77E-8	Body mass index	
PCPG	cis	1	rs1707336	chr1:46493460	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.72	5.4E-8	Body mass index	
PCPG	cis	1	rs1707340	chr1:46514942	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.68	6.5E-8	Body mass index	
PCPG	cis	1	rs17096228	chr14:74558669	LIN52	chr14:74551656-74667117:+	0.3	5.68	6.42E-8	Common traits (Other)	
PCPG	cis	1	rs1715218	chr15:65721328	DPP8	chr15:65737999-65810035:-	-0.17	-4.1	6.56E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs17164851	chr7:130003487	CPA5	chr7:129984630-130008571:+	0.62	5.47	1.74E-7	Age-related hearing impairment (interaction)	
PCPG	cis	1	rs1716642	chr3:41965865	ULK4	chr3:41288091-42003660:-	-0.78	-11.6	9.07E-23	Diastolic blood pressure	
PCPG	cis	1	rs1716644	chr3:41968028	ULK4	chr3:41288091-42003660:-	-0.8	-11.66	6.5E-23	Diastolic blood pressure	
PCPG	cis	1	rs1716651	chr3:41975099	ULK4	chr3:41288091-42003660:-	-0.78	-11.6	9.07E-23	Diastolic blood pressure	
PCPG	cis	1	rs1716657	chr3:41918456	ULK4	chr3:41288091-42003660:-	-0.77	-11	3.91E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716660	chr3:41929960	ULK4	chr3:41288091-42003660:-	-0.78	-11.07	2.59E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716661	chr3:41962818	ULK4	chr3:41288091-42003660:-	-0.78	-11.6	9.07E-23	Diastolic blood pressure	
PCPG	cis	1	rs1716664	chr3:41948378	ULK4	chr3:41288091-42003660:-	-0.78	-11.2	1.12E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716668	chr3:41907850	ULK4	chr3:41288091-42003660:-	0.76	10.86	9.25E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716669	chr3:41908681	ULK4	chr3:41288091-42003660:-	0.77	11.08	2.32E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716676	chr3:41903208	ULK4	chr3:41288091-42003660:-	0.76	10.86	9.25E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716683	chr3:41923074	ULK4	chr3:41288091-42003660:-	-0.79	-11.17	1.36E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716685	chr3:41925301	ULK4	chr3:41288091-42003660:-	0.77	10.83	1.15E-20	Diastolic blood pressure	
PCPG	cis	1	rs1716688	chr3:41926546	ULK4	chr3:41288091-42003660:-	-0.79	-11.1	2.04E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716690	chr3:41922102	ULK4	chr3:41288091-42003660:-	-0.79	-11.17	1.36E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716692	chr3:41983786	ULK4	chr3:41288091-42003660:-	-0.78	-11.31	5.76E-22	Diastolic blood pressure	
PCPG	cis	1	rs1716693	chr3:41985600	ULK4	chr3:41288091-42003660:-	-0.78	-11.43	2.66E-22	Diastolic blood pressure	
PCPG	cis	1	rs1716696	chr3:41935811	ULK4	chr3:41288091-42003660:-	-0.78	-11.07	2.59E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716984	chr3:41965532	ULK4	chr3:41288091-42003660:-	-0.78	-11.53	1.46E-22	Diastolic blood pressure	
PCPG	cis	1	rs1716987	chr3:41970516	ULK4	chr3:41288091-42003660:-	-0.8	-11.66	6.5E-23	Diastolic blood pressure	
PCPG	cis	1	rs1716993	chr3:41974556	ULK4	chr3:41288091-42003660:-	-0.8	-11.66	6.5E-23	Diastolic blood pressure	
PCPG	cis	1	rs1716997	chr3:41924333	ULK4	chr3:41288091-42003660:-	-0.79	-11.17	1.36E-21	Diastolic blood pressure	
PCPG	cis	1	rs1716999	chr3:41930041	ULK4	chr3:41288091-42003660:-	-0.78	-11.07	2.59E-21	Diastolic blood pressure	
PCPG	cis	1	rs1717000	chr3:41930219	ULK4	chr3:41288091-42003660:-	-0.77	-10.89	7.53E-21	Diastolic blood pressure	
PCPG	cis	1	rs1717001	chr3:41934949	ULK4	chr3:41288091-42003660:-	-0.78	-10.94	5.64E-21	Diastolic blood pressure	
PCPG	cis	1	rs1717006	chr3:41940448	ULK4	chr3:41288091-42003660:-	0.75	10.64	3.61E-20	Diastolic blood pressure	
PCPG	cis	1	rs1717009	chr3:41946308	ULK4	chr3:41288091-42003660:-	-0.78	-11.33	4.89E-22	Diastolic blood pressure	
PCPG	cis	1	rs1717011	chr3:41980199	ULK4	chr3:41288091-42003660:-	-0.78	-11.6	9.07E-23	Diastolic blood pressure	
PCPG	cis	1	rs1717014	chr3:41917395	ULK4	chr3:41288091-42003660:-	0.77	11	3.91E-21	Diastolic blood pressure	
PCPG	cis	1	rs1717017	chr3:41915616	ULK4	chr3:41288091-42003660:-	0.77	11	3.91E-21	Diastolic blood pressure	
PCPG	cis	1	rs1717020	chr3:41981490	ULK4	chr3:41288091-42003660:-	0.75	11.04	3.13E-21	Diastolic blood pressure	
PCPG	cis	1	rs1717021	chr3:41983860	ULK4	chr3:41288091-42003660:-	-0.78	-11.31	5.76E-22	Diastolic blood pressure	
PCPG	cis	1	rs1717024	chr3:41984888	ULK4	chr3:41288091-42003660:-	-0.72	-10.39	1.71E-19	Diastolic blood pressure	
PCPG	cis	1	rs1717027	chr3:41987920	ULK4	chr3:41288091-42003660:-	-0.78	-11.43	2.66E-22	Diastolic blood pressure	
PCPG	cis	1	rs1717031	chr3:41905791	ULK4	chr3:41288091-42003660:-	0.76	10.86	9.25E-21	Diastolic blood pressure	
PCPG	cis	1	rs1717033	chr3:41910216	ULK4	chr3:41288091-42003660:-	0.77	11.08	2.32E-21	Diastolic blood pressure	
PCPG	cis	1	rs17183295	chr17:31078272	SUZ12	chr17:30264044-30328057:+	-0.36	-4.07	7.46E-5	Refractive error	
PCPG	cis	1	rs17223420	chr12:983720	RAD52	chr12:1021255-1099219:-	-0.44	-4.89	2.46E-6	Colorectal cancer	
PCPG	cis	1	rs17227484	chr11:4793882	NUP98	chr11:3696241-3818892:-	-0.37	-4.3	3.0E-5	Malaria	
PCPG	cis	1	rs17311679	chr19:50521331	SIGLEC16	chr19:50472912-50479075:+	-0.77	-5.1	9.92E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs173334	chr6:88080223	C6orf162	chr6:88032306-88052043:+	-0.49	-5.58	1.06E-7	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs17347505	chr7:23915283	C7orf46	chr7:23719749-23742268:+	0.44	5.73	5.01E-8	Schizophrenia	
PCPG	cis	1	rs17347692	chr7:23918367	C7orf46	chr7:23719749-23742268:+	0.44	5.73	5.02E-8	Schizophrenia	
PCPG	cis	1	rs17347733	chr7:23918510	C7orf46	chr7:23719749-23742268:+	0.45	5.74	4.77E-8	Schizophrenia	
PCPG	cis	1	rs1737947	chr17:18831432	FOXO3B	chr17:18569236-18576494:-	0.37	4.18	4.84E-5	Pancreatic cancer	
PCPG	cis	1	rs17386555	chr2:242371825	ANO7	chr2:242127924-242164791:+	0.39	4.06	7.77E-5	Prostate cancer	
PCPG	cis	1	rs17386695	chr2:242379751	ANO7	chr2:242127924-242164791:+	-0.39	-4.06	7.71E-5	Prostate cancer	
PCPG	cis	1	rs17433780	chr1:89474818	GBP3	chr1:89472367-89488549:-	0.64	12.16	2.91E-24	Carotid intima media thickness	
PCPG	cis	1	rs17596617	chr11:43690717	HSD17B12	chr11:43702143-43878160:+	-0.5	-6.51	1.01E-9	Forced vital capacity	
PCPG	cis	1	rs17600551	chr15:85319258	WDR73	chr15:85186012-85197524:-	-0.41	-4.03	8.8E-5	Schizophrenia	
PCPG	cis	1	rs17605685	chr19:50486741	SIGLEC16	chr19:50472912-50479075:+	0.75	4.95	1.89E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs17608059	chr17:13910549	CDRT15P	chr17:13927815-13928915:+	-0.41	-4.41	1.94E-5	Temperament	
PCPG	cis	1	rs17645523	chr15:50882645	SPPL2A	chr15:50999739-51057910:-	0.36	5.31	3.82E-7	QT interval	
PCPG	cis	1	rs17645649	chr15:50900370	SPPL2A	chr15:50999739-51057910:-	0.32	4.61	8.43E-6	QT interval	
PCPG	cis	1	rs17645826	chr15:50950141	SPPL2A	chr15:50999739-51057910:-	0.32	4.6	8.6E-6	QT interval	
PCPG	cis	1	rs17661933	chr19:50534520	SIGLEC16	chr19:50472912-50479075:+	-0.77	-5.1	9.92E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs17671194	chr15:40667539	C15orf23	chr15:40674922-40686488:+	1.08	10.57	5.79E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs17671250	chr15:40673124	C15orf23	chr15:40674922-40686488:+	-0.85	-8.09	1.63E-13	Heschl's gyrus morphology	
PCPG	cis	1	rs1768803	chr1:46546208	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.91	2.14E-8	Body mass index	
PCPG	cis	1	rs17691170	chr3:121357626	IQCB1	chr3:121488610-121553926:-	0.48	5.69	6.21E-8	Cognitive performance	
PCPG	cis	1	rs17694011	chr3:134213981	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs1775148	chr1:205757824	RAB7L1	chr1:205737115-205744610:-	0.35	4.88	2.63E-6	Prostate cancer	
PCPG	cis	1	rs1775151	chr1:205745684	RAB7L1	chr1:205737115-205744610:-	0.36	4.52	1.21E-5	Parkinson's disease	
PCPG	cis	1	rs17761723	chr17:2107090	SRR	chr17:2207248-2228553:+	0.67	7.59	2.94E-12	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs17761864	chr17:2171637	SRR	chr17:2207248-2228553:+	-0.61	-6.8	2.21E-10	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs1778508	chr6:28229881	ZNF187	chr6:28234788-28245978:+	0.32	4.39	2.1E-5	Depression	
PCPG	cis	1	rs1778511	chr6:28229411	ZNF187	chr6:28234788-28245978:+	0.32	4.39	2.1E-5	Depression	
PCPG	cis	1	rs17809330	chr15:65889250	DPP8	chr15:65737999-65810035:-	0.2	4.69	6.07E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs17834627	chr17:2198892	SRR	chr17:2207248-2228553:+	-0.59	-6.42	1.59E-9	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs17860606	chr6:170099561	WDR27	chr6:169857307-170102159:-	-0.52	-5.57	1.11E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs1795379	chr12:75941042	GLIPR1L2	chr12:75784889-75825591:+	-0.5	-4.96	1.89E-6	Polycystic ovary syndrome	
PCPG	cis	1	rs1814336	chr3:134200823	ANAPC13	chr3:134196547-134204865:-	0.35	4.66	6.83E-6	Height	
PCPG	cis	1	rs1814337	chr3:134200682	ANAPC13	chr3:134196547-134204865:-	0.33	4.46	1.54E-5	Height	
PCPG	cis	1	rs1830074	chr7:6718674	C7orf28B	chr7:6838572-6865861:-	-0.44	-4.03	8.73E-5	Body mass index	
PCPG	cis	1	rs1833896	chr5:56097669	C5orf35	chr5:56205103-56213010:+	0.88	8.92	1.3E-15	Type 2 diabetes	
PCPG	cis	1	rs1857964	chr6:86635994	SNHG5	chr6:86386726-86388451:-	-0.49	-6.12	7.32E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs1857965	chr6:86630776	SNHG5	chr6:86386726-86388451:-	-0.49	-6.23	4.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs1862619	chr5:56098256	C5orf35	chr5:56205103-56213010:+	0.88	8.92	1.3E-15	Type 2 diabetes	
PCPG	cis	1	rs1863913	chr3:134200205	ANAPC13	chr3:134196547-134204865:-	0.33	4.46	1.54E-5	Height	
PCPG	cis	1	rs1868179	chr3:143505568	PAQR9	chr3:142668006-142682178:-	-0.26	-4.13	5.95E-5	Response to angiotensin II receptor blocker therapy	
PCPG	cis	1	rs1875124	chr12:58196802	FAM119B	chr12:58166383-58176323:+	0.56	5.26	4.78E-7	Multiple sclerosis	
PCPG	cis	1	rs1875124	chr12:58196802	TSFM	chr12:58176536-58191367:+	-0.62	-7.67	1.83E-12	Multiple sclerosis	
PCPG	cis	1	rs1880376	chr3:134270347	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs1880377	chr3:134270468	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs1881245	chr2:73649928	ALMS1P	chr2:73872046-73912692:+	0.61	6.12	7.53E-9	Metabolite levels	
PCPG	cis	1	rs1885986	chr17:2203175	SRR	chr17:2207248-2228553:+	-0.58	-6.36	2.14E-9	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs1886242	chr6:35117656	UHRF1BP1	chr6:34759794-34853117:+	0.32	4.6	8.87E-6	Airway responsiveness in chronic obstructive pulmonary disease	
PCPG	cis	1	rs1888997	chr20:25298988	ENTPD6	chr20:25176339-25207360:+	0.34	4.2	4.44E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1888997	chr20:25298988	FAM182A	chr20:26035250-26067552:+	0.5	5.92	2.06E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1888998	chr20:25291826	ENTPD6	chr20:25176339-25207360:+	0.34	4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1888998	chr20:25291826	FAM182A	chr20:26035250-26067552:+	0.55	6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1888999	chr20:25291848	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.03	8.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs1888999	chr20:25291848	FAM182A	chr20:26035250-26067552:+	-0.55	-6.71	3.44E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs189218934	chr15:78903987	CHRNA5	chr15:78857906-78886458:+	-0.33	-4.35	2.49E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs190414	chr5:56116772	C5orf35	chr5:56205103-56213010:+	0.98	9.32	1.15E-16	Type 2 diabetes	
PCPG	cis	1	rs1911552	chr6:86638024	SNHG5	chr6:86386726-86388451:-	-0.47	-6.15	6.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs1911553	chr6:86630892	SNHG5	chr6:86386726-86388451:-	-0.5	-6.31	2.85E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs1917130	chr3:134313773	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.94	2.04E-6	Height	
PCPG	cis	1	rs1919948	chr7:143762843	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs1919949	chr7:143767723	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.08	7.11E-5	Obesity-related traits	
PCPG	cis	1	rs1919950	chr7:143767898	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.09	6.82E-5	Obesity-related traits	
PCPG	cis	1	rs1919951	chr7:143768891	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.07	7.49E-5	Obesity-related traits	
PCPG	cis	1	rs1925148	chr6:56095672	COL21A1	chr6:55921389-56258892:-	0.75	11.9	1.48E-23	Pulse pressure	
PCPG	cis	1	rs1925152	chr6:56102709	COL21A1	chr6:55921389-56258892:-	0.7	10.35	2.13E-19	Pulse pressure	
PCPG	cis	1	rs1930961	chr22:25875265	CRYBB2	chr22:25615612-25627836:+	0.71	6.18	5.54E-9	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs1936365	chr6:28268452	ZNF187	chr6:28234788-28245978:+	0.3	4.4	1.98E-5	Depression	
PCPG	cis	1	rs1936365	chr6:28268452	ZSCAN23	chr6:28393287-28411279:-	-0.24	-4.15	5.52E-5	Depression	
PCPG	cis	1	rs1936812	chr6:127390685	THEMIS	chr6:128029346-128239742:-	0.27	4.07	7.56E-5	Iron status biomarkers	
PCPG	cis	1	rs1936813	chr6:127392421	THEMIS	chr6:128029346-128239742:-	0.27	4.07	7.56E-5	Iron status biomarkers	
PCPG	cis	1	rs1953099	chr1:111290542	ATP5F1	chr1:111991462-112004523:+	-0.34	-4.12	6.08E-5	Acute lymphoblastic leukemia (childhood)	
PCPG	cis	1	rs1953126	chr9:123640500	LOC253039	chr9:123605320-123616644:+	-0.57	-5.47	1.81E-7	Rheumatoid arthritis	
PCPG	cis	1	rs1962716	chr6:86648436	SNHG5	chr6:86386726-86388451:-	-0.55	-6.78	2.46E-10	Response to antipsychotic treatment	
PCPG	cis	1	rs1979	chr6:26377591	BTN3A2	chr6:26365398-26378546:+	-1.02	-8.28	5.59E-14	Schizophrenia	
PCPG	cis	1	rs1986074	chr15:50857452	SPPL2A	chr15:50999739-51057910:-	0.37	5.39	2.57E-7	QT interval	
PCPG	cis	1	rs1994157	chr3:41897482	ULK4	chr3:41288091-42003660:-	0.71	8.51	1.45E-14	Diastolic blood pressure	
PCPG	cis	1	rs1995688	chr6:86632319	SNHG5	chr6:86386726-86388451:-	-0.5	-6.31	2.85E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs1999852	chr6:86705738	SNHG5	chr6:86386726-86388451:-	-0.5	-6.26	3.59E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs2006751	chr11:43670501	HSD17B12	chr11:43702143-43878160:+	-0.43	-5	1.56E-6	Forced vital capacity	
PCPG	cis	1	rs2011064	chr15:50957625	SPPL2A	chr15:50999739-51057910:-	0.32	4.71	5.57E-6	QT interval	
PCPG	cis	1	rs2017962	chr19:22208751	ZNF257	chr19:22235266-22273901:+	0.5	4.88	2.67E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PCPG	cis	1	rs2019097	chr2:202193463	PPIL3	chr2:201735680-201753999:-	-0.61	-5.48	1.67E-7	Rheumatoid arthritis	
PCPG	cis	1	rs2023786	chr7:23915153	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs2023787	chr7:23915140	C7orf46	chr7:23719749-23742268:+	0.44	5.73	5.01E-8	Schizophrenia	
PCPG	cis	1	rs2027003	chr20:25350498	ENTPD6	chr20:25176339-25207360:+	0.33	4.03	8.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2027003	chr20:25350498	FAM182A	chr20:26035250-26067552:+	0.55	6.71	3.44E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2027004	chr20:25350618	ENTPD6	chr20:25176339-25207360:+	0.33	4.03	8.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2027004	chr20:25350618	FAM182A	chr20:26035250-26067552:+	0.55	6.71	3.44E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2031494	chr1:92965969	EVI5	chr1:92974255-93257961:-	-0.3	-4.13	5.87E-5	Cholesterol, total	
PCPG	cis	1	rs2036534	chr15:78826948	CHRNA5	chr15:78857906-78886458:+	0.37	4.72	5.34E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs2038227	chr16:539140	CHTF18	chr16:838622-848072:+	0.25	4.12	6.25E-5	Venous thromboembolism (SNP x SNP interaction)	
PCPG	cis	1	rs2045554	chr3:48494542	TREX1	chr3:48501186-48509043:+	0.28	4.29	3.17E-5	Longevity	
PCPG	cis	1	rs2056486	chr2:73717567	ALMS1P	chr2:73872046-73912692:+	0.6	5.9	2.19E-8	Metabolite levels	
PCPG	cis	1	rs2056603	chr3:134312749	ANAPC13	chr3:134196547-134204865:-	0.36	5.08	1.06E-6	Height	
PCPG	cis	1	rs2056604	chr3:134312648	ANAPC13	chr3:134196547-134204865:-	0.35	4.93	2.07E-6	Height	
PCPG	cis	1	rs2058059	chr7:72311817	TYW1B	chr7:72023729-72298813:-	-0.75	-6.82	1.96E-10	Subcutaneous adipose tissue	
PCPG	cis	1	rs2062340	chr2:54480245	C2orf73	chr2:54558071-54588714:+	0.63	4.57	9.77E-6	Telomere length	
PCPG	cis	1	rs2069502	chr12:58144665	FAM119B	chr12:58166383-58176323:+	-0.57	-5.52	1.4E-7	Multiple sclerosis	
PCPG	cis	1	rs2069502	chr12:58144665	TSFM	chr12:58176536-58191367:+	0.58	7.3	1.42E-11	Multiple sclerosis	
PCPG	cis	1	rs2070180	chr3:121351338	IQCB1	chr3:121488610-121553926:-	-0.43	-5.2	6.39E-7	Cognitive performance	
PCPG	cis	1	rs207145	chr1:55808143	DHCR24	chr1:55315300-55352921:-	0.37	4.14	5.63E-5	Age-related cataracts (age at onset)	
PCPG	cis	1	rs2072052	chr12:58146719	FAM119B	chr12:58166383-58176323:+	0.54	5.15	7.7E-7	Multiple sclerosis	
PCPG	cis	1	rs2072052	chr12:58146719	TSFM	chr12:58176536-58191367:+	-0.6	-7.64	2.11E-12	Multiple sclerosis	
PCPG	cis	1	rs2072293	chr14:74537885	LIN52	chr14:74551656-74667117:+	0.3	5.77	4.33E-8	Common traits (Other)	
PCPG	cis	1	rs2077808	chr1:45988115	CCDC163P	chr1:45960581-45965646:-	-0.6	-9.63	1.84E-17	Homocysteine levels	
PCPG	cis	1	rs2078089	chr19:22209753	ZNF257	chr19:22235266-22273901:+	0.5	4.88	2.67E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PCPG	cis	1	rs2080303	chr2:202165206	ALS2CR12	chr2:202153148-202222101:-	-0.41	-4.53	1.17E-5	Basal cell carcinoma	
PCPG	cis	1	rs2106747	chr7:23911499	C7orf46	chr7:23719749-23742268:+	0.44	5.65	7.42E-8	Schizophrenia	
PCPG	cis	1	rs2106748	chr7:23911313	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs2113078	chr5:56087190	C5orf35	chr5:56205103-56213010:+	0.91	8.34	3.83E-14	Type 2 diabetes	
PCPG	cis	1	rs2113079	chr5:56157951	C5orf35	chr5:56205103-56213010:+	1.05	10.09	1.09E-18	Type 2 diabetes	
PCPG	cis	1	rs2115671	chr15:50956432	SPPL2A	chr15:50999739-51057910:-	0.32	4.82	3.44E-6	QT interval	
PCPG	cis	1	rs2121285	chr2:215656168	BARD1	chr2:215593275-215674428:-	0.32	4.47	1.49E-5	Neuroblastoma	
PCPG	cis	1	rs2123694	chr2:108857505	SULT1C2	chr2:108905095-108926370:+	0.57	5.67	6.8E-8	Blood pressure	
PCPG	cis	1	rs2128834	chr3:41862645	ULK4	chr3:41288091-42003660:-	0.71	10.2	5.63E-19	Diastolic blood pressure	
PCPG	cis	1	rs2128835	chr3:41862873	ULK4	chr3:41288091-42003660:-	0.8	10.9	7.1E-21	Diastolic blood pressure	
PCPG	cis	1	rs2140195	chr2:73702344	ALMS1P	chr2:73872046-73912692:+	0.58	5.75	4.6E-8	Metabolite levels	
PCPG	cis	1	rs2148709	chr6:112121228	FYN	chr6:111982487-112194627:-	-0.32	-4.16	5.31E-5	Anger	
PCPG	cis	1	rs2148710	chr6:112122226	FYN	chr6:111982487-112194627:-	-0.33	-4.32	2.81E-5	Anger	
PCPG	cis	1	rs2154536	chr21:38492147	PIGP	chr21:38437664-38445458:-	-0.38	-4.28	3.3E-5	Eye color traits	
PCPG	cis	1	rs2166663	chr6:86593896	SNHG5	chr6:86386726-86388451:-	-0.45	-5.79	3.74E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs2169748	chr2:28957753	TRMT61B	chr2:29072690-29093175:-	0.46	4.27	3.35E-5	Body mass index	
PCPG	cis	1	rs2169751	chr2:28966758	TRMT61B	chr2:29072690-29093175:-	-0.5	-4.82	3.35E-6	Body mass index	
PCPG	cis	1	rs2174608	chr15:50871993	SPPL2A	chr15:50999739-51057910:-	0.35	5.23	5.52E-7	QT interval	
PCPG	cis	1	rs2175366	chr19:22128279	ZNF257	chr19:22235266-22273901:+	0.51	5.03	1.37E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PCPG	cis	1	rs2177601	chr3:134245434	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.95	1.97E-6	Height	
PCPG	cis	1	rs2182643	chr6:112121096	FYN	chr6:111982487-112194627:-	-0.33	-4.19	4.65E-5	Anger	
PCPG	cis	1	rs2184000	chr20:25395878	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2184000	chr20:25395878	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2198463	chr2:108875093	SULT1C2	chr2:108905095-108926370:+	0.56	5.38	2.7E-7	Blood pressure	
PCPG	cis	1	rs2206734	chr6:20694884	CDKAL1	chr6:20534688-21232632:+	-0.41	-4.21	4.32E-5	Type 2 diabetes	
PCPG	cis	1	rs2227336	chr17:38174855	GSDMA	chr17:38119226-38134019:+	-0.67	-8.35	3.76E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs2236087	chr20:3255905	ITPA	chr20:3190056-3204504:+	-0.3	-4.37	2.27E-5	IFN-related cytopenia	
PCPG	cis	1	rs2236104	chr20:3277602	ITPA	chr20:3190056-3204504:+	-0.3	-4.17	5.04E-5	IFN-related cytopenia	
PCPG	cis	1	rs2236118	chr20:3302058	ITPA	chr20:3190056-3204504:+	-0.3	-4.23	3.98E-5	IFN-related cytopenia	
PCPG	cis	1	rs2236122	chr20:3305240	ITPA	chr20:3190056-3204504:+	-0.29	-4.15	5.48E-5	IFN-related cytopenia	
PCPG	cis	1	rs2236123	chr20:3305305	ITPA	chr20:3190056-3204504:+	0.29	4.13	5.97E-5	IFN-related cytopenia	
PCPG	cis	1	rs2239557	chr14:74551970	LIN52	chr14:74551656-74667117:+	0.3	5.68	6.42E-8	Common traits (Other)	
PCPG	cis	1	rs2241107	chr1:156182710	ETV3	chr1:157094459-157108383:-	0.17	4.11	6.29E-5	Testicular germ cell tumor	
PCPG	cis	1	rs2241108	chr1:156181007	ETV3	chr1:157094459-157108383:-	-0.17	-4.02	8.98E-5	Testicular germ cell tumor	
PCPG	cis	1	rs224329	chr20:34019579	CPNE1	chr20:34213968-34262539:-	-0.3	-4.2	4.52E-5	Height	
PCPG	cis	1	rs224329	chr20:34019579	UQCC	chr20:33890383-33999833:-	-0.41	-5.25	4.9E-7	Height	
PCPG	cis	1	rs224333	chr20:34023962	UQCC	chr20:33890383-33999833:-	-0.43	-5.52	1.4E-7	Height	
PCPG	cis	1	rs2245715	chr15:43818052	ADAL	chr15:43622872-43646094:+	-0.56	-5.54	1.28E-7	Tumor biomarkers	
PCPG	cis	1	rs2247139	chr12:122380274	PSMD9	chr12:122326646-122355770:+	-0.46	-4.31	2.89E-5	Urinary metabolites	
PCPG	cis	1	rs2248393	chr20:33926103	CPNE1	chr20:34213968-34262539:-	-0.31	-4.37	2.31E-5	Height	
PCPG	cis	1	rs2248393	chr20:33926103	UQCC	chr20:33890383-33999833:-	-0.4	-5.08	1.1E-6	Height	
PCPG	cis	1	rs2251844	chr15:43836478	ADAL	chr15:43622872-43646094:+	-0.61	-6.04	1.11E-8	Tumor biomarkers	
PCPG	cis	1	rs2255042	chr15:43834318	ADAL	chr15:43622872-43646094:+	0.62	6.03	1.16E-8	Tumor biomarkers	
PCPG	cis	1	rs2255051	chr15:43846161	ADAL	chr15:43622872-43646094:+	-0.61	-5.97	1.55E-8	Tumor biomarkers	
PCPG	cis	1	rs2255440	chr15:43830467	ADAL	chr15:43622872-43646094:+	-0.61	-6.04	1.11E-8	Tumor biomarkers	
PCPG	cis	1	rs2257420	chr20:25275890	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.28E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257420	chr20:25275890	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.61E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257432	chr20:25271086	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257432	chr20:25271086	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257496	chr20:25279315	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257496	chr20:25279315	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257808	chr20:25266450	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.27	3.34E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257808	chr20:25266450	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.61E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257809	chr20:25266476	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.27	3.34E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257809	chr20:25266476	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.61E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257982	chr20:25269630	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257982	chr20:25269630	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257985	chr20:25269743	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257985	chr20:25269743	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257988	chr20:25270003	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257988	chr20:25270003	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257991	chr20:25270339	ENTPD6	chr20:25176339-25207360:+	0.34	4.29	3.11E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2257991	chr20:25270339	FAM182A	chr20:26035250-26067552:+	0.48	5.82	3.23E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258066	chr20:25271326	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258066	chr20:25271326	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258135	chr20:25272323	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258135	chr20:25272323	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258201	chr20:25272490	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258201	chr20:25272490	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258563	chr20:25273435	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258563	chr20:25273435	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258617	chr20:25274318	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258617	chr20:25274318	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258719	chr20:25275843	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258719	chr20:25275843	FAM182A	chr20:26035250-26067552:+	-0.55	-6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258769	chr20:25276680	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258769	chr20:25276680	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258879	chr20:25279213	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258879	chr20:25279213	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258884	chr20:25279539	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2258884	chr20:25279539	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259837	chr20:25280205	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259837	chr20:25280205	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259873	chr20:25280781	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259873	chr20:25280781	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259926	chr20:25281733	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259926	chr20:25281733	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259928	chr20:25281834	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259928	chr20:25281834	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259956	chr20:25282433	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2259956	chr20:25282433	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2260160	chr15:43895643	ADAL	chr15:43622872-43646094:+	-0.58	-5.63	8.46E-8	Tumor biomarkers	
PCPG	cis	1	rs2262909	chr19:22135270	ZNF257	chr19:22235266-22273901:+	0.51	4.89	2.5E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PCPG	cis	1	rs2272006	chr3:41997059	ULK4	chr3:41288091-42003660:-	-0.78	-11.43	2.66E-22	Diastolic blood pressure	
PCPG	cis	1	rs2272007	chr3:41996136	ULK4	chr3:41288091-42003660:-	-0.78	-11.43	2.66E-22	Diastolic blood pressure	
PCPG	cis	1	rs2272390	chr2:202195311	PPIL3	chr2:201735680-201753999:-	-0.74	-4.89	2.53E-6	Rheumatoid arthritis	
PCPG	cis	1	rs2275426	chr1:46487552	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.53	1.37E-7	Body mass index	
PCPG	cis	1	rs2276547	chr2:28975107	TRMT61B	chr2:29072690-29093175:-	-0.49	-4.56	1.06E-5	Body mass index	
PCPG	cis	1	rs2277862	chr20:34152782	CPNE1	chr20:34213968-34262539:-	-0.62	-7.51	4.56E-12	Cholesterol, total	
PCPG	cis	1	rs2277869	chr12:1016910	RAD52	chr12:1021255-1099219:-	-0.45	-4.92	2.17E-6	Colorectal cancer	
PCPG	cis	1	rs2280141	chr10:124193181	PLEKHA1	chr10:124134220-124191866:+	-0.36	-5.13	8.74E-7	Height	
PCPG	cis	1	rs2287679	chr19:33600764	GPATCH1	chr19:33571786-33621318:+	0.39	5.17	7.12E-7	Bone properties (heel)	
PCPG	cis	1	rs2287680	chr19:33608566	GPATCH1	chr19:33571786-33621318:+	-0.38	-4.98	1.67E-6	Bone properties (heel)	
PCPG	cis	1	rs2291394	chr17:80403894	C17orf62	chr17:80400520-80408694:-	-0.51	-4.55	1.09E-5	Protein quantitative trait loci	
PCPG	cis	1	rs2292174	chr15:50924956	SPPL2A	chr15:50999739-51057910:-	0.33	4.75	4.64E-6	QT interval	
PCPG	cis	1	rs2292239	chr12:56482180	RPS26	chr12:56435686-56438005:+	0.64	7.03	6.14E-11	Cognitive function	
PCPG	cis	1	rs2292626	chr10:124186714	PLEKHA1	chr10:124134220-124191866:+	-0.3	-4.29	3.14E-5	Height	
PCPG	cis	1	rs2297496	chr20:25295787	ENTPD6	chr20:25176339-25207360:+	0.34	4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2297496	chr20:25295787	FAM182A	chr20:26035250-26067552:+	0.48	5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2297497	chr20:25297909	ENTPD6	chr20:25176339-25207360:+	0.32	4.02	9.08E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2297497	chr20:25297909	FAM182A	chr20:26035250-26067552:+	0.5	6.08	9.3E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2306940	chr1:113241052	ST7L	chr1:113066142-113162405:-	0.46	4.28	3.28E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs2324843	chr6:86617501	SNHG5	chr6:86386726-86388451:-	-0.51	-6.24	3.99E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs2351706	chr15:90384115	AP3S2	chr15:90373832-90456222:-	-0.79	-9.39	7.55E-17	Type 2 diabetes	
PCPG	cis	1	rs2351707	chr15:90384045	AP3S2	chr15:90373832-90456222:-	-0.79	-9.5	4.06E-17	Type 2 diabetes	
PCPG	cis	1	rs2356559	chr1:45981512	CCDC163P	chr1:45960581-45965646:-	-0.58	-9.01	7.68E-16	Homocysteine levels	
PCPG	cis	1	rs2356561	chr1:45980862	CCDC163P	chr1:45960581-45965646:-	-0.55	-8.71	4.39E-15	Homocysteine levels	
PCPG	cis	1	rs2358628	chr14:74631757	LIN52	chr14:74551656-74667117:+	-0.3	-5.66	7.18E-8	Common traits (Other)	
PCPG	cis	1	rs2358633	chr14:74647418	LIN52	chr14:74551656-74667117:+	-0.3	-5.56	1.18E-7	Common traits (Other)	
PCPG	cis	1	rs2359821	chr19:22208314	ZNF257	chr19:22235266-22273901:+	0.5	4.88	2.67E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PCPG	cis	1	rs236121	chr20:5972594	MCM8	chr20:5931298-5975829:+	-0.31	-4.25	3.69E-5	HIV-1 viral setpoint	
PCPG	cis	1	rs2362450	chr3:48461313	TREX1	chr3:48501186-48509043:+	-0.26	-4.02	9.1E-5	Longevity	
PCPG	cis	1	rs2362452	chr3:48418214	TREX1	chr3:48501186-48509043:+	0.28	4.31	2.85E-5	Longevity	
PCPG	cis	1	rs2363731	chr2:88521793	THNSL2	chr2:88469835-88486145:+	-0.81	-5.21	6.11E-7	Plasma clusterin levels	
PCPG	cis	1	rs2370578	chr3:134199612	ANAPC13	chr3:134196547-134204865:-	0.33	4.49	1.36E-5	Height	
PCPG	cis	1	rs2370641	chr3:134222161	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs2370642	chr3:134222136	ANAPC13	chr3:134196547-134204865:-	0.36	4.91	2.3E-6	Height	
PCPG	cis	1	rs2371244	chr7:143757611	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.08	7.09E-5	Obesity-related traits	
PCPG	cis	1	rs2371247	chr7:143764179	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs2371248	chr7:143764189	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs2371623	chr3:41761083	ULK4	chr3:41288091-42003660:-	0.72	10.19	5.75E-19	Diastolic blood pressure	
PCPG	cis	1	rs2371627	chr3:41839219	ULK4	chr3:41288091-42003660:-	0.74	10.74	1.98E-20	Diastolic blood pressure	
PCPG	cis	1	rs2373865	chr3:134291556	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.85E-6	Height	
PCPG	cis	1	rs2387880	chr20:25377787	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2387880	chr20:25377787	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2387881	chr20:25378172	ENTPD6	chr20:25176339-25207360:+	0.34	4.29	3.16E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2387881	chr20:25378172	FAM182A	chr20:26035250-26067552:+	0.46	5.53	1.37E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2387884	chr20:25379069	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2387884	chr20:25379069	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2390847	chr7:23911701	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs2391160	chr1:92992797	EVI5	chr1:92974255-93257961:-	-0.29	-4.03	8.73E-5	Cholesterol, total	
PCPG	cis	1	rs2414060	chr15:50873262	SPPL2A	chr15:50999739-51057910:-	0.35	5.23	5.52E-7	QT interval	
PCPG	cis	1	rs2414884	chr15:66075872	DPP8	chr15:65737999-65810035:-	-0.19	-4.65	7.18E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs2414885	chr15:66034624	DPP8	chr15:65737999-65810035:-	-0.19	-4.71	5.48E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs2421016	chr10:124167512	PLEKHA1	chr10:124134220-124191866:+	-0.3	-4.39	2.09E-5	Height	
PCPG	cis	1	rs2421017	chr10:124148167	PLEKHA1	chr10:124134220-124191866:+	-0.34	-4.73	4.95E-6	Height	
PCPG	cis	1	rs2421021	chr10:124157046	PLEKHA1	chr10:124134220-124191866:+	-0.32	-4.47	1.53E-5	Height	
PCPG	cis	1	rs2421555	chr2:73816955	ALMS1P	chr2:73872046-73912692:+	0.59	5.92	1.99E-8	Metabolite levels	
PCPG	cis	1	rs242271	chr6:88082029	C6orf162	chr6:88032306-88052043:+	-0.47	-5.3	3.97E-7	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs2424700	chr20:25266513	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.33E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424700	chr20:25266513	FAM182A	chr20:26035250-26067552:+	-0.48	-5.96	1.62E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424704	chr20:25273929	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424704	chr20:25273929	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424710	chr20:25283886	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.17	5.0E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424710	chr20:25283886	FAM182A	chr20:26035250-26067552:+	-0.5	-5.93	1.88E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424712	chr20:25416942	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424712	chr20:25416942	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424713	chr20:25418482	ENTPD6	chr20:25176339-25207360:+	-0.37	-4.45	1.65E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424713	chr20:25418482	FAM182A	chr20:26035250-26067552:+	-0.52	-6.21	4.82E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424716	chr20:25423538	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.32	2.81E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2424716	chr20:25423538	FAM182A	chr20:26035250-26067552:+	-0.46	-5.57	1.09E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2425065	chr20:33926268	CPNE1	chr20:34213968-34262539:-	-0.3	-4.21	4.39E-5	Height	
PCPG	cis	1	rs2425065	chr20:33926268	UQCC	chr20:33890383-33999833:-	-0.42	-5.41	2.42E-7	Height	
PCPG	cis	1	rs2425066	chr20:33927006	CPNE1	chr20:34213968-34262539:-	-0.3	-4.21	4.31E-5	Height	
PCPG	cis	1	rs2425066	chr20:33927006	UQCC	chr20:33890383-33999833:-	-0.42	-5.42	2.23E-7	Height	
PCPG	cis	1	rs2432195	chr5:56120413	C5orf35	chr5:56205103-56213010:+	0.94	9.22	2.15E-16	Type 2 diabetes	
PCPG	cis	1	rs2447196	chr15:43893818	ADAL	chr15:43622872-43646094:+	0.53	5.27	4.61E-7	Tumor biomarkers	
PCPG	cis	1	rs2447208	chr15:43933895	ADAL	chr15:43622872-43646094:+	-0.51	-5.03	1.37E-6	Tumor biomarkers	
PCPG	cis	1	rs2447211	chr15:43936351	ADAL	chr15:43622872-43646094:+	-0.51	-5	1.57E-6	Tumor biomarkers	
PCPG	cis	1	rs2456009	chr15:65840082	DPP8	chr15:65737999-65810035:-	0.17	4.06	7.82E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs2463505	chr5:9357056	CCT5	chr5:10250282-10266500:+	-0.8	-4.24	3.9E-5	3-hydroxy-1-methylpropylmercapturic acid levels in smokers	
PCPG	cis	1	rs246454	chr5:96123264	ERAP1	chr5:96096515-96149837:-	-0.33	-5	1.54E-6	Ankylosing spondylitis	
PCPG	cis	1	rs246454	chr5:96123264	ERAP2	chr5:96211644-96255398:+	0.42	4.24	3.89E-5	Ankylosing spondylitis	
PCPG	cis	1	rs2470134	chr15:43849886	ADAL	chr15:43622872-43646094:+	0.54	5.19	6.63E-7	Tumor biomarkers	
PCPG	cis	1	rs2474777	chr20:25272633	FAM182A	chr20:26035250-26067552:+	-0.39	-4.74	4.89E-6	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482911	chr20:25395528	ENTPD6	chr20:25176339-25207360:+	0.35	4.21	4.28E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482911	chr20:25395528	FAM182A	chr20:26035250-26067552:+	0.49	5.79	3.8E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482919	chr20:25299756	ENTPD6	chr20:25176339-25207360:+	0.34	4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482919	chr20:25299756	FAM182A	chr20:26035250-26067552:+	0.55	6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482927	chr20:25327151	ENTPD6	chr20:25176339-25207360:+	0.33	4.03	8.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482927	chr20:25327151	FAM182A	chr20:26035250-26067552:+	0.55	6.71	3.44E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482928	chr20:25331530	ENTPD6	chr20:25176339-25207360:+	0.33	4.1	6.79E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482928	chr20:25331530	FAM182A	chr20:26035250-26067552:+	0.51	6.06	1.0E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482930	chr20:25334115	ENTPD6	chr20:25176339-25207360:+	0.34	4.2	4.44E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482930	chr20:25334115	FAM182A	chr20:26035250-26067552:+	0.5	5.92	2.06E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482931	chr20:25334445	ENTPD6	chr20:25176339-25207360:+	0.34	4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482931	chr20:25334445	FAM182A	chr20:26035250-26067552:+	0.55	6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482937	chr20:25340786	ENTPD6	chr20:25176339-25207360:+	0.33	4.1	6.79E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482937	chr20:25340786	FAM182A	chr20:26035250-26067552:+	0.51	6.06	1.0E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482940	chr20:25349830	ENTPD6	chr20:25176339-25207360:+	0.33	4.03	8.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482940	chr20:25349830	FAM182A	chr20:26035250-26067552:+	0.55	6.71	3.44E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482941	chr20:25361216	ENTPD6	chr20:25176339-25207360:+	0.34	4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482941	chr20:25361216	FAM182A	chr20:26035250-26067552:+	0.55	6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482943	chr20:25380593	ENTPD6	chr20:25176339-25207360:+	0.37	4.39	2.09E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2482943	chr20:25380593	FAM182A	chr20:26035250-26067552:+	0.52	6.11	7.81E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2486447	chr1:46545724	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.68	6.69E-8	Body mass index	
PCPG	cis	1	rs2500404	chr20:25359758	ENTPD6	chr20:25176339-25207360:+	0.34	4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500404	chr20:25359758	FAM182A	chr20:26035250-26067552:+	0.55	6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500405	chr20:25360826	ENTPD6	chr20:25176339-25207360:+	0.34	4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500405	chr20:25360826	FAM182A	chr20:26035250-26067552:+	0.55	6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500418	chr20:25382268	ENTPD6	chr20:25176339-25207360:+	0.35	4.16	5.22E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500418	chr20:25382268	FAM182A	chr20:26035250-26067552:+	0.54	6.44	1.47E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500424	chr20:25391969	ENTPD6	chr20:25176339-25207360:+	0.35	4.16	5.22E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500424	chr20:25391969	FAM182A	chr20:26035250-26067552:+	0.54	6.44	1.47E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500432	chr20:25290512	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.09	6.8E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500432	chr20:25290512	FAM182A	chr20:26035250-26067552:+	-0.49	-5.82	3.35E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500436	chr20:25406366	ENTPD6	chr20:25176339-25207360:+	0.37	4.52	1.22E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500436	chr20:25406366	FAM182A	chr20:26035250-26067552:+	0.47	5.51	1.49E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500443	chr20:25331442	ENTPD6	chr20:25176339-25207360:+	0.33	4.1	6.79E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500443	chr20:25331442	FAM182A	chr20:26035250-26067552:+	0.51	6.06	1.0E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500446	chr20:25339664	ENTPD6	chr20:25176339-25207360:+	0.33	4.1	6.79E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500446	chr20:25339664	FAM182A	chr20:26035250-26067552:+	0.51	6.06	1.0E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500448	chr20:25404027	ENTPD6	chr20:25176339-25207360:+	0.35	4.16	5.22E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2500448	chr20:25404027	FAM182A	chr20:26035250-26067552:+	0.54	6.44	1.47E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2502610	chr6:158524591	SERAC1	chr6:158530536-158589312:-	-0.57	-4.41	1.93E-5	Smoking quantity	
PCPG	cis	1	rs2510340	chr18:21142438	NPC1	chr18:21108363-21166581:-	0.3	4.61	8.31E-6	Body mass index	
PCPG	cis	1	rs2524005	chr6:29899677	HCG4	chr6:29758809-29760850:-	-0.6	-5.71	5.6E-8	Bipolar disorder and schizophrenia	
PCPG	cis	1	rs2524005	chr6:29899677	ZFP57	chr6:29640171-29648887:-	0.54	4.85	2.93E-6	Bipolar disorder and schizophrenia	
PCPG	cis	1	rs252887	chr5:56166188	C5orf35	chr5:56205103-56213010:+	1.09	10.42	1.43E-19	Type 2 diabetes	
PCPG	cis	1	rs252898	chr5:56188931	C5orf35	chr5:56205103-56213010:+	1.05	10.6	4.57E-20	Type 2 diabetes	
PCPG	cis	1	rs252902	chr5:56116085	C5orf35	chr5:56205103-56213010:+	1.02	9.83	5.15E-18	Type 2 diabetes	
PCPG	cis	1	rs252904	chr5:56118733	C5orf35	chr5:56205103-56213010:+	0.94	8.48	1.71E-14	Type 2 diabetes	
PCPG	cis	1	rs252909	chr5:56121131	C5orf35	chr5:56205103-56213010:+	0.97	9.01	7.58E-16	Type 2 diabetes	
PCPG	cis	1	rs252910	chr5:56192983	C5orf35	chr5:56205103-56213010:+	1.1	10.64	3.71E-20	Type 2 diabetes	
PCPG	cis	1	rs252915	chr5:56121754	C5orf35	chr5:56205103-56213010:+	-0.99	-9.3	1.34E-16	Type 2 diabetes	
PCPG	cis	1	rs252916	chr5:56121788	C5orf35	chr5:56205103-56213010:+	0.94	9.22	2.15E-16	Type 2 diabetes	
PCPG	cis	1	rs252919	chr5:56124111	C5orf35	chr5:56205103-56213010:+	0.93	8.07	1.91E-13	Type 2 diabetes	
PCPG	cis	1	rs252921	chr5:56137787	C5orf35	chr5:56205103-56213010:+	1.01	10	1.83E-18	Type 2 diabetes	
PCPG	cis	1	rs252922	chr5:56136343	C5orf35	chr5:56205103-56213010:+	0.99	9.65	1.55E-17	Type 2 diabetes	
PCPG	cis	1	rs2540173	chr1:156188214	ETV3	chr1:157094459-157108383:-	-0.18	-4.12	6.13E-5	Testicular germ cell tumor	
PCPG	cis	1	rs2548664	chr5:56133555	C5orf35	chr5:56205103-56213010:+	1.03	9.49	4.08E-17	Type 2 diabetes	
PCPG	cis	1	rs2548665	chr5:56131805	C5orf35	chr5:56205103-56213010:+	1.03	9.49	4.08E-17	Type 2 diabetes	
PCPG	cis	1	rs2614811	chr15:43913487	ADAL	chr15:43622872-43646094:+	-0.5	-4.74	4.75E-6	Tumor biomarkers	
PCPG	cis	1	rs2625667	chr3:41900951	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs2625668	chr3:41905930	ULK4	chr3:41288091-42003660:-	0.76	10.86	9.25E-21	Diastolic blood pressure	
PCPG	cis	1	rs2630	chr15:50849399	SPPL2A	chr15:50999739-51057910:-	0.36	5.21	6.09E-7	QT interval	
PCPG	cis	1	rs2638953	chr12:28534415	CCDC91	chr12:28332210-28703098:+	-0.36	-4.37	2.23E-5	Height	
PCPG	cis	1	rs26510	chr5:96125910	ERAP1	chr5:96096515-96149837:-	-0.33	-5	1.54E-6	Ankylosing spondylitis	
PCPG	cis	1	rs26510	chr5:96125910	ERAP2	chr5:96211644-96255398:+	0.42	4.24	3.89E-5	Ankylosing spondylitis	
PCPG	cis	1	rs2683695	chr3:41914928	ULK4	chr3:41288091-42003660:-	0.77	11.12	1.81E-21	Diastolic blood pressure	
PCPG	cis	1	rs2683696	chr3:41914898	ULK4	chr3:41288091-42003660:-	0.77	11.04	2.98E-21	Diastolic blood pressure	
PCPG	cis	1	rs26965	chr5:112739017	SRP19	chr5:112196993-112228774:+	0.44	4.13	5.89E-5	F-cell distribution	
PCPG	cis	1	rs2705520	chr3:112269287	C3orf17	chr3:112721294-112738555:-	0.31	4.49	1.42E-5	Asthma (childhood onset)	
PCPG	cis	1	rs2727099	chr15:66063428	DPP8	chr15:65737999-65810035:-	-0.19	-4.65	7.18E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs2734839	chr11:113286490	TTC12	chr11:113185251-113244016:+	-0.44	-5.47	1.77E-7	Information processing speed	
PCPG	cis	1	rs2736345	chr8:11352485	TDH	chr8:11197146-11225961:+	0.37	4.04	8.46E-5	Systemic lupus erythematosus	
PCPG	cis	1	rs27529	chr5:96126308	ERAP1	chr5:96096515-96149837:-	-0.31	-4.68	6.19E-6	Ankylosing spondylitis	
PCPG	cis	1	rs27529	chr5:96126308	ERAP2	chr5:96211644-96255398:+	0.42	4.26	3.57E-5	Ankylosing spondylitis	
PCPG	cis	1	rs27710	chr5:96126197	ERAP1	chr5:96096515-96149837:-	0.31	4.73	4.96E-6	Ankylosing spondylitis	
PCPG	cis	1	rs27710	chr5:96126197	ERAP2	chr5:96211644-96255398:+	-0.42	-4.22	4.12E-5	Ankylosing spondylitis	
PCPG	cis	1	rs2799077	chr6:28234597	ZNF187	chr6:28234788-28245978:+	-0.32	-4.39	2.1E-5	Depression	
PCPG	cis	1	rs2799079	chr6:28235176	ZNF187	chr6:28234788-28245978:+	-0.32	-4.52	1.2E-5	Depression	
PCPG	cis	1	rs2812972	chr6:86669880	SNHG5	chr6:86386726-86388451:-	-0.47	-6.12	7.36E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs2816815	chr6:86691656	SNHG5	chr6:86386726-86388451:-	-0.48	-6.28	3.23E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs2816821	chr6:86657084	SNHG5	chr6:86386726-86388451:-	-0.47	-6.12	7.36E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs282802	chr15:80072820	MTHFS	chr15:80137320-80189370:-	0.37	4.73	5.05E-6	Disease-free survival in breast cancer	
PCPG	cis	1	rs282804	chr15:80071108	MTHFS	chr15:80137320-80189370:-	-0.38	-4.77	4.15E-6	Disease-free survival in breast cancer	
PCPG	cis	1	rs2834204	chr21:34737098	IFNGR2	chr21:34775202-34809827:+	-0.45	-5.36	3.04E-7	Cognitive decline (age-related)	
PCPG	cis	1	rs2835607	chr21:38491973	PIGP	chr21:38437664-38445458:-	-0.4	-4.5	1.34E-5	Eye color traits	
PCPG	cis	1	rs2835608	chr21:38493455	PIGP	chr21:38437664-38445458:-	-0.38	-4.28	3.3E-5	Eye color traits	
PCPG	cis	1	rs28360661	chr21:40681972	PSMG1	chr21:40547390-40555440:-	-0.36	-4.44	1.72E-5	Cognitive function	
PCPG	cis	1	rs2836974	chr21:40663181	PSMG1	chr21:40547390-40555440:-	0.32	4.04	8.37E-5	Cognitive function	
PCPG	cis	1	rs2838009	chr21:42694284	FAM3B	chr21:42676177-42729654:+	-0.56	-6.1	8.25E-9	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PCPG	cis	1	rs28380602	chr15:24778146	PWRN1	chr15:24778839-24832924:+	0.45	5.64	7.99E-8	Plasma omega-3 polyunsaturated fatty acid levels (docosahexaenoic acid)	
PCPG	cis	1	rs2839181	chr21:47685939	C21orf57	chr21:47706267-47717664:+	-0.52	-7.38	9.36E-12	Testicular germ cell tumor	
PCPG	cis	1	rs2839186	chr21:47690068	C21orf57	chr21:47706267-47717664:+	-0.58	-8.38	3.11E-14	Testicular germ cell tumor	
PCPG	cis	1	rs28409322	chr3:134252385	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.95	1.97E-6	Height	
PCPG	cis	1	rs28416696	chr2:54484326	C2orf73	chr2:54558071-54588714:+	0.58	4.43	1.81E-5	Telomere length	
PCPG	cis	1	rs28437878	chr15:78807872	CHRNA5	chr15:78857906-78886458:+	0.37	4.66	6.89E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs28444423	chr15:65982141	DPP8	chr15:65737999-65810035:-	-0.19	-4.71	5.38E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs28485881	chr17:80690014	FN3KRP	chr17:80674582-80685889:+	-0.51	-5.09	1.03E-6	Glycated hemoglobin levels	
PCPG	cis	1	rs28494067	chr15:50908272	SPPL2A	chr15:50999739-51057910:-	0.34	4.88	2.6E-6	QT interval	
PCPG	cis	1	rs28510818	chr5:176982662	HK3	chr5:176307871-176326333:-	-0.58	-4.56	1.06E-5	Alzheimer disease and age of onset	
PCPG	cis	1	rs28556680	chr15:66023799	DPP8	chr15:65737999-65810035:-	-0.19	-4.69	5.86E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs2856	chr20:25433536	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2856	chr20:25433536	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs2862961	chr11:43656535	HSD17B12	chr11:43702143-43878160:+	0.39	4.53	1.19E-5	Forced vital capacity	
PCPG	cis	1	rs2862963	chr11:43640115	HSD17B12	chr11:43702143-43878160:+	0.45	5.55	1.24E-7	Forced vital capacity	
PCPG	cis	1	rs2862996	chr11:43653833	HSD17B12	chr11:43702143-43878160:+	-0.44	-5.41	2.32E-7	Forced vital capacity	
PCPG	cis	1	rs28640237	chr15:66070962	DPP8	chr15:65737999-65810035:-	-0.19	-4.65	7.1E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs28661978	chr3:156579739	LEKR1	chr3:156544076-156763918:+	-0.48	-4.3	3.02E-5	Bone mineral density	
PCPG	cis	1	rs28702390	chr3:41889920	ULK4	chr3:41288091-42003660:-	0.71	8.51	1.45E-14	Diastolic blood pressure	
PCPG	cis	1	rs28718130	chr15:50909489	SPPL2A	chr15:50999739-51057910:-	0.34	4.88	2.6E-6	QT interval	
PCPG	cis	1	rs28733681	chr3:41863444	ULK4	chr3:41288091-42003660:-	0.8	10.56	6.05E-20	Diastolic blood pressure	
PCPG	cis	1	rs2874490	chr3:156635513	LEKR1	chr3:156544076-156763918:+	-0.5	-4.67	6.41E-6	Bone mineral density	
PCPG	cis	1	rs2874491	chr3:156649111	LEKR1	chr3:156544076-156763918:+	-0.55	-5.18	6.88E-7	Bone mineral density	
PCPG	cis	1	rs28755797	chr3:41774446	ULK4	chr3:41288091-42003660:-	0.61	7.22	2.24E-11	Diastolic blood pressure	
PCPG	cis	1	rs2881040	chr6:112114308	FYN	chr6:111982487-112194627:-	-0.35	-4.45	1.62E-5	Anger	
PCPG	cis	1	rs28817917	chr15:50965846	SPPL2A	chr15:50999739-51057910:-	0.33	4.84	3.07E-6	QT interval	
PCPG	cis	1	rs28824259	chr3:48425675	TREX1	chr3:48501186-48509043:+	-0.28	-4.12	6.11E-5	Longevity	
PCPG	cis	1	rs2885510	chr3:48418226	TREX1	chr3:48501186-48509043:+	0.29	4.26	3.55E-5	Longevity	
PCPG	cis	1	rs2887797	chr3:134202506	ANAPC13	chr3:134196547-134204865:-	0.35	4.66	6.83E-6	Height	
PCPG	cis	1	rs2899462	chr15:50939254	SPPL2A	chr15:50999739-51057910:-	0.3	4.27	3.35E-5	QT interval	
PCPG	cis	1	rs2901438	chr2:73665656	ALMS1P	chr2:73872046-73912692:+	0.6	5.98	1.5E-8	Metabolite levels	
PCPG	cis	1	rs2920293	chr8:143765414	LY6K	chr8:143781529-143785582:+	0.34	4.02	9.15E-5	Gastric adenocarcinoma (histologically verified);Non-cardia gastric cancer;Gastric cancer;Duodenal ulcer;Bladder cancer	
PCPG	cis	1	rs2920781	chr15:43924682	ADAL	chr15:43622872-43646094:+	-0.51	-4.93	2.07E-6	Tumor biomarkers	
PCPG	cis	1	rs2927072	chr15:43922398	ADAL	chr15:43622872-43646094:+	-0.51	-4.93	2.07E-6	Tumor biomarkers	
PCPG	cis	1	rs2935183	chr17:45607572	C17orf57	chr17:45401142-45518675:+	-0.4	-4.6	8.63E-6	Multiple sclerosis or amyotrophic lateral sclerosis	
PCPG	cis	1	rs2951353	chr7:143761116	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs2951354	chr7:143761001	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs2951360	chr7:143757349	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.15	5.39E-5	Obesity-related traits	
PCPG	cis	1	rs2961117	chr7:143755253	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.24	3.88E-5	Obesity-related traits	
PCPG	cis	1	rs2961120	chr7:143756585	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.04	8.32E-5	Obesity-related traits	
PCPG	cis	1	rs2961125	chr7:143761770	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs2961126	chr7:143762736	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs2961128	chr7:143763483	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.19	4.64E-5	Obesity-related traits	
PCPG	cis	1	rs2961132	chr7:143768128	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.09	6.82E-5	Obesity-related traits	
PCPG	cis	1	rs2961134	chr7:143771062	ARHGEF35	chr7:143883677-143892736:-	-0.37	-4.47	1.49E-5	Obesity-related traits	
PCPG	cis	1	rs2977993	chr9:131608786	ENDOG	chr9:131580779-131584954:+	0.24	4.2	4.44E-5	Schizophrenia	
PCPG	cis	1	rs2993259	chr1:46001550	CCDC163P	chr1:45960581-45965646:-	-0.54	-8.52	1.39E-14	Homocysteine levels	
PCPG	cis	1	rs3002702	chr20:25268920	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs3002702	chr20:25268920	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs30187	chr5:96124330	ERAP1	chr5:96096515-96149837:-	-0.33	-5	1.54E-6	Ankylosing spondylitis	
PCPG	cis	1	rs30187	chr5:96124330	ERAP2	chr5:96211644-96255398:+	0.42	4.24	3.89E-5	Ankylosing spondylitis	
PCPG	cis	1	rs30378	chr5:96121994	ERAP1	chr5:96096515-96149837:-	-0.33	-5	1.54E-6	Ankylosing spondylitis	
PCPG	cis	1	rs30378	chr5:96121994	ERAP2	chr5:96211644-96255398:+	0.42	4.24	3.89E-5	Ankylosing spondylitis	
PCPG	cis	1	rs30379	chr5:96122260	ERAP1	chr5:96096515-96149837:-	-0.33	-5	1.54E-6	Ankylosing spondylitis	
PCPG	cis	1	rs30379	chr5:96122260	ERAP2	chr5:96211644-96255398:+	0.42	4.24	3.89E-5	Ankylosing spondylitis	
PCPG	cis	1	rs30380	chr5:96122281	ERAP1	chr5:96096515-96149837:-	-0.33	-5	1.54E-6	Ankylosing spondylitis	
PCPG	cis	1	rs30380	chr5:96122281	ERAP2	chr5:96211644-96255398:+	0.42	4.24	3.89E-5	Ankylosing spondylitis	
PCPG	cis	1	rs30731	chr5:66150737	ERBB2IP	chr5:65222384-65376850:+	0.26	4.32	2.83E-5	Epilepsy (generalized)	
PCPG	cis	1	rs308096	chr7:5881748	ZNF815	chr7:5862791-5894066:+	-0.85	-4.66	6.67E-6	IgG glycosylation	
PCPG	cis	1	rs308097	chr7:5880377	ZNF815	chr7:5862791-5894066:+	-0.86	-4.71	5.38E-6	IgG glycosylation	
PCPG	cis	1	rs3099459	chr5:56137170	C5orf35	chr5:56205103-56213010:+	1.03	9.49	4.08E-17	Type 2 diabetes	
PCPG	cis	1	rs3101443	chr15:43912372	ADAL	chr15:43622872-43646094:+	-0.5	-4.74	4.75E-6	Tumor biomarkers	
PCPG	cis	1	rs3101852	chr15:50848370	SPPL2A	chr15:50999739-51057910:-	-0.37	-5.34	3.27E-7	QT interval	
PCPG	cis	1	rs3101853	chr15:50848382	SPPL2A	chr15:50999739-51057910:-	-0.35	-5.05	1.26E-6	QT interval	
PCPG	cis	1	rs3101855	chr15:50859874	SPPL2A	chr15:50999739-51057910:-	0.37	5.34	3.27E-7	QT interval	
PCPG	cis	1	rs3105590	chr15:50864145	SPPL2A	chr15:50999739-51057910:-	0.36	5.29	4.1E-7	QT interval	
PCPG	cis	1	rs3105591	chr15:50869042	SPPL2A	chr15:50999739-51057910:-	0.37	5.4	2.46E-7	QT interval	
PCPG	cis	1	rs3105593	chr15:50845018	SPPL2A	chr15:50999739-51057910:-	0.3	4.28	3.33E-5	QT interval	
PCPG	cis	1	rs3109878	chr15:50836243	SPPL2A	chr15:50999739-51057910:-	0.3	4.29	3.16E-5	QT interval	
PCPG	cis	1	rs3109879	chr15:50837618	SPPL2A	chr15:50999739-51057910:-	0.36	5.23	5.44E-7	QT interval	
PCPG	cis	1	rs3109880	chr15:50837812	SPPL2A	chr15:50999739-51057910:-	0.36	5.23	5.44E-7	QT interval	
PCPG	cis	1	rs3109881	chr15:50839272	SPPL2A	chr15:50999739-51057910:-	0.36	5.23	5.44E-7	QT interval	
PCPG	cis	1	rs3109888	chr15:50860694	SPPL2A	chr15:50999739-51057910:-	0.37	5.34	3.27E-7	QT interval	
PCPG	cis	1	rs3109892	chr15:50877011	SPPL2A	chr15:50999739-51057910:-	0.35	5.23	5.52E-7	QT interval	
PCPG	cis	1	rs3109894	chr15:50878574	SPPL2A	chr15:50999739-51057910:-	0.37	5.46	1.89E-7	QT interval	
PCPG	cis	1	rs3109895	chr15:50880560	SPPL2A	chr15:50999739-51057910:-	0.36	5.34	3.32E-7	QT interval	
PCPG	cis	1	rs3131573	chr15:50869601	SPPL2A	chr15:50999739-51057910:-	0.35	5.12	8.86E-7	QT interval	
PCPG	cis	1	rs3131577	chr15:50863516	SPPL2A	chr15:50999739-51057910:-	0.37	5.44	2.07E-7	QT interval	
PCPG	cis	1	rs3131578	chr15:50861470	SPPL2A	chr15:50999739-51057910:-	-0.36	-5.23	5.43E-7	QT interval	
PCPG	cis	1	rs3131580	chr15:50854926	SPPL2A	chr15:50999739-51057910:-	0.37	5.34	3.27E-7	QT interval	
PCPG	cis	1	rs3131582	chr15:50879670	SPPL2A	chr15:50999739-51057910:-	0.34	4.99	1.61E-6	QT interval	
PCPG	cis	1	rs3131584	chr15:50847401	SPPL2A	chr15:50999739-51057910:-	0.36	5.27	4.6E-7	QT interval	
PCPG	cis	1	rs3131585	chr15:50845796	SPPL2A	chr15:50999739-51057910:-	0.36	5.27	4.6E-7	QT interval	
PCPG	cis	1	rs3131586	chr15:50845236	SPPL2A	chr15:50999739-51057910:-	0.38	5.58	1.03E-7	QT interval	
PCPG	cis	1	rs3131587	chr15:50845101	SPPL2A	chr15:50999739-51057910:-	0.36	5.19	6.59E-7	QT interval	
PCPG	cis	1	rs3131589	chr15:50841053	SPPL2A	chr15:50999739-51057910:-	0.36	5.08	1.06E-6	QT interval	
PCPG	cis	1	rs3131590	chr15:50840955	SPPL2A	chr15:50999739-51057910:-	0.37	5.22	5.82E-7	QT interval	
PCPG	cis	1	rs3131596	chr15:50877575	SPPL2A	chr15:50999739-51057910:-	0.33	4.76	4.41E-6	QT interval	
PCPG	cis	1	rs315135	chr12:69762987	YEATS4	chr12:69753532-69784575:+	0.71	4.65	7.21E-6	Response to diuretic therapy	
PCPG	cis	1	rs3213762	chr17:38178627	GSDMA	chr17:38119226-38134019:+	-0.68	-8.51	1.42E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs3214041	chr3:48454468	TREX1	chr3:48501186-48509043:+	-0.28	-4.17	5.06E-5	Longevity	
PCPG	cis	1	rs321622	chr4:48024380	CNGA1	chr4:47937996-48018610:-	0.47	5.28	4.39E-7	Renal underexcretion gout;Gout	
PCPG	cis	1	rs33322	chr5:56175226	C5orf35	chr5:56205103-56213010:+	1.09	10.55	6.23E-20	Type 2 diabetes	
PCPG	cis	1	rs33325	chr5:56142547	C5orf35	chr5:56205103-56213010:+	1.01	10	1.83E-18	Type 2 diabetes	
PCPG	cis	1	rs33326	chr5:56142601	C5orf35	chr5:56205103-56213010:+	1.05	9.86	4.35E-18	Type 2 diabetes	
PCPG	cis	1	rs335472	chr5:176984163	HK3	chr5:176307871-176326333:-	0.51	4.13	5.83E-5	Alzheimer disease and age of onset	
PCPG	cis	1	rs34086988	chr3:121352745	IQCB1	chr3:121488610-121553926:-	0.47	5.56	1.15E-7	Cognitive performance	
PCPG	cis	1	rs34088794	chr15:40665420	C15orf23	chr15:40674922-40686488:+	1.08	10.55	6.29E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs34102169	chr1:46424864	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.7	5.81E-8	Body mass index	
PCPG	cis	1	rs34106666	chr6:86676258	SNHG5	chr6:86386726-86388451:-	-0.48	-6.03	1.15E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs34138960	chr15:78831668	CHRNA5	chr15:78857906-78886458:+	0.36	4.47	1.51E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs34281561	chr6:86701872	SNHG5	chr6:86386726-86388451:-	-0.49	-6.19	5.12E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs344081	chr3:156555984	LEKR1	chr3:156544076-156763918:+	-0.51	-5.31	3.83E-7	Bone mineral density	
PCPG	cis	1	rs344088	chr3:156561361	LEKR1	chr3:156544076-156763918:+	-0.5	-4.94	2.03E-6	Bone mineral density	
PCPG	cis	1	rs344090	chr3:156563140	LEKR1	chr3:156544076-156763918:+	-0.5	-4.94	2.03E-6	Bone mineral density	
PCPG	cis	1	rs34428306	chr1:152184316	FLG	chr1:152274651-152297679:-	0.59	5.98	1.52E-8	Inflammatory skin disease	
PCPG	cis	1	rs34581302	chr6:86705948	SNHG5	chr6:86386726-86388451:-	-0.49	-6.19	5.12E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs34622557	chr6:86630852	SNHG5	chr6:86386726-86388451:-	-0.5	-6.31	2.85E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs34645895	chr20:25368373	ENTPD6	chr20:25176339-25207360:+	0.32	4.06	7.89E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs34645895	chr20:25368373	FAM182A	chr20:26035250-26067552:+	0.51	6.35	2.33E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs34848593	chr1:113240106	ST7L	chr1:113066142-113162405:-	0.46	4.28	3.28E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs34852683	chr6:86702330	SNHG5	chr6:86386726-86388451:-	-0.5	-6.39	1.92E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs34900908	chr15:85257599	WDR73	chr15:85186012-85197524:-	-0.45	-4.45	1.66E-5	Schizophrenia	
PCPG	cis	1	rs35060985	chr11:43693110	HSD17B12	chr11:43702143-43878160:+	-0.5	-6.07	9.59E-9	Forced vital capacity	
PCPG	cis	1	rs35212593	chr15:78831826	CHRNA5	chr15:78857906-78886458:+	0.36	4.53	1.16E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs352476	chr15:65805389	DPP8	chr15:65737999-65810035:-	0.17	4.09	6.95E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs352479	chr15:65803428	DPP8	chr15:65737999-65810035:-	0.18	4.29	3.11E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs35316992	chr15:85248133	WDR73	chr15:85186012-85197524:-	-0.45	-4.45	1.66E-5	Schizophrenia	
PCPG	cis	1	rs35341640	chr17:18818228	FOXO3B	chr17:18569236-18576494:-	0.36	4.05	8.23E-5	Pancreatic cancer	
PCPG	cis	1	rs35385043	chr6:86648546	SNHG5	chr6:86386726-86388451:-	-0.47	-6.15	6.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs35419329	chr6:86702291	SNHG5	chr6:86386726-86388451:-	-0.49	-6.19	5.12E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs35435780	chr17:79579602	TSPAN10	chr17:79609349-79615778:+	0.62	8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs35524990	chr15:85258203	WDR73	chr15:85186012-85197524:-	-0.45	-4.45	1.66E-5	Schizophrenia	
PCPG	cis	1	rs35602488	chr3:94246319	STX19	chr3:93733215-93747454:-	0.47	4.32	2.82E-5	Blood pressure measurement (high sodium intervention)	
PCPG	cis	1	rs35612982	chr6:20682622	CDKAL1	chr6:20534688-21232632:+	-0.4	-4.2	4.52E-5	Type 2 diabetes	
PCPG	cis	1	rs35718987	chr3:134272783	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs35760725	chr6:86648985	SNHG5	chr6:86386726-86388451:-	-0.47	-6.15	6.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs35761942	chr6:86629504	SNHG5	chr6:86386726-86388451:-	-0.52	-6.31	2.76E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs35797755	chr6:86706554	SNHG5	chr6:86386726-86388451:-	-0.5	-6.26	3.59E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs359031	chr3:8457992	SRGAP3	chr3:9022278-9291311:-	-0.3	-4.12	6.23E-5	Low high density lipoprotein cholesterol levels	
PCPG	cis	1	rs36033486	chr15:85319692	WDR73	chr15:85186012-85197524:-	-0.41	-4.03	8.8E-5	Schizophrenia	
PCPG	cis	1	rs36034439	chr13:36707106	FAM48A	chr13:37583453-37633850:-	-0.57	-4.07	7.58E-5	Post bronchodilator FEV1	
PCPG	cis	1	rs36096931	chr6:86693134	SNHG5	chr6:86386726-86388451:-	-0.5	-6.33	2.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs371674	chr21:42695445	FAM3B	chr21:42676177-42729654:+	0.57	6.03	1.17E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PCPG	cis	1	rs3731714	chr2:202060820	ALS2CR12	chr2:202153148-202222101:-	-0.49	-4.6	8.6E-6	Trans fatty acid levels	
PCPG	cis	1	rs3738848	chr2:73761881	ALMS1P	chr2:73872046-73912692:+	0.6	5.87	2.64E-8	Metabolite levels	
PCPG	cis	1	rs3742500	chr14:24611978	FAM158A	chr14:24608175-24610797:-	-0.28	-4.35	2.42E-5	IgG glycosylation	
PCPG	cis	1	rs3743161	chr15:85430838	WDR73	chr15:85186012-85197524:-	-0.47	-4.04	8.29E-5	Alzheimer's disease (age of onset)	
PCPG	cis	1	rs3743162	chr15:85430969	WDR73	chr15:85186012-85197524:-	-0.47	-4.07	7.55E-5	Alzheimer's disease (age of onset)	
PCPG	cis	1	rs3745937	chr19:42071289	CEACAM21	chr19:42055886-42093196:+	0.62	8.99	8.65E-16	Schizophrenia	
PCPG	cis	1	rs3748656	chr1:113236681	ST7L	chr1:113066142-113162405:-	0.46	4.28	3.28E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs3751913	chr17:80405552	C17orf62	chr17:80400520-80408694:-	-0.47	-4.26	3.52E-5	Protein quantitative trait loci	
PCPG	cis	1	rs3760891	chr19:33599708	GPATCH1	chr19:33571786-33621318:+	0.39	5.17	7.12E-7	Bone properties (heel)	
PCPG	cis	1	rs3761117	chr20:25388070	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs3761117	chr20:25388070	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs3764068	chr13:24042898	C1QTNF9	chr13:24553839-24896665:+	0.8	4.11	6.31E-5	Blood pressure (smoking interaction)	
PCPG	cis	1	rs3768707	chr2:215645135	BARD1	chr2:215593275-215674428:-	-0.28	-4.11	6.35E-5	Neuroblastoma	
PCPG	cis	1	rs3771564	chr2:242355701	ANO7	chr2:242127924-242164791:+	0.39	4.1	6.78E-5	Prostate cancer	
PCPG	cis	1	rs3771570	chr2:242382864	ANO7	chr2:242127924-242164791:+	0.39	4.04	8.43E-5	Prostate cancer	
PCPG	cis	1	rs3772128	chr3:121345094	IQCB1	chr3:121488610-121553926:-	0.45	5.42	2.29E-7	Cognitive performance	
PCPG	cis	1	rs3772130	chr3:121344140	IQCB1	chr3:121488610-121553926:-	0.45	5.42	2.29E-7	Cognitive performance	
PCPG	cis	1	rs3774372	chr3:41877414	ULK4	chr3:41288091-42003660:-	0.75	8.8	2.57E-15	Diastolic blood pressure	
PCPG	cis	1	rs3782130	chr12:58161898	FAM119B	chr12:58166383-58176323:+	0.48	4.5	1.33E-5	Multiple sclerosis	
PCPG	cis	1	rs3782130	chr12:58161898	TSFM	chr12:58176536-58191367:+	-0.58	-7.25	1.94E-11	Multiple sclerosis	
PCPG	cis	1	rs3786835	chr19:39155880	LGALS7	chr19:39261608-39264157:-	-0.35	-4.06	7.73E-5	Heart rate	
PCPG	cis	1	rs3786851	chr19:39215333	LGALS7	chr19:39261608-39264157:-	-0.34	-4.09	6.82E-5	Heart rate	
PCPG	cis	1	rs3786933	chr19:33602881	GPATCH1	chr19:33571786-33621318:+	0.39	5.17	7.12E-7	Bone properties (heel)	
PCPG	cis	1	rs3794695	chr16:72097827	ZFHX3	chr16:72816788-73093237:-	0.43	4.25	3.76E-5	Haptoglobin levels;Cholesterol, total;LDL cholesterol	
PCPG	cis	1	rs3795819	chr1:113234179	ST7L	chr1:113066142-113162405:-	-0.52	-4.82	3.42E-6	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs3803358	chr15:40662773	C15orf23	chr15:40674922-40686488:+	1.11	10.1	1.03E-18	Heschl's gyrus morphology	
PCPG	cis	1	rs3809868	chr17:45750596	C17orf57	chr17:45401142-45518675:+	-0.38	-4.38	2.23E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs3813227	chr2:73651967	ALMS1P	chr2:73872046-73912692:+	-0.58	-5.81	3.43E-8	Metabolite levels	
PCPG	cis	1	rs3816804	chr12:56680745	NAB2	chr12:57482677-57489258:+	-0.5	-4.26	3.54E-5	Height	
PCPG	cis	1	rs3825079	chr12:58203354	FAM119B	chr12:58166383-58176323:+	0.56	5.31	3.72E-7	Multiple sclerosis	
PCPG	cis	1	rs3825079	chr12:58203354	TSFM	chr12:58176536-58191367:+	-0.6	-7.36	1.0E-11	Multiple sclerosis	
PCPG	cis	1	rs3826331	chr17:38150492	GSDMA	chr17:38119226-38134019:+	0.66	7.92	4.46E-13	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs3846055	chr3:134203973	ANAPC13	chr3:134196547-134204865:-	0.35	4.66	6.83E-6	Height	
PCPG	cis	1	rs3846056	chr3:134227292	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs3846926	chr6:56092186	COL21A1	chr6:55921389-56258892:-	0.75	11.89	1.51E-23	Pulse pressure	
PCPG	cis	1	rs3847669	chr12:75949158	GLIPR1L2	chr12:75784889-75825591:+	-0.4	-4.08	7.33E-5	Polycystic ovary syndrome	
PCPG	cis	1	rs3848129	chr15:50892064	SPPL2A	chr15:50999739-51057910:-	0.36	5.34	3.32E-7	QT interval	
PCPG	cis	1	rs3848130	chr15:50892111	SPPL2A	chr15:50999739-51057910:-	0.34	4.99	1.61E-6	QT interval	
PCPG	cis	1	rs3858534	chr12:75947084	GLIPR1L2	chr12:75784889-75825591:+	-0.41	-4.07	7.5E-5	Polycystic ovary syndrome	
PCPG	cis	1	rs3890604	chr3:41760625	ULK4	chr3:41288091-42003660:-	0.68	9.66	1.49E-17	Diastolic blood pressure	
PCPG	cis	1	rs3892630	chr19:33181484	NUDT19	chr19:33182867-33204701:+	0.42	4.51	1.28E-5	Red blood cell traits	
PCPG	cis	1	rs3925074	chr16:31347807	ITGAX	chr16:31366509-31394318:+	0.21	4.43	1.77E-5	IgA nephropathy	
PCPG	cis	1	rs3925075	chr16:31347748	ITGAX	chr16:31366509-31394318:+	-0.22	-4.59	8.98E-6	IgA nephropathy	
PCPG	cis	1	rs3932818	chr3:134206069	ANAPC13	chr3:134196547-134204865:-	0.33	4.57	9.76E-6	Height	
PCPG	cis	1	rs3934103	chr3:41977214	ULK4	chr3:41288091-42003660:-	-0.8	-11.66	6.5E-23	Diastolic blood pressure	
PCPG	cis	1	rs3935543	chr17:79579874	TSPAN10	chr17:79609349-79615778:+	0.62	8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs3960018	chr15:90383307	AP3S2	chr15:90373832-90456222:-	-0.79	-9.39	7.55E-17	Type 2 diabetes	
PCPG	cis	1	rs397119	chr20:25440187	FAM182A	chr20:26035250-26067552:+	-0.46	-5.58	1.04E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs398036	chr20:25439850	FAM182A	chr20:26035250-26067552:+	-0.46	-5.58	1.04E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs3981351	chr10:115515120	CASP7	chr10:115438935-115490662:+	0.44	4.77	4.29E-6	Obesity-related traits	
PCPG	cis	1	rs39841	chr5:96120170	ERAP2	chr5:96211644-96255398:+	0.45	4.38	2.21E-5	Inflammatory skin disease	
PCPG	cis	1	rs401166	chr20:25446308	FAM182A	chr20:26035250-26067552:+	-0.48	-5.87	2.54E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs404394	chr20:25447896	FAM182A	chr20:26035250-26067552:+	-0.48	-5.87	2.54E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs406900	chr6:88085447	C6orf162	chr6:88032306-88052043:+	-0.49	-5.61	8.95E-8	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs4073846	chr1:46462881	CCDC163P	chr1:45960581-45965646:-	0.4	6.03	1.15E-8	Body mass index	
PCPG	cis	1	rs4074170	chr17:28381141	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs4074915	chr17:79579230	TSPAN10	chr17:79609349-79615778:+	-0.62	-8.28	5.52E-14	Eye color traits	
PCPG	cis	1	rs4074916	chr17:79579248	TSPAN10	chr17:79609349-79615778:+	-0.62	-8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs4075623	chr17:28386526	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs41265383	chr6:170068025	WDR27	chr6:169857307-170102159:-	-0.57	-6.26	3.71E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs41266839	chr6:26409890	BTN3A2	chr6:26365398-26378546:+	-0.84	-5.14	8.41E-7	Schizophrenia	
PCPG	cis	1	rs41313321	chr9:131051316	URM1	chr9:131133598-131153015:+	-0.38	-4.16	5.19E-5	Coenzyme Q10 levels	
PCPG	cis	1	rs4134386	chr1:46395089	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.52	1.42E-7	Body mass index	
PCPG	cis	1	rs414013	chr6:88085866	C6orf162	chr6:88032306-88052043:+	-0.49	-5.61	8.95E-8	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs4140574	chr6:56099424	COL21A1	chr6:55921389-56258892:-	0.75	11.43	2.75E-22	Pulse pressure	
PCPG	cis	1	rs4140575	chr6:56099222	COL21A1	chr6:55921389-56258892:-	0.74	11.89	1.5E-23	Pulse pressure	
PCPG	cis	1	rs4146894	chr10:124155381	PLEKHA1	chr10:124134220-124191866:+	-0.32	-4.47	1.53E-5	Height	
PCPG	cis	1	rs4149420	chr2:108913090	SULT1C2	chr2:108905095-108926370:+	0.77	7.56	3.45E-12	Lobe size	
PCPG	cis	1	rs4149423	chr2:108916044	SULT1C2	chr2:108905095-108926370:+	0.83	8.07	1.82E-13	Lobe size	
PCPG	cis	1	rs422424	chr20:25445446	FAM182A	chr20:26035250-26067552:+	-0.48	-5.87	2.54E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs422844	chr20:25445591	FAM182A	chr20:26035250-26067552:+	-0.48	-5.87	2.54E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4237643	chr11:43648368	HSD17B12	chr11:43702143-43878160:+	0.45	5.54	1.28E-7	Forced vital capacity	
PCPG	cis	1	rs4239227	chr17:28389103	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs4263408	chr4:39785276	RPL9	chr4:39455747-39460568:-	-0.57	-5.99	1.41E-8	Plasma amyloid beta peptide concentrations (ABx-40)	
PCPG	cis	1	rs4294134	chr7:135293128	SLC13A4	chr7:135365993-135412933:-	-0.55	-5.17	7.13E-7	Paget's disease	
PCPG	cis	1	rs429657	chr15:65813764	DPP8	chr15:65737999-65810035:-	0.17	4.16	5.21E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs4309773	chr3:134277301	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs4311997	chr10:124179299	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.36	2.33E-5	Height	
PCPG	cis	1	rs431328	chr19:22222236	ZNF257	chr19:22235266-22273901:+	0.51	5.27	4.5E-7	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PCPG	cis	1	rs43184	chr5:56141777	C5orf35	chr5:56205103-56213010:+	1.05	9.87	4.06E-18	Type 2 diabetes	
PCPG	cis	1	rs4323544	chr9:123647377	LOC253039	chr9:123605320-123616644:+	-0.56	-5.43	2.15E-7	Rheumatoid arthritis	
PCPG	cis	1	rs4328498	chr17:28344276	EFCAB5	chr17:28256874-28435469:+	-0.44	-4.33	2.7E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs4334685	chr3:134304335	ANAPC13	chr3:134196547-134204865:-	0.35	4.81	3.5E-6	Height	
PCPG	cis	1	rs4351999	chr15:65992380	DPP8	chr15:65737999-65810035:-	-0.19	-4.71	5.38E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs436039	chr19:22214873	ZNF257	chr19:22235266-22273901:+	0.5	4.88	2.67E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PCPG	cis	1	rs4366668	chr15:65903398	DPP8	chr15:65737999-65810035:-	-0.19	-4.63	7.79E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs4367113	chr3:134287975	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.45E-6	Height	
PCPG	cis	1	rs4368544	chr3:134300014	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.85E-6	Height	
PCPG	cis	1	rs4372836	chr2:28973883	TRMT61B	chr2:29072690-29093175:-	-0.49	-4.8	3.65E-6	Body mass index	
PCPG	cis	1	rs4375281	chr1:92987575	EVI5	chr1:92974255-93257961:-	-0.29	-4.03	8.73E-5	Cholesterol, total	
PCPG	cis	1	rs4375701	chr17:45712218	C17orf57	chr17:45401142-45518675:+	0.39	4.57	9.87E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs4376778	chr1:46288846	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.53	1.34E-7	Body mass index	
PCPG	cis	1	rs439295	chr3:156572455	LEKR1	chr3:156544076-156763918:+	-0.5	-4.94	2.03E-6	Bone mineral density	
PCPG	cis	1	rs4407214	chr2:29118258	TRMT61B	chr2:29072690-29093175:-	0.43	4.09	7.02E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
PCPG	cis	1	rs4408846	chr3:41753679	ULK4	chr3:41288091-42003660:-	0.72	9.66	1.53E-17	Diastolic blood pressure	
PCPG	cis	1	rs4411512	chr16:31347445	ITGAX	chr16:31366509-31394318:+	0.22	4.59	8.98E-6	IgA nephropathy	
PCPG	cis	1	rs4417907	chr3:134291363	ANAPC13	chr3:134196547-134204865:-	0.37	5	1.53E-6	Height	
PCPG	cis	1	rs441810	chr21:42698907	FAM3B	chr21:42676177-42729654:+	0.57	6.03	1.17E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PCPG	cis	1	rs4423809	chr3:134300107	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.85E-6	Height	
PCPG	cis	1	rs4465649	chr17:28394747	EFCAB5	chr17:28256874-28435469:+	-0.43	-4.21	4.24E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs4465650	chr17:28396721	EFCAB5	chr17:28256874-28435469:+	0.45	4.37	2.27E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs447722	chr20:25443510	FAM182A	chr20:26035250-26067552:+	-0.48	-5.87	2.54E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs448396	chr20:25440269	FAM182A	chr20:26035250-26067552:+	-0.48	-5.87	2.54E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs449043	chr21:42700410	FAM3B	chr21:42676177-42729654:+	-0.53	-5.65	7.7E-8	Elevated serum carcinoembryonic antigen levels;Tumor biomarkers	
PCPG	cis	1	rs4498009	chr3:134198008	ANAPC13	chr3:134196547-134204865:-	0.34	4.72	5.33E-6	Height	
PCPG	cis	1	rs4506917	chr16:31347350	ITGAX	chr16:31366509-31394318:+	0.22	4.59	8.98E-6	IgA nephropathy	
PCPG	cis	1	rs4509126	chr6:170068058	WDR27	chr6:169857307-170102159:-	-0.57	-6.26	3.71E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs4509958	chr15:50894175	SPPL2A	chr15:50999739-51057910:-	0.32	4.63	7.58E-6	QT interval	
PCPG	cis	1	rs453329	chr20:25440593	FAM182A	chr20:26035250-26067552:+	-0.49	-5.91	2.1E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs453329	chr20:25440593	FAM182B	chr20:25744102-25848786:-	0.31	4.03	8.62E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4533340	chr17:28277951	EFCAB5	chr17:28256874-28435469:+	0.42	4.09	6.92E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs4535272	chr3:134299916	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.81E-6	Height	
PCPG	cis	1	rs454422	chr20:5943693	MCM8	chr20:5931298-5975829:+	-0.32	-4.21	4.29E-5	HIV-1 viral setpoint	
PCPG	cis	1	rs4545281	chr1:46360054	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.92	2.05E-8	Body mass index	
PCPG	cis	1	rs4549034	chr2:28972579	TRMT61B	chr2:29072690-29093175:-	-0.5	-4.82	3.35E-6	Body mass index	
PCPG	cis	1	rs4560868	chr9:115985499	CDC26	chr9:116029290-116037869:-	0.49	6.48	1.19E-9	Hematology traits	
PCPG	cis	1	rs4572812	chr3:134291177	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.85E-6	Height	
PCPG	cis	1	rs4575590	chr17:28361969	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs4605213	chr17:49244747	NME1-NME2	chr17:49230920-49249104:+	0.34	4.13	6.04E-5	Height	
PCPG	cis	1	rs4606360	chr1:173699007	SERPINC1	chr1:173872943-173886516:-	0.4	4.13	5.95E-5	Subjective well-being	
PCPG	cis	1	rs4640348	chr2:28965479	TRMT61B	chr2:29072690-29093175:-	-0.48	-4.61	8.38E-6	Body mass index	
PCPG	cis	1	rs4643294	chr15:85250253	WDR73	chr15:85186012-85197524:-	-0.45	-4.45	1.66E-5	Schizophrenia	
PCPG	cis	1	rs4646536	chr12:58157988	FAM119B	chr12:58166383-58176323:+	0.51	4.86	2.85E-6	Multiple sclerosis	
PCPG	cis	1	rs4646536	chr12:58157988	TSFM	chr12:58176536-58191367:+	-0.54	-6.55	7.93E-10	Multiple sclerosis	
PCPG	cis	1	rs4660306	chr1:45978675	CCDC163P	chr1:45960581-45965646:-	0.57	9.28	1.48E-16	Homocysteine levels	
PCPG	cis	1	rs4660317	chr1:46326226	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.97E-7	Body mass index	
PCPG	cis	1	rs4660319	chr1:46341623	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.97E-7	Body mass index	
PCPG	cis	1	rs4660321	chr1:46366760	CCDC163P	chr1:45960581-45965646:-	-0.37	-5.29	4.19E-7	Body mass index	
PCPG	cis	1	rs4660898	chr1:46402171	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.55	1.23E-7	Body mass index	
PCPG	cis	1	rs4660910	chr1:46548402	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.91	2.14E-8	Body mass index	
PCPG	cis	1	rs4666118	chr2:28951698	TRMT61B	chr2:29072690-29093175:-	-0.51	-5.07	1.14E-6	Body mass index	
PCPG	cis	1	rs4666119	chr2:28975690	TRMT61B	chr2:29072690-29093175:-	-0.49	-4.73	4.96E-6	Body mass index	
PCPG	cis	1	rs4687552	chr3:52838402	ITIH4	chr3:52847007-52866554:-	0.34	5.02	1.41E-6	Bipolar disorder	
PCPG	cis	1	rs4690909	chr4:159629151	ETFDH	chr4:159593277-159629839:+	-0.37	-4.78	4.09E-6	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PCPG	cis	1	rs469758	chr5:96121715	ERAP1	chr5:96096515-96149837:-	-0.33	-5	1.54E-6	Ankylosing spondylitis	
PCPG	cis	1	rs469758	chr5:96121715	ERAP2	chr5:96211644-96255398:+	0.42	4.24	3.89E-5	Ankylosing spondylitis	
PCPG	cis	1	rs470119	chr22:50966914	TYMP	chr22:50964184-50968514:-	-0.17	-4.2	4.46E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs4706254	chr6:86602813	SNHG5	chr6:86386726-86388451:-	-0.47	-6.13	6.94E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs4707239	chr6:86610717	SNHG5	chr6:86386726-86388451:-	-0.47	-6.15	6.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs4710941	chr6:20694228	CDKAL1	chr6:20534688-21232632:+	-0.43	-4.41	1.92E-5	Type 2 diabetes	
PCPG	cis	1	rs4712120	chr6:56092916	COL21A1	chr6:55921389-56258892:-	0.72	10.75	1.85E-20	Pulse pressure	
PCPG	cis	1	rs4715590	chr6:56060017	COL21A1	chr6:55921389-56258892:-	0.74	11.39	3.39E-22	Pulse pressure	
PCPG	cis	1	rs4716375	chr6:170071218	WDR27	chr6:169857307-170102159:-	-0.57	-6.26	3.71E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs4716378	chr6:170086568	WDR27	chr6:169857307-170102159:-	-0.55	-5.69	6.29E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs4716380	chr6:170090399	WDR27	chr6:169857307-170102159:-	-0.51	-5.47	1.75E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs4722286	chr7:23913624	C7orf46	chr7:23719749-23742268:+	-0.41	-5.26	4.73E-7	Schizophrenia	
PCPG	cis	1	rs4726669	chr7:143758191	ARHGEF35	chr7:143883677-143892736:-	-0.35	-4.08	7.09E-5	Obesity-related traits	
PCPG	cis	1	rs473073	chr10:131429646	MGMT	chr10:131265454-131565783:+	0.37	4.9	2.44E-6	Response to temozolomide	
PCPG	cis	1	rs473771	chr10:131408155	MGMT	chr10:131265454-131565783:+	0.36	4.7	5.68E-6	Response to temozolomide	
PCPG	cis	1	rs4750759	chr10:131436603	MGMT	chr10:131265454-131565783:+	-0.37	-4.88	2.66E-6	Response to temozolomide	
PCPG	cis	1	rs4755726	chr11:43642130	HSD17B12	chr11:43702143-43878160:+	-0.46	-5.71	5.69E-8	Forced vital capacity	
PCPG	cis	1	rs4759229	chr12:56474480	RPS26	chr12:56435686-56438005:+	-0.64	-7.01	7.13E-11	Cognitive function	
PCPG	cis	1	rs4763879	chr12:9910164	CLECL1	chr12:9868457-9885860:-	-0.39	-4.9	2.41E-6	Type 1 diabetes	
PCPG	cis	1	rs4769474	chr13:26731453	CDK8	chr13:26828756-26978569:+	0.3	4.5	1.33E-5	Response to Homoharringtonine (cytotoxicity)	
PCPG	cis	1	rs4769475	chr13:26731714	CDK8	chr13:26828756-26978569:+	0.3	4.5	1.33E-5	Response to Homoharringtonine (cytotoxicity)	
PCPG	cis	1	rs4775893	chr15:50898695	SPPL2A	chr15:50999739-51057910:-	0.35	5.07	1.12E-6	QT interval	
PCPG	cis	1	rs4775897	chr15:50944066	SPPL2A	chr15:50999739-51057910:-	0.33	4.74	4.93E-6	QT interval	
PCPG	cis	1	rs477692	chr10:131426022	MGMT	chr10:131265454-131565783:+	0.39	5.08	1.09E-6	Response to temozolomide	
PCPG	cis	1	rs4789693	chr17:80421870	HEXDC	chr17:80376252-80400515:+	0.32	4.63	7.61E-6	Glucocorticoid-induced osteonecrosis	
PCPG	cis	1	rs4794016	chr17:45725931	C17orf57	chr17:45401142-45518675:+	-0.4	-4.61	8.54E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs4794048	chr17:45763073	C17orf57	chr17:45401142-45518675:+	0.38	4.47	1.49E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs479478	chr10:131428959	MGMT	chr10:131265454-131565783:+	0.36	4.72	5.28E-6	Response to temozolomide	
PCPG	cis	1	rs4794823	chr17:38166265	GSDMA	chr17:38119226-38134019:+	-0.67	-8.35	3.63E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs4794824	chr17:38179290	GSDMA	chr17:38119226-38134019:+	-0.67	-8.26	6.37E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs4795412	chr17:38150604	GSDMA	chr17:38119226-38134019:+	-0.67	-8.15	1.2E-13	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs4795415	chr17:38157995	GSDMA	chr17:38119226-38134019:+	-0.67	-8.22	7.91E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs4795416	chr17:38158133	GSDMA	chr17:38119226-38134019:+	-0.67	-8.22	7.91E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs4795418	chr17:38164851	GSDMA	chr17:38119226-38134019:+	-0.67	-8.35	3.63E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs4795525	chr17:28388487	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs4803480	chr19:42066279	CEACAM21	chr19:42055886-42093196:+	0.59	8.61	8.25E-15	Schizophrenia	
PCPG	cis	1	rs4808801	chr19:18571141	ELL	chr19:18553475-18632937:-	-0.37	-4.13	6.01E-5	Breast cancer	
PCPG	cis	1	rs4813562	chr20:25352588	FAM182A	chr20:26035250-26067552:+	0.52	6.5	1.05E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4813563	chr20:25365340	ENTPD6	chr20:25176339-25207360:+	0.34	4.3	3.04E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4813563	chr20:25365340	FAM182A	chr20:26035250-26067552:+	0.47	5.71	5.57E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4813566	chr20:25386465	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4813566	chr20:25386465	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815404	chr20:25301845	ENTPD6	chr20:25176339-25207360:+	0.34	4.3	3.04E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815404	chr20:25301845	FAM182A	chr20:26035250-26067552:+	0.47	5.71	5.57E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815405	chr20:25317492	ENTPD6	chr20:25176339-25207360:+	0.34	4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815405	chr20:25317492	FAM182A	chr20:26035250-26067552:+	0.48	5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815406	chr20:25341316	FAM182A	chr20:26035250-26067552:+	0.52	6.5	1.05E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815407	chr20:25341478	ENTPD6	chr20:25176339-25207360:+	0.33	4.19	4.63E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815407	chr20:25341478	FAM182A	chr20:26035250-26067552:+	0.48	5.86	2.76E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815408	chr20:25346678	ENTPD6	chr20:25176339-25207360:+	0.34	4.3	3.04E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815408	chr20:25346678	FAM182A	chr20:26035250-26067552:+	0.47	5.71	5.57E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815409	chr20:25346697	ENTPD6	chr20:25176339-25207360:+	0.32	4.06	7.89E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815409	chr20:25346697	FAM182A	chr20:26035250-26067552:+	0.51	6.35	2.33E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815411	chr20:25350223	ENTPD6	chr20:25176339-25207360:+	0.32	4.04	8.27E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815411	chr20:25350223	FAM182A	chr20:26035250-26067552:+	0.52	6.51	9.79E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815412	chr20:25350325	FAM182A	chr20:26035250-26067552:+	-0.52	-6.5	1.05E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815417	chr20:25379526	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815417	chr20:25379526	FAM182A	chr20:26035250-26067552:+	0.51	6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815418	chr20:25382211	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815418	chr20:25382211	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815420	chr20:25383979	FAM182A	chr20:26035250-26067552:+	0.5	6.08	9.2E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815421	chr20:25386509	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815421	chr20:25386509	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815424	chr20:25390284	ENTPD6	chr20:25176339-25207360:+	0.34	4.31	2.85E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815424	chr20:25390284	FAM182A	chr20:26035250-26067552:+	0.46	5.58	1.05E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815426	chr20:25405186	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs4815426	chr20:25405186	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs485576	chr10:131425496	MGMT	chr10:131265454-131565783:+	0.39	5.08	1.09E-6	Response to temozolomide	
PCPG	cis	1	rs4858817	chr3:48416756	TREX1	chr3:48501186-48509043:+	0.27	4.12	6.13E-5	Longevity	
PCPG	cis	1	rs486301	chr15:43836949	ADAL	chr15:43622872-43646094:+	-0.6	-5.84	3.02E-8	Tumor biomarkers	
PCPG	cis	1	rs4869313	chr5:96223880	ERAP2	chr5:96211644-96255398:+	-1.1	-18.31	1.71E-40	Pediatric autoimmune diseases	
PCPG	cis	1	rs4869313	chr5:96223880	LNPEP	chr5:96271346-96365115:+	-0.2	-4.28	3.24E-5	Pediatric autoimmune diseases	
PCPG	cis	1	rs4886018	chr13:52990717	CKAP2	chr13:53029495-53050763:+	-0.46	-7.13	3.73E-11	Lewy body disease	
PCPG	cis	1	rs4903201	chr14:74659690	LIN52	chr14:74551656-74667117:+	-0.32	-5.98	1.48E-8	Common traits (Other)	
PCPG	cis	1	rs4903202	chr14:74660302	LIN52	chr14:74551656-74667117:+	-0.32	-5.98	1.48E-8	Common traits (Other)	
PCPG	cis	1	rs4903203	chr14:74660508	LIN52	chr14:74551656-74667117:+	-0.32	-5.98	1.48E-8	Common traits (Other)	
PCPG	cis	1	rs4911178	chr20:33952620	UQCC	chr20:33890383-33999833:-	0.42	5.4	2.53E-7	Height	
PCPG	cis	1	rs4911180	chr20:33972948	UQCC	chr20:33890383-33999833:-	0.39	4.94	1.99E-6	Height	
PCPG	cis	1	rs4911491	chr20:33947285	UQCC	chr20:33890383-33999833:-	0.42	5.39	2.62E-7	Height	
PCPG	cis	1	rs4911492	chr20:33951799	UQCC	chr20:33890383-33999833:-	0.42	5.4	2.53E-7	Height	
PCPG	cis	1	rs4911494	chr20:33971914	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs4911496	chr20:33972053	CPNE1	chr20:34213968-34262539:-	-0.33	-4.5	1.35E-5	Height	
PCPG	cis	1	rs4911496	chr20:33972053	UQCC	chr20:33890383-33999833:-	-0.48	-6.18	5.4E-9	Height	
PCPG	cis	1	rs4919690	chr10:104616500	AS3MT	chr10:104613967-104661653:+	0.31	5.08	1.08E-6	Arsenic metabolism	
PCPG	cis	1	rs4919690	chr10:104616500	C10orf32	chr10:104613967-104624718:+	0.61	7.62	2.36E-12	Arsenic metabolism	
PCPG	cis	1	rs4924935	chr17:18753870	FOXO3B	chr17:18569236-18576494:-	-0.4	-4.44	1.71E-5	Pancreatic cancer	
PCPG	cis	1	rs4925166	chr17:18210810	LOC220594	chr17:18414577-18445234:-	-0.41	-4.2	4.58E-5	Multiple sclerosis	
PCPG	cis	1	rs4925166	chr17:18210810	SHMT1	chr17:18231195-18266856:-	0.42	6.1	8.35E-9	Multiple sclerosis	
PCPG	cis	1	rs4925540	chr1:247214878	ZNF670	chr1:247200087-247242069:-	-0.45	-5.95	1.75E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs4930726	chr12:124428331	DNAH10	chr12:124247042-124420265:+	0.32	4.06	7.91E-5	Waist-to-hip ratio adjusted for body mass index	
PCPG	cis	1	rs4932148	chr15:90394356	AP3S2	chr15:90373832-90456222:-	-0.7	-7.92	4.48E-13	Type 2 diabetes	
PCPG	cis	1	rs4951261	chr1:205717823	RAB7L1	chr1:205737115-205744610:-	-0.37	-5.02	1.41E-6	Menarche (age at onset)	
PCPG	cis	1	rs4955485	chr3:134295843	ANAPC13	chr3:134196547-134204865:-	0.36	4.86	2.81E-6	Height	
PCPG	cis	1	rs4955555	chr3:134286427	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.45E-6	Height	
PCPG	cis	1	rs4958422	chr5:150186734	LOC134466	chr5:150310000-150326146:-	0.75	4.13	6.04E-5	Crohn's disease	
PCPG	cis	1	rs496584	chr15:43831923	ADAL	chr15:43622872-43646094:+	-0.57	-5.73	5.06E-8	Tumor biomarkers	
PCPG	cis	1	rs4970696	chr1:92968853	EVI5	chr1:92974255-93257961:-	-0.31	-4.12	6.24E-5	Cholesterol, total	
PCPG	cis	1	rs4970709	chr1:92988592	EVI5	chr1:92974255-93257961:-	-0.29	-4.03	8.73E-5	Cholesterol, total	
PCPG	cis	1	rs4970710	chr1:92988717	EVI5	chr1:92974255-93257961:-	-0.29	-4.03	8.73E-5	Cholesterol, total	
PCPG	cis	1	rs4971316	chr1:247210903	ZNF670	chr1:247200087-247242069:-	-0.47	-5.93	1.96E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs4971319	chr1:247211565	ZNF670	chr1:247200087-247242069:-	-0.47	-5.93	1.96E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs4973991	chr3:41927273	ULK4	chr3:41288091-42003660:-	-0.79	-11.1	2.04E-21	Diastolic blood pressure	
PCPG	cis	1	rs4974483	chr3:134219001	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs4974484	chr3:134219019	ANAPC13	chr3:134196547-134204865:-	0.35	4.76	4.46E-6	Height	
PCPG	cis	1	rs4974493	chr3:134219993	ANAPC13	chr3:134196547-134204865:-	0.36	4.91	2.3E-6	Height	
PCPG	cis	1	rs501220	chr6:25873025	BTN3A2	chr6:26365398-26378546:+	-0.51	-4.02	8.99E-5	Homocysteine levels	
PCPG	cis	1	rs503660	chr10:131418999	MGMT	chr10:131265454-131565783:+	0.37	4.84	3.18E-6	Response to temozolomide	
PCPG	cis	1	rs506274	chr10:131409392	MGMT	chr10:131265454-131565783:+	0.35	4.55	1.1E-5	Response to temozolomide	
PCPG	cis	1	rs508303	chr10:131424996	MGMT	chr10:131265454-131565783:+	-0.37	-4.73	5.03E-6	Response to temozolomide	
PCPG	cis	1	rs513736	chr10:131406489	MGMT	chr10:131265454-131565783:+	0.36	4.65	7.13E-6	Response to temozolomide	
PCPG	cis	1	rs516704	chr10:131419879	MGMT	chr10:131265454-131565783:+	0.37	4.83	3.29E-6	Response to temozolomide	
PCPG	cis	1	rs522891	chr10:131430916	MGMT	chr10:131265454-131565783:+	-0.37	-4.9	2.4E-6	Response to temozolomide	
PCPG	cis	1	rs530466	chr10:131427717	MGMT	chr10:131265454-131565783:+	0.4	5.13	8.55E-7	Response to temozolomide	
PCPG	cis	1	rs531572	chr10:131427569	MGMT	chr10:131265454-131565783:+	-0.37	-4.91	2.33E-6	Response to temozolomide	
PCPG	cis	1	rs538969	chr10:131410608	MGMT	chr10:131265454-131565783:+	0.35	4.58	9.68E-6	Response to temozolomide	
PCPG	cis	1	rs548390	chr10:131417427	MGMT	chr10:131265454-131565783:+	0.37	4.86	2.85E-6	Response to temozolomide	
PCPG	cis	1	rs553371	chr10:131413676	MGMT	chr10:131265454-131565783:+	0.37	4.86	2.81E-6	Response to temozolomide	
PCPG	cis	1	rs554792	chr10:131423181	MGMT	chr10:131265454-131565783:+	0.37	4.85	3.0E-6	Response to temozolomide	
PCPG	cis	1	rs55742763	chr16:31340368	ZNF764	chr16:30565086-30569584:-	-0.32	-4.09	6.99E-5	IgA nephropathy	
PCPG	cis	1	rs55788133	chr15:40664239	C15orf23	chr15:40674922-40686488:+	1.08	10.55	6.29E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs55791720	chr12:1066834	RAD52	chr12:1021255-1099219:-	0.32	4.75	4.7E-6	Lung cancer	
PCPG	cis	1	rs55835850	chr2:28949296	TRMT61B	chr2:29072690-29093175:-	0.51	5	1.57E-6	Body mass index	
PCPG	cis	1	rs558764	chr10:131426957	MGMT	chr10:131265454-131565783:+	-0.37	-4.9	2.38E-6	Response to temozolomide	
PCPG	cis	1	rs55879323	chr1:152168740	FLG	chr1:152274651-152297679:-	-0.39	-5.24	5.19E-7	Inflammatory skin disease	
PCPG	cis	1	rs55913793	chr3:134285968	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.45E-6	Height	
PCPG	cis	1	rs55914901	chr19:50528346	SIGLEC16	chr19:50472912-50479075:+	0.77	5.1	9.92E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs56015123	chr15:50977228	SPPL2A	chr15:50999739-51057910:-	0.33	4.93	2.06E-6	QT interval	
PCPG	cis	1	rs56040780	chr16:28861881	EIF3CL	chr16:28699879-28747052:+;chr16	0.41	4.82	3.39E-6	Educational attainment;Inflammatory bowel disease (early onset);Educational attainment (years of education)	
PCPG	cis	1	rs56043407	chr17:2166078	SRR	chr17:2207248-2228553:+	-0.59	-6.34	2.46E-9	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs56069965	chr15:50966973	SPPL2A	chr15:50999739-51057910:-	0.33	4.84	3.07E-6	QT interval	
PCPG	cis	1	rs56080544	chr15:50950970	SPPL2A	chr15:50999739-51057910:-	0.33	4.73	5.02E-6	QT interval	
PCPG	cis	1	rs56118429	chr15:50923849	SPPL2A	chr15:50999739-51057910:-	0.34	4.88	2.6E-6	QT interval	
PCPG	cis	1	rs56121764	chr3:41883975	ULK4	chr3:41288091-42003660:-	0.71	8.51	1.45E-14	Diastolic blood pressure	
PCPG	cis	1	rs56145559	chr2:73623439	ALMS1P	chr2:73872046-73912692:+	0.61	5.71	5.78E-8	Schizophrenia	
PCPG	cis	1	rs56154726	chr2:73721767	ALMS1P	chr2:73872046-73912692:+	0.59	5.67	6.93E-8	Metabolite levels	
PCPG	cis	1	rs56158380	chr3:41885588	ULK4	chr3:41288091-42003660:-	0.71	8.51	1.45E-14	Diastolic blood pressure	
PCPG	cis	1	rs56207540	chr3:41976627	ULK4	chr3:41288091-42003660:-	0.87	9.29	1.41E-16	Diastolic blood pressure	
PCPG	cis	1	rs56227395	chr2:54487496	C2orf73	chr2:54558071-54588714:+	0.59	4.82	3.34E-6	Telomere length	
PCPG	cis	1	rs56306402	chr20:33937704	CPNE1	chr20:34213968-34262539:-	0.3	4.14	5.59E-5	Height	
PCPG	cis	1	rs56306402	chr20:33937704	UQCC	chr20:33890383-33999833:-	0.44	5.71	5.65E-8	Height	
PCPG	cis	1	rs56314138	chr3:121356656	IQCB1	chr3:121488610-121553926:-	0.48	5.69	6.21E-8	Cognitive performance	
PCPG	cis	1	rs56317427	chr10:81861934	MBL1P	chr10:81664654-81710783:+	0.61	4.31	2.96E-5	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs56365761	chr19:39148103	LGALS7	chr19:39261608-39264157:-	-0.35	-4.15	5.59E-5	Heart rate	
PCPG	cis	1	rs565974	chr10:131423274	MGMT	chr10:131265454-131565783:+	0.37	4.85	3.0E-6	Response to temozolomide	
PCPG	cis	1	rs56672945	chr2:73622663	ALMS1P	chr2:73872046-73912692:+	0.65	6.13	7.01E-9	Metabolite levels	
PCPG	cis	1	rs56681864	chr15:24057623	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs567700	chr10:131423126	MGMT	chr10:131265454-131565783:+	0.37	4.85	3.0E-6	Response to temozolomide	
PCPG	cis	1	rs56776628	chr3:41866856	ULK4	chr3:41288091-42003660:-	0.81	11.25	8.48E-22	Diastolic blood pressure	
PCPG	cis	1	rs568617	chr11:65653242	CTSW	chr11:65647284-65651212:+	-0.55	-5.66	7.23E-8	Crohn's disease	
PCPG	cis	1	rs568617	chr11:65653242	SNX32	chr11:65601410-65621170:+	0.49	4.83	3.3E-6	Crohn's disease	
PCPG	cis	1	rs56884994	chr1:247211057	ZNF670	chr1:247200087-247242069:-	-0.47	-6.01	1.28E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs56911651	chr15:24057483	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs56922390	chr17:38157021	GSDMA	chr17:38119226-38134019:+	-0.67	-8.22	7.91E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs569235	chr10:131411620	MGMT	chr10:131265454-131565783:+	0.36	4.66	6.9E-6	Response to temozolomide	
PCPG	cis	1	rs57002197	chr15:50873760	SPPL2A	chr15:50999739-51057910:-	0.33	4.89	2.53E-6	QT interval	
PCPG	cis	1	rs57060498	chr2:54479230	C2orf73	chr2:54558071-54588714:+	0.57	4.32	2.79E-5	Telomere length	
PCPG	cis	1	rs57064725	chr15:78833036	CHRNA5	chr15:78857906-78886458:+	0.34	4.34	2.56E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs57196672	chr2:242235193	ANO7	chr2:242127924-242164791:+	0.39	4.03	8.65E-5	Prostate cancer	
PCPG	cis	1	rs573666	chr13:51194405	WDFY2	chr13:52158484-52336170:+	-0.35	-4.32	2.77E-5	Osteosarcoma	
PCPG	cis	1	rs57411618	chr17:28273052	EFCAB5	chr17:28256874-28435469:+	0.41	4.06	7.74E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs57479675	chr3:41798038	ULK4	chr3:41288091-42003660:-	0.73	10.41	1.52E-19	Diastolic blood pressure	
PCPG	cis	1	rs5758659	chr22:42622003	CYP2D6	chr22:42522502-42526883:-	-0.35	-4.86	2.81E-6	Cognitive function	
PCPG	cis	1	rs5758660	chr22:42623718	CYP2D6	chr22:42522502-42526883:-	-0.35	-4.86	2.81E-6	Cognitive function	
PCPG	cis	1	rs5760216	chr22:24539734	SUSD2	chr22:24577444-24585074:+	0.79	4.68	6.32E-6	Amyotrophic lateral sclerosis	
PCPG	cis	1	rs5760229	chr22:24560254	SUSD2	chr22:24577444-24585074:+	0.78	4.29	3.11E-5	Amyotrophic lateral sclerosis	
PCPG	cis	1	rs577227	chr10:131404528	MGMT	chr10:131265454-131565783:+	0.35	4.58	9.68E-6	Response to temozolomide	
PCPG	cis	1	rs57775263	chr15:24060026	WHAMML1	chr15:23187731-23208357:-	0.69	4.11	6.47E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs57804141	chr3:129962512	COL6A4P2	chr3:129931663-129992648:+	0.4	4.24	3.84E-5	Response to amphetamines	
PCPG	cis	1	rs580745	chr10:131414401	MGMT	chr10:131265454-131565783:+	0.38	4.87	2.72E-6	Response to temozolomide	
PCPG	cis	1	rs58416181	chr15:85264461	WDR73	chr15:85186012-85197524:-	-0.44	-4.36	2.38E-5	Schizophrenia	
PCPG	cis	1	rs58603761	chr2:73726605	ALMS1P	chr2:73872046-73912692:+	0.6	5.91	2.07E-8	Metabolite levels	
PCPG	cis	1	rs58823966	chr15:24060127	WHAMML1	chr15:23187731-23208357:-	0.69	4.11	6.47E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs58889739	chr15:24060240	WHAMML1	chr15:23187731-23208357:-	0.69	4.11	6.47E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs59005008	chr15:24058129	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs590958	chr15:65735707	DPP8	chr15:65737999-65810035:-	-0.18	-4.33	2.71E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs59104589	chr2:242237902	ANO7	chr2:242127924-242164791:+	0.3	4.24	3.85E-5	Fibrinogen levels	
PCPG	cis	1	rs59244547	chr3:156582997	LEKR1	chr3:156544076-156763918:+	-0.49	-4.38	2.21E-5	Bone mineral density	
PCPG	cis	1	rs59496049	chr2:242260756	ANO7	chr2:242127924-242164791:+	0.37	4.04	8.44E-5	Prostate cancer	
PCPG	cis	1	rs59715748	chr5:150189287	LOC134466	chr5:150310000-150326146:-	0.75	4.13	6.04E-5	Crohn's disease	
PCPG	cis	1	rs59925331	chr17:38169273	GSDMA	chr17:38119226-38134019:+	-0.67	-8.35	3.61E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs5995808	chr22:40469292	XPNPEP3	chr22:41253094-41363888:+	0.55	5.06	1.16E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs6001728	chr22:40434757	XPNPEP3	chr22:41253094-41363888:+	0.51	4.77	4.16E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs6001734	chr22:40443219	XPNPEP3	chr22:41253094-41363888:+	0.54	4.99	1.61E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs6001740	chr22:40460111	XPNPEP3	chr22:41253094-41363888:+	0.55	5.06	1.16E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs6001749	chr22:40475326	XPNPEP3	chr22:41253094-41363888:+	0.5	4.75	4.63E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs6001773	chr22:40505863	XPNPEP3	chr22:41253094-41363888:+	0.49	4.69	5.99E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs6001774	chr22:40513589	XPNPEP3	chr22:41253094-41363888:+	0.49	4.69	5.99E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs600193	chr15:65729409	DPP8	chr15:65737999-65810035:-	0.17	4.2	4.55E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs6003958	chr22:24264089	GSTT1	chr22:24376141-24384284:-	-0.61	-6.3	2.97E-9	S-phenylmercapturic acid levels in smokers	
PCPG	cis	1	rs6003958	chr22:24264089	GSTT2	chr22:24322314-24326104:+;chr22	0.47	4.35	2.42E-5	S-phenylmercapturic acid levels in smokers	
PCPG	cis	1	rs6003958	chr22:24264089	LOC391322	chr22:24373117-24374043:+	-0.53	-5.23	5.43E-7	S-phenylmercapturic acid levels in smokers	
PCPG	cis	1	rs6004654	chr22:25855204	CRYBB2	chr22:25615612-25627836:+	0.69	5.8	3.62E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004655	chr22:25855629	CRYBB2	chr22:25615612-25627836:+	0.67	5.52	1.42E-7	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004658	chr22:25856231	CRYBB2	chr22:25615612-25627836:+	0.69	5.8	3.62E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004659	chr22:25856411	CRYBB2	chr22:25615612-25627836:+	0.69	5.8	3.62E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004662	chr22:25862124	CRYBB2	chr22:25615612-25627836:+	0.68	5.71	5.64E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004667	chr22:25874464	CRYBB2	chr22:25615612-25627836:+	-0.66	-5.9	2.28E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004668	chr22:25874502	CRYBB2	chr22:25615612-25627836:+	-0.71	-6.18	5.54E-9	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004671	chr22:25879474	CRYBB2	chr22:25615612-25627836:+	0.75	6.53	9.04E-10	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004672	chr22:25881013	CRYBB2	chr22:25615612-25627836:+	0.68	5.97	1.55E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004675	chr22:25889385	CRYBB2	chr22:25615612-25627836:+	0.65	5.8	3.62E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6004862	chr22:26378073	HPS4	chr22:26847447-26879820:-	-0.39	-4.09	6.95E-5	Urate levels in lean individuals	
PCPG	cis	1	rs60253563	chr6:170083019	WDR27	chr6:169857307-170102159:-	-0.54	-5.64	7.98E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs60326608	chr15:24057746	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs6037086	chr20:25306338	ENTPD6	chr20:25176339-25207360:+	0.34	4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037086	chr20:25306338	FAM182A	chr20:26035250-26067552:+	0.55	6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037095	chr20:25335687	ENTPD6	chr20:25176339-25207360:+	0.34	4.3	3.04E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037095	chr20:25335687	FAM182A	chr20:26035250-26067552:+	0.47	5.71	5.57E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037099	chr20:25356876	ENTPD6	chr20:25176339-25207360:+	0.32	4.06	7.89E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037099	chr20:25356876	FAM182A	chr20:26035250-26067552:+	0.51	6.35	2.33E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037105	chr20:25374199	ENTPD6	chr20:25176339-25207360:+	0.32	4.06	7.89E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037105	chr20:25374199	FAM182A	chr20:26035250-26067552:+	0.51	6.35	2.33E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037121	chr20:25428311	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037121	chr20:25428311	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6037547	chr20:3299228	ITPA	chr20:3190056-3204504:+	-0.3	-4.17	5.04E-5	IFN-related cytopenia	
PCPG	cis	1	rs6037560	chr20:3323055	ITPA	chr20:3190056-3204504:+	-0.29	-4.04	8.55E-5	IFN-related cytopenia	
PCPG	cis	1	rs6037562	chr20:3326141	ITPA	chr20:3190056-3204504:+	-0.29	-4.04	8.55E-5	IFN-related cytopenia	
PCPG	cis	1	rs6037567	chr20:3332160	ITPA	chr20:3190056-3204504:+	-0.29	-4.04	8.55E-5	IFN-related cytopenia	
PCPG	cis	1	rs6037590	chr20:3374085	ITPA	chr20:3190056-3204504:+	-0.3	-4.12	6.18E-5	IFN-related cytopenia	
PCPG	cis	1	rs6050542	chr20:25318879	ENTPD6	chr20:25176339-25207360:+	0.34	4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050542	chr20:25318879	FAM182A	chr20:26035250-26067552:+	0.48	5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050544	chr20:25320228	ENTPD6	chr20:25176339-25207360:+	0.34	4.3	3.04E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050544	chr20:25320228	FAM182A	chr20:26035250-26067552:+	0.47	5.71	5.57E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050547	chr20:25326012	ENTPD6	chr20:25176339-25207360:+	0.33	4.17	4.97E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050547	chr20:25326012	FAM182A	chr20:26035250-26067552:+	0.49	6.11	7.7E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050555	chr20:25328543	FAM182A	chr20:26035250-26067552:+	0.51	6.4	1.73E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050559	chr20:25329915	ENTPD6	chr20:25176339-25207360:+	-0.35	-4.48	1.48E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050559	chr20:25329915	FAM182A	chr20:26035250-26067552:+	-0.43	-5.27	4.56E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050561	chr20:25334855	ENTPD6	chr20:25176339-25207360:+	0.32	4.06	7.89E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050561	chr20:25334855	FAM182A	chr20:26035250-26067552:+	0.51	6.35	2.33E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050562	chr20:25336186	ENTPD6	chr20:25176339-25207360:+	0.34	4.3	3.04E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050562	chr20:25336186	FAM182A	chr20:26035250-26067552:+	0.47	5.71	5.57E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050564	chr20:25344231	ENTPD6	chr20:25176339-25207360:+	0.32	4.06	7.89E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050564	chr20:25344231	FAM182A	chr20:26035250-26067552:+	0.51	6.35	2.33E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050565	chr20:25347563	ENTPD6	chr20:25176339-25207360:+	0.32	4.09	6.8E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050565	chr20:25347563	FAM182A	chr20:26035250-26067552:+	0.5	6.23	4.15E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050566	chr20:25351071	ENTPD6	chr20:25176339-25207360:+	0.33	4.19	4.63E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050566	chr20:25351071	FAM182A	chr20:26035250-26067552:+	0.48	5.86	2.76E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050573	chr20:25366065	FAM182A	chr20:26035250-26067552:+	-0.5	-6.25	3.8E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050590	chr20:25384994	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050590	chr20:25384994	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050598	chr20:25397257	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050598	chr20:25397257	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050599	chr20:25400240	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050599	chr20:25400240	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050602	chr20:25401203	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050602	chr20:25401203	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050609	chr20:25411751	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050609	chr20:25411751	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050617	chr20:25421648	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050617	chr20:25421648	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050626	chr20:25428261	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.44E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050626	chr20:25428261	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.84E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050629	chr20:25430680	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050629	chr20:25430680	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050630	chr20:25430745	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050630	chr20:25430745	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050631	chr20:25431749	ENTPD6	chr20:25176339-25207360:+	-0.35	-4.3	3.06E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050631	chr20:25431749	FAM182A	chr20:26035250-26067552:+	-0.47	-5.6	9.78E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050632	chr20:25432601	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.07	7.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6050632	chr20:25432601	FAM182A	chr20:26035250-26067552:+	-0.51	-6.2	4.85E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6051080	chr20:25975674	FAM182B	chr20:25744102-25848786:-	0.48	6.62	5.72E-10	Colorectal or endometrial cancer	
PCPG	cis	1	rs6051672	chr20:3224819	ITPA	chr20:3190056-3204504:+	-0.32	-4.54	1.14E-5	IFN-related cytopenia	
PCPG	cis	1	rs6051723	chr20:3278512	ITPA	chr20:3190056-3204504:+	-0.3	-4.18	4.94E-5	IFN-related cytopenia	
PCPG	cis	1	rs6051732	chr20:3294182	ITPA	chr20:3190056-3204504:+	-0.3	-4.18	4.94E-5	IFN-related cytopenia	
PCPG	cis	1	rs6051736	chr20:3296898	ITPA	chr20:3190056-3204504:+	-0.3	-4.17	5.04E-5	IFN-related cytopenia	
PCPG	cis	1	rs6051831	chr20:3373712	ITPA	chr20:3190056-3204504:+	0.31	4.22	4.08E-5	IFN-related cytopenia	
PCPG	cis	1	rs6052772	chr20:4675980	PRNP	chr20:4666797-4682233:+	0.3	4.08	7.08E-5	Creutzfeldt-Jakob disease (variant);Creutzfeldt-Jakob disease (sporadic)	
PCPG	cis	1	rs60529510	chr17:80407480	C17orf62	chr17:80400520-80408694:-	-0.48	-4.25	3.69E-5	Protein quantitative trait loci	
PCPG	cis	1	rs6053816	chr20:5970750	MCM8	chr20:5931298-5975829:+	-0.3	-4.1	6.76E-5	HIV-1 viral setpoint	
PCPG	cis	1	rs6060401	chr20:34005214	CPNE1	chr20:34213968-34262539:-	0.3	4.04	8.35E-5	Height	
PCPG	cis	1	rs6060401	chr20:34005214	UQCC	chr20:33890383-33999833:-	0.41	5.21	5.89E-7	Height	
PCPG	cis	1	rs6060402	chr20:34005240	UQCC	chr20:33890383-33999833:-	0.4	5	1.52E-6	Height	
PCPG	cis	1	rs6063349	chr20:47681882	DDX27	chr20:47835832-47860612:+	0.33	4.05	8.24E-5	Non-response to citalopram or escitalopram and depression	
PCPG	cis	1	rs6076336	chr20:25319212	ENTPD6	chr20:25176339-25207360:+	0.34	4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6076336	chr20:25319212	FAM182A	chr20:26035250-26067552:+	0.48	5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6076339	chr20:25348712	FAM182A	chr20:26035250-26067552:+	0.55	6.96	9.02E-11	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6076345	chr20:25381895	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6076345	chr20:25381895	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs60772114	chr15:24057447	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs6083804	chr20:25317060	ENTPD6	chr20:25176339-25207360:+	0.34	4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083804	chr20:25317060	FAM182A	chr20:26035250-26067552:+	0.48	5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083805	chr20:25317356	ENTPD6	chr20:25176339-25207360:+	0.34	4.3	3.04E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083805	chr20:25317356	FAM182A	chr20:26035250-26067552:+	0.47	5.71	5.57E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083809	chr20:25329309	FAM182A	chr20:26035250-26067552:+	0.52	6.5	1.05E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083813	chr20:25337671	FAM182A	chr20:26035250-26067552:+	0.52	6.36	2.24E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083825	chr20:25366424	ENTPD6	chr20:25176339-25207360:+	0.32	4.06	7.89E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083825	chr20:25366424	FAM182A	chr20:26035250-26067552:+	0.51	6.35	2.33E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083828	chr20:25369918	ENTPD6	chr20:25176339-25207360:+	0.33	4.08	7.21E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083828	chr20:25369918	FAM182A	chr20:26035250-26067552:+	0.52	6.42	1.62E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083844	chr20:25386832	FAM182A	chr20:26035250-26067552:+	0.5	6.08	9.09E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083856	chr20:25407585	ENTPD6	chr20:25176339-25207360:+	0.37	4.52	1.22E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083856	chr20:25407585	FAM182A	chr20:26035250-26067552:+	0.47	5.51	1.49E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6083862	chr20:25411086	FAM182A	chr20:26035250-26067552:+	0.43	5.49	1.64E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs60844734	chr2:73623205	ALMS1P	chr2:73872046-73912692:+	0.65	6.13	7.01E-9	Metabolite levels	
PCPG	cis	1	rs6087698	chr20:33948919	UQCC	chr20:33890383-33999833:-	0.42	5.39	2.62E-7	Height	
PCPG	cis	1	rs6087702	chr20:33995945	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6087703	chr20:33996433	CPNE1	chr20:34213968-34262539:-	0.3	4.13	5.99E-5	Height	
PCPG	cis	1	rs6087703	chr20:33996433	UQCC	chr20:33890383-33999833:-	0.43	5.47	1.81E-7	Height	
PCPG	cis	1	rs6087704	chr20:34001058	CPNE1	chr20:34213968-34262539:-	0.3	4.13	5.99E-5	Height	
PCPG	cis	1	rs6087704	chr20:34001058	UQCC	chr20:33890383-33999833:-	0.43	5.47	1.81E-7	Height	
PCPG	cis	1	rs6087705	chr20:34001250	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6088799	chr20:33934301	UQCC	chr20:33890383-33999833:-	0.42	5.39	2.62E-7	Height	
PCPG	cis	1	rs6088812	chr20:33974163	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6088813	chr20:33975181	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6088815	chr20:33976474	UQCC	chr20:33890383-33999833:-	0.4	5.17	7.29E-7	Height	
PCPG	cis	1	rs6088816	chr20:33982435	CPNE1	chr20:34213968-34262539:-	0.3	4.15	5.43E-5	Height	
PCPG	cis	1	rs6088816	chr20:33982435	UQCC	chr20:33890383-33999833:-	0.41	5.37	2.92E-7	Height	
PCPG	cis	1	rs6088820	chr20:33987298	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6088821	chr20:33987576	CPNE1	chr20:34213968-34262539:-	0.3	4.13	5.99E-5	Height	
PCPG	cis	1	rs6088821	chr20:33987576	UQCC	chr20:33890383-33999833:-	0.43	5.47	1.81E-7	Height	
PCPG	cis	1	rs6088823	chr20:33994265	CPNE1	chr20:34213968-34262539:-	0.3	4.13	5.99E-5	Height	
PCPG	cis	1	rs6088823	chr20:33994265	UQCC	chr20:33890383-33999833:-	0.43	5.47	1.81E-7	Height	
PCPG	cis	1	rs6088825	chr20:33995972	CPNE1	chr20:34213968-34262539:-	0.3	4.15	5.43E-5	Height	
PCPG	cis	1	rs6088825	chr20:33995972	UQCC	chr20:33890383-33999833:-	0.41	5.37	2.92E-7	Height	
PCPG	cis	1	rs60957376	chr15:85280792	WDR73	chr15:85186012-85197524:-	-0.42	-4.21	4.4E-5	Schizophrenia	
PCPG	cis	1	rs60967688	chr17:28437052	EFCAB5	chr17:28256874-28435469:+	0.42	4.11	6.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs61037750	chr11:43681372	HSD17B12	chr11:43702143-43878160:+	-0.44	-5.06	1.2E-6	Forced vital capacity	
PCPG	cis	1	rs6107033	chr20:25363591	FAM182A	chr20:26035250-26067552:+	0.55	6.96	9.02E-11	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6107045	chr20:25441936	ENTPD6	chr20:25176339-25207360:+	-0.35	-4.25	3.74E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6107045	chr20:25441936	FAM182A	chr20:26035250-26067552:+	-0.46	-5.34	3.25E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6107046	chr20:25442049	ENTPD6	chr20:25176339-25207360:+	-0.35	-4.25	3.74E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6107046	chr20:25442049	FAM182A	chr20:26035250-26067552:+	-0.46	-5.34	3.25E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6107047	chr20:25442097	ENTPD6	chr20:25176339-25207360:+	-0.35	-4.25	3.74E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6107047	chr20:25442097	FAM182A	chr20:26035250-26067552:+	-0.46	-5.34	3.25E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6107516	chr20:4677092	PRNP	chr20:4666797-4682233:+	0.31	4.21	4.41E-5	Creutzfeldt-Jakob disease (variant);Creutzfeldt-Jakob disease (sporadic)	
PCPG	cis	1	rs61102033	chr1:46382441	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.92E-7	Body mass index	
PCPG	cis	1	rs61142792	chr5:176983463	HK3	chr5:176307871-176326333:-	-0.61	-4.3	3.01E-5	Alzheimer disease and age of onset	
PCPG	cis	1	rs6115140	chr20:25285507	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.2	4.44E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115140	chr20:25285507	FAM182A	chr20:26035250-26067552:+	-0.5	-5.92	2.06E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115146	chr20:25304507	ENTPD6	chr20:25176339-25207360:+	0.34	4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115146	chr20:25304507	FAM182A	chr20:26035250-26067552:+	0.48	5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115153	chr20:25325567	FAM182A	chr20:26035250-26067552:+	0.52	6.5	1.05E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115159	chr20:25350944	FAM182A	chr20:26035250-26067552:+	0.52	6.5	1.05E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115168	chr20:25372891	ENTPD6	chr20:25176339-25207360:+	0.32	4.06	7.83E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115168	chr20:25372891	FAM182A	chr20:26035250-26067552:+	0.51	6.35	2.35E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115182	chr20:25410259	ENTPD6	chr20:25176339-25207360:+	0.33	4.07	7.46E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115182	chr20:25410259	FAM182A	chr20:26035250-26067552:+	0.51	6.21	4.83E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115191	chr20:25440478	ENTPD6	chr20:25176339-25207360:+	-0.35	-4.25	3.74E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6115191	chr20:25440478	FAM182A	chr20:26035250-26067552:+	-0.46	-5.34	3.25E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs61204066	chr15:78815298	CHRNA5	chr15:78857906-78886458:+	0.37	4.64	7.53E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs6120974	chr20:34126827	CPNE1	chr20:34213968-34262539:-	-0.6	-7.21	2.38E-11	Triglycerides	
PCPG	cis	1	rs61261756	chr15:24060123	WHAMML1	chr15:23187731-23208357:-	0.69	4.11	6.47E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs6132835	chr20:25434667	FAM182A	chr20:26035250-26067552:+	-0.48	-5.76	4.42E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6138572	chr20:25435934	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.15	5.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6138572	chr20:25435934	FAM182A	chr20:26035250-26067552:+	-0.51	-6.02	1.24E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6138575	chr20:25438952	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.15	5.45E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6138575	chr20:25438952	FAM182A	chr20:26035250-26067552:+	-0.51	-6.02	1.24E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6139068	chr20:3284393	ITPA	chr20:3190056-3204504:+	-0.3	-4.18	4.94E-5	IFN-related cytopenia	
PCPG	cis	1	rs6139088	chr20:3329063	ITPA	chr20:3190056-3204504:+	-0.29	-4.04	8.55E-5	IFN-related cytopenia	
PCPG	cis	1	rs6139117	chr20:3387785	ITPA	chr20:3190056-3204504:+	-0.33	-4.48	1.43E-5	IFN-related cytopenia	
PCPG	cis	1	rs6141546	chr20:33949282	UQCC	chr20:33890383-33999833:-	0.42	5.39	2.62E-7	Height	
PCPG	cis	1	rs6141548	chr20:33971085	UQCC	chr20:33890383-33999833:-	0.4	5.04	1.27E-6	Height	
PCPG	cis	1	rs6141549	chr20:33974051	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6142358	chr20:33960308	UQCC	chr20:33890383-33999833:-	-0.39	-4.91	2.32E-6	Height	
PCPG	cis	1	rs6142359	chr20:33960450	UQCC	chr20:33890383-33999833:-	0.4	5.02	1.44E-6	Height	
PCPG	cis	1	rs6142360	chr20:33960486	UQCC	chr20:33890383-33999833:-	0.44	5.65	7.39E-8	Height	
PCPG	cis	1	rs6142369	chr20:33973315	CPNE1	chr20:34213968-34262539:-	0.3	4.13	5.99E-5	Height	
PCPG	cis	1	rs6142369	chr20:33973315	UQCC	chr20:33890383-33999833:-	0.43	5.47	1.81E-7	Height	
PCPG	cis	1	rs6142370	chr20:33973378	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6142373	chr20:33983314	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6142374	chr20:33985568	CPNE1	chr20:34213968-34262539:-	0.3	4.13	5.99E-5	Height	
PCPG	cis	1	rs6142374	chr20:33985568	UQCC	chr20:33890383-33999833:-	0.43	5.47	1.81E-7	Height	
PCPG	cis	1	rs6142376	chr20:33992761	CPNE1	chr20:34213968-34262539:-	0.3	4.15	5.43E-5	Height	
PCPG	cis	1	rs6142376	chr20:33992761	UQCC	chr20:33890383-33999833:-	0.41	5.37	2.92E-7	Height	
PCPG	cis	1	rs6142379	chr20:33999267	CPNE1	chr20:34213968-34262539:-	0.3	4.13	5.99E-5	Height	
PCPG	cis	1	rs6142379	chr20:33999267	UQCC	chr20:33890383-33999833:-	0.43	5.47	1.81E-7	Height	
PCPG	cis	1	rs61505517	chr5:176982391	HK3	chr5:176307871-176326333:-	-0.61	-4.3	3.01E-5	Alzheimer disease and age of onset	
PCPG	cis	1	rs6151429	chr22:51063477	ARSA	chr22:51063450-51066607:-	-1.09	-10.44	1.28E-19	Blood metabolite levels	
PCPG	cis	1	rs61524473	chr15:45646283	GATM	chr15:45653324-45670980:-	-0.51	-5.18	6.82E-7	Metabolite levels (small molecules and protein measures)	
PCPG	cis	1	rs61524473	chr15:45646283	SPATA5L1	chr15:45694519-45713614:+	0.44	5.33	3.49E-7	Metabolite levels (small molecules and protein measures)	
PCPG	cis	1	rs61530437	chr15:24060720	WHAMML1	chr15:23187731-23208357:-	0.69	4.11	6.47E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs61744385	chr3:41756986	ULK4	chr3:41288091-42003660:-	0.72	9.66	1.53E-17	Diastolic blood pressure	
PCPG	cis	1	rs61744388	chr3:41756965	ULK4	chr3:41288091-42003660:-	0.72	9.66	1.53E-17	Diastolic blood pressure	
PCPG	cis	1	rs61783200	chr1:46297403	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.49	1.61E-7	Body mass index	
PCPG	cis	1	rs61783220	chr1:46335312	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.97E-7	Body mass index	
PCPG	cis	1	rs61818802	chr1:113181739	ST7L	chr1:113066142-113162405:-	0.44	4.02	8.98E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs61826828	chr1:174015261	SERPINC1	chr1:173872943-173886516:-	0.54	5.07	1.11E-6	Schizophrenia	
PCPG	cis	1	rs61852630	chr1:247210193	ZNF670	chr1:247200087-247242069:-	-0.47	-5.93	1.96E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs61852637	chr1:247219636	ZNF670	chr1:247200087-247242069:-	-0.44	-5.49	1.64E-7	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs62017189	chr15:50922032	SPPL2A	chr15:50999739-51057910:-	0.32	4.54	1.13E-5	QT interval	
PCPG	cis	1	rs62017206	chr15:50955626	SPPL2A	chr15:50999739-51057910:-	0.32	4.72	5.21E-6	QT interval	
PCPG	cis	1	rs62017210	chr15:50960620	SPPL2A	chr15:50999739-51057910:-	0.32	4.72	5.21E-6	QT interval	
PCPG	cis	1	rs62019464	chr15:85294469	WDR73	chr15:85186012-85197524:-	-0.42	-4.12	6.18E-5	Schizophrenia	
PCPG	cis	1	rs62019469	chr15:85321220	WDR73	chr15:85186012-85197524:-	-0.41	-4.03	8.8E-5	Schizophrenia	
PCPG	cis	1	rs62021219	chr15:85256159	WDR73	chr15:85186012-85197524:-	-0.46	-4.57	1.0E-5	Schizophrenia	
PCPG	cis	1	rs62070270	chr17:28263980	EFCAB5	chr17:28256874-28435469:+	0.41	4.12	6.25E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs62139251	chr2:54478605	C2orf73	chr2:54558071-54588714:+	0.59	4.17	5.0E-5	Telomere length	
PCPG	cis	1	rs62139254	chr2:54480336	C2orf73	chr2:54558071-54588714:+	0.63	4.57	9.77E-6	Telomere length	
PCPG	cis	1	rs62151652	chr2:73700131	ALMS1P	chr2:73872046-73912692:+	0.59	5.72	5.48E-8	Metabolite levels	
PCPG	cis	1	rs62184315	chr2:190771945	ORMDL1	chr2:190634994-190649097:-	0.41	5.74	4.96E-8	Alcohol dependence (age at onset)	
PCPG	cis	1	rs62190367	chr2:242376276	ANO7	chr2:242127924-242164791:+	0.39	4.03	8.65E-5	Prostate cancer	
PCPG	cis	1	rs62190370	chr2:242384194	ANO7	chr2:242127924-242164791:+	0.39	4.04	8.43E-5	Prostate cancer	
PCPG	cis	1	rs62211529	chr20:33959315	UQCC	chr20:33890383-33999833:-	0.42	5.33	3.47E-7	Height	
PCPG	cis	1	rs62265556	chr3:94243253	STX19	chr3:93733215-93747454:-	0.49	4.72	5.15E-6	Blood pressure measurement (high sodium intervention)	
PCPG	cis	1	rs62268732	chr3:121370455	IQCB1	chr3:121488610-121553926:-	0.5	5.61	9.37E-8	Cognitive performance	
PCPG	cis	1	rs62269547	chr3:134214042	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs62271513	chr3:134298412	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.85E-6	Height	
PCPG	cis	1	rs62271514	chr3:134298554	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.85E-6	Height	
PCPG	cis	1	rs62271515	chr3:134300507	ANAPC13	chr3:134196547-134204865:-	0.36	4.86	2.81E-6	Height	
PCPG	cis	1	rs62281663	chr3:99936137	LNP1	chr3:100120037-100175169:+	-0.3	-4.14	5.77E-5	Visceral adipose tissue/subcutaneous adipose tissue ratio	
PCPG	cis	1	rs62327566	chr4:142150894	ZNF330	chr4:142142049-142155848:+	-0.33	-4.02	9.05E-5	Conduct disorder	
PCPG	cis	1	rs62402013	chr6:26915000	LOC100270746	chr6:26987146-26988085:-	-0.36	-4.26	3.57E-5	Schizophrenia	
PCPG	cis	1	rs62404566	chr6:35118432	UHRF1BP1	chr6:34759794-34853117:+	-0.3	-4.47	1.48E-5	Airway responsiveness in chronic obstructive pulmonary disease	
PCPG	cis	1	rs641018	chr11:65655393	CTSW	chr11:65647284-65651212:+	-0.55	-5.66	7.23E-8	Crohn's disease	
PCPG	cis	1	rs641018	chr11:65655393	SNX32	chr11:65601410-65621170:+	0.49	4.83	3.3E-6	Crohn's disease	
PCPG	cis	1	rs6428476	chr1:89126005	CCBL2	chr1:89401456-89458643:-	0.5	6.51	1.01E-9	Height	
PCPG	cis	1	rs6429567	chr1:45956700	CCDC163P	chr1:45960581-45965646:-	-0.59	-9.72	1.05E-17	Homocysteine levels	
PCPG	cis	1	rs6429569	chr1:46001330	CCDC163P	chr1:45960581-45965646:-	-0.48	-7.28	1.63E-11	Homocysteine levels	
PCPG	cis	1	rs6429582	chr1:46321843	CCDC163P	chr1:45960581-45965646:-	0.38	5.05	1.24E-6	Body mass index	
PCPG	cis	1	rs6439484	chr3:134249899	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs6439487	chr3:134260860	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs6441104	chr3:156681441	LEKR1	chr3:156544076-156763918:+	-0.61	-5.83	3.21E-8	Bone mineral density	
PCPG	cis	1	rs6442117	chr3:48419897	TREX1	chr3:48501186-48509043:+	0.29	4.24	3.86E-5	Longevity	
PCPG	cis	1	rs6442118	chr3:48440047	TREX1	chr3:48501186-48509043:+	-0.28	-4.21	4.4E-5	Longevity	
PCPG	cis	1	rs6442119	chr3:48440178	TREX1	chr3:48501186-48509043:+	-0.29	-4.31	2.92E-5	Longevity	
PCPG	cis	1	rs6445358	chr3:52308845	GNL3	chr3:52719936-52728508:+	-0.27	-4.02	8.97E-5	Electroencephalogram traits	
PCPG	cis	1	rs6450408	chr5:56098146	C5orf35	chr5:56205103-56213010:+	0.89	7.81	8.29E-13	Type 2 diabetes	
PCPG	cis	1	rs6450409	chr5:56101399	C5orf35	chr5:56205103-56213010:+	0.88	8.92	1.3E-15	Type 2 diabetes	
PCPG	cis	1	rs6454513	chr6:86720049	SNHG5	chr6:86386726-86388451:-	0.46	6.03	1.15E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs6456371	chr6:20714466	CDKAL1	chr6:20534688-21232632:+	-0.4	-4.3	3.02E-5	Type 2 diabetes	
PCPG	cis	1	rs6457805	chr6:35120443	UHRF1BP1	chr6:34759794-34853117:+	-0.34	-4.83	3.23E-6	Airway responsiveness in chronic obstructive pulmonary disease	
PCPG	cis	1	rs6459657	chr6:170136454	WDR27	chr6:169857307-170102159:-	-0.47	-4.55	1.07E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs6464574	chr7:143748257	ARHGEF35	chr7:143883677-143892736:-	-0.36	-4.09	6.93E-5	Obesity-related traits	
PCPG	cis	1	rs6478484	chr9:123652380	LOC253039	chr9:123605320-123616644:+	-0.56	-5.43	2.17E-7	Rheumatoid arthritis	
PCPG	cis	1	rs6478486	chr9:123655329	LOC253039	chr9:123605320-123616644:+	-0.58	-5.48	1.7E-7	Rheumatoid arthritis	
PCPG	cis	1	rs6485438	chr11:43686618	HSD17B12	chr11:43702143-43878160:+	-0.48	-6.04	1.11E-8	Forced vital capacity	
PCPG	cis	1	rs6485443	chr11:43696316	HSD17B12	chr11:43702143-43878160:+	0.48	6.03	1.16E-8	Forced vital capacity	
PCPG	cis	1	rs6494521	chr15:65739928	DPP8	chr15:65737999-65810035:-	-0.18	-4.33	2.71E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs6494528	chr15:65865632	DPP8	chr15:65737999-65810035:-	-0.18	-4.47	1.5E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs6494529	chr15:65902922	DPP8	chr15:65737999-65810035:-	-0.19	-4.63	7.79E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs6494532	chr15:65975798	DPP8	chr15:65737999-65810035:-	-0.19	-4.65	7.18E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs6494537	chr15:66051345	DPP8	chr15:65737999-65810035:-	-0.19	-4.65	7.23E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs6503530	chr17:38161823	GSDMA	chr17:38119226-38134019:+	-0.67	-8.35	3.63E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs6505152	chr17:28331466	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs6505158	chr17:28403348	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.31	2.93E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs6510348	chr19:33601946	GPATCH1	chr19:33571786-33621318:+	0.39	5.17	7.12E-7	Bone properties (heel)	
PCPG	cis	1	rs6515651	chr20:25414539	ENTPD6	chr20:25176339-25207360:+	0.34	4.31	2.85E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6515651	chr20:25414539	FAM182A	chr20:26035250-26067552:+	0.46	5.58	1.05E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs6519611	chr22:25845855	CRYBB2	chr22:25615612-25627836:+	0.67	5.34	3.26E-7	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs6545883	chr2:61772257	AHSA2	chr2:61404553-61414058:+	-0.33	-4.76	4.4E-6	Tuberculosis	
PCPG	cis	1	rs6545883	chr2:61772257	C2orf74	chr2:61372243-61391964:+	0.34	4.48	1.45E-5	Tuberculosis	
PCPG	cis	1	rs6546835	chr2:73664715	ALMS1P	chr2:73872046-73912692:+	0.6	5.99	1.44E-8	Metabolite levels	
PCPG	cis	1	rs6546836	chr2:73677833	ALMS1P	chr2:73872046-73912692:+	0.58	5.69	6.08E-8	Metabolite levels	
PCPG	cis	1	rs6546837	chr2:73677898	ALMS1P	chr2:73872046-73912692:+	0.59	5.75	4.69E-8	Metabolite levels	
PCPG	cis	1	rs6546838	chr2:73679280	ALMS1P	chr2:73872046-73912692:+	0.59	5.75	4.69E-8	Metabolite levels	
PCPG	cis	1	rs6546839	chr2:73680508	ALMS1P	chr2:73872046-73912692:+	0.59	5.75	4.69E-8	Metabolite levels	
PCPG	cis	1	rs6547872	chr2:28978074	TRMT61B	chr2:29072690-29093175:-	-0.51	-5.18	6.89E-7	Body mass index	
PCPG	cis	1	rs656980	chr11:65656282	CTSW	chr11:65647284-65651212:+	-0.55	-5.66	7.23E-8	Crohn's disease	
PCPG	cis	1	rs656980	chr11:65656282	SNX32	chr11:65601410-65621170:+	0.49	4.83	3.3E-6	Crohn's disease	
PCPG	cis	1	rs6573333	chr14:61308337	C14orf135	chr14:60558629-60635851:+	0.59	5.21	6.02E-7	Immune reponse to smallpox (secreted IFN-alpha)	
PCPG	cis	1	rs6573333	chr14:61308337	MNAT1	chr14:61201470-61435396:+	0.59	4.17	5.04E-5	Immune reponse to smallpox (secreted IFN-alpha)	
PCPG	cis	1	rs6579234	chr20:33983485	UQCC	chr20:33890383-33999833:-	0.4	5.15	7.93E-7	Height	
PCPG	cis	1	rs6579245	chr20:34125271	CPNE1	chr20:34213968-34262539:-	-0.6	-7.3	1.46E-11	Cholesterol, total	
PCPG	cis	1	rs6581155	chr12:58178162	FAM119B	chr12:58166383-58176323:+	0.49	4.71	5.48E-6	Multiple sclerosis	
PCPG	cis	1	rs6581155	chr12:58178162	TSFM	chr12:58176536-58191367:+	-0.58	-7.3	1.43E-11	Multiple sclerosis	
PCPG	cis	1	rs6585827	chr10:124165615	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.4	1.99E-5	Height	
PCPG	cis	1	rs6599170	chr3:41772718	ULK4	chr3:41288091-42003660:-	0.72	10.32	2.64E-19	Diastolic blood pressure	
PCPG	cis	1	rs6599175	chr3:41786009	ULK4	chr3:41288091-42003660:-	-0.7	-10.34	2.36E-19	Diastolic blood pressure	
PCPG	cis	1	rs6599176	chr3:41788492	ULK4	chr3:41288091-42003660:-	-0.75	-11.14	1.63E-21	Diastolic blood pressure	
PCPG	cis	1	rs6599178	chr3:41842129	ULK4	chr3:41288091-42003660:-	0.74	10.74	1.98E-20	Diastolic blood pressure	
PCPG	cis	1	rs6599179	chr3:41855284	ULK4	chr3:41288091-42003660:-	0.74	10.69	2.71E-20	Diastolic blood pressure	
PCPG	cis	1	rs6603981	chr1:92993807	EVI5	chr1:92974255-93257961:-	-0.29	-4.03	8.73E-5	Cholesterol, total	
PCPG	cis	1	rs6603982	chr1:92994033	EVI5	chr1:92974255-93257961:-	-0.29	-4.03	8.73E-5	Cholesterol, total	
PCPG	cis	1	rs664172	chr15:78862762	CHRNA5	chr15:78857906-78886458:+	0.3	4.02	9.07E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs6656992	chr1:46333068	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.97E-7	Body mass index	
PCPG	cis	1	rs6661910	chr1:46290632	CCDC163P	chr1:45960581-45965646:-	-0.36	-5.13	8.79E-7	Body mass index	
PCPG	cis	1	rs6662641	chr1:46571509	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.64	7.77E-8	Body mass index	
PCPG	cis	1	rs6667191	chr1:45982844	CCDC163P	chr1:45960581-45965646:-	-0.59	-9.56	2.71E-17	Homocysteine levels	
PCPG	cis	1	rs6668284	chr1:46354510	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.46	1.87E-7	Body mass index	
PCPG	cis	1	rs6669522	chr1:46397941	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.52	1.42E-7	Body mass index	
PCPG	cis	1	rs6672898	chr1:46290588	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.53	1.37E-7	Body mass index	
PCPG	cis	1	rs66753001	chr19:17394839	MRPL34	chr19:17416477-17417652:+	-0.44	-4.62	8.05E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PCPG	cis	1	rs6675726	chr1:46560643	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.88	2.45E-8	Body mass index	
PCPG	cis	1	rs6675946	chr1:46371774	CCDC163P	chr1:45960581-45965646:-	-0.37	-5.29	4.19E-7	Body mass index	
PCPG	cis	1	rs6677007	chr1:46400590	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.55	1.23E-7	Body mass index	
PCPG	cis	1	rs6679	chr1:113243048	ST7L	chr1:113066142-113162405:-	0.46	4.19	4.62E-5	Diastolic blood pressure;Blood pressure	
PCPG	cis	1	rs6680380	chr1:46300189	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.49	1.61E-7	Body mass index	
PCPG	cis	1	rs6695809	chr1:46285461	CCDC163P	chr1:45960581-45965646:-	-0.37	-5.42	2.25E-7	Body mass index	
PCPG	cis	1	rs6699417	chr1:89123443	CCBL2	chr1:89401456-89458643:-	-0.49	-6.47	1.23E-9	Height	
PCPG	cis	1	rs6700597	chr1:46284246	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.4	2.43E-7	Body mass index	
PCPG	cis	1	rs6701614	chr1:46309420	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.51	1.51E-7	Body mass index	
PCPG	cis	1	rs6705489	chr2:73648811	ALMS1P	chr2:73872046-73912692:+	0.62	5.86	2.67E-8	Metabolite levels	
PCPG	cis	1	rs67073037	chr2:29119585	TRMT61B	chr2:29072690-29093175:-	0.43	4.11	6.39E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
PCPG	cis	1	rs6707722	chr2:73654363	ALMS1P	chr2:73872046-73912692:+	0.6	5.97	1.58E-8	Metabolite levels	
PCPG	cis	1	rs6707848	chr2:28988083	TRMT61B	chr2:29072690-29093175:-	-0.52	-5.26	4.78E-7	Body mass index	
PCPG	cis	1	rs6710438	chr2:73820108	ALMS1P	chr2:73872046-73912692:+	-0.56	-5.4	2.49E-7	Metabolite levels	
PCPG	cis	1	rs6710959	chr2:28958603	TRMT61B	chr2:29072690-29093175:-	-0.5	-4.84	3.17E-6	Body mass index	
PCPG	cis	1	rs6711033	chr2:73746643	ALMS1P	chr2:73872046-73912692:+	0.57	5.65	7.63E-8	Metabolite levels	
PCPG	cis	1	rs6711127	chr2:202213515	PPIL3	chr2:201735680-201753999:-	-0.66	-4.83	3.27E-6	Rheumatoid arthritis	
PCPG	cis	1	rs6711941	chr2:202178130	PPIL3	chr2:201735680-201753999:-	-0.68	-5.59	1.01E-7	Rheumatoid arthritis	
PCPG	cis	1	rs67131976	chr6:20686878	CDKAL1	chr6:20534688-21232632:+	-0.44	-4.5	1.33E-5	Type 2 diabetes	
PCPG	cis	1	rs6715284	chr2:202154397	PPIL3	chr2:201735680-201753999:-	-0.63	-5.9	2.18E-8	Rheumatoid arthritis	
PCPG	cis	1	rs6715380	chr2:202214505	PPIL3	chr2:201735680-201753999:-	-0.66	-4.83	3.27E-6	Rheumatoid arthritis	
PCPG	cis	1	rs6715819	chr2:73772309	ALMS1P	chr2:73872046-73912692:+	0.58	5.73	5.02E-8	Metabolite levels	
PCPG	cis	1	rs6720809	chr2:88528943	THNSL2	chr2:88469835-88486145:+	-0.72	-4.49	1.39E-5	Plasma clusterin levels	
PCPG	cis	1	rs6722069	chr2:88533151	THNSL2	chr2:88469835-88486145:+	-0.72	-4.49	1.39E-5	Plasma clusterin levels	
PCPG	cis	1	rs6724782	chr2:73679990	ALMS1P	chr2:73872046-73912692:+	0.59	5.75	4.69E-8	Metabolite levels	
PCPG	cis	1	rs6736866	chr2:73661986	ALMS1P	chr2:73872046-73912692:+	0.62	5.67	6.91E-8	Metabolite levels	
PCPG	cis	1	rs6740223	chr2:73653332	ALMS1P	chr2:73872046-73912692:+	0.6	5.97	1.58E-8	Metabolite levels	
PCPG	cis	1	rs6740641	chr2:54482989	C2orf73	chr2:54558071-54588714:+	0.54	4.11	6.41E-5	Telomere length	
PCPG	cis	1	rs6742276	chr2:61768745	AHSA2	chr2:61404553-61414058:+	-0.34	-4.93	2.1E-6	Tuberculosis	
PCPG	cis	1	rs6742276	chr2:61768745	C2orf74	chr2:61372243-61391964:+	0.35	4.54	1.14E-5	Tuberculosis	
PCPG	cis	1	rs6745368	chr2:73809974	ALMS1P	chr2:73872046-73912692:+	0.61	5.82	3.31E-8	Metabolite levels	
PCPG	cis	1	rs6752050	chr2:242228780	ANO7	chr2:242127924-242164791:+	0.39	4.06	7.71E-5	Prostate cancer	
PCPG	cis	1	rs6753344	chr2:73653138	ALMS1P	chr2:73872046-73912692:+	-0.56	-5.3	3.95E-7	Metabolite levels	
PCPG	cis	1	rs6755217	chr2:73641285	ALMS1P	chr2:73872046-73912692:+	0.64	5.82	3.23E-8	Metabolite levels	
PCPG	cis	1	rs6755241	chr2:73641364	ALMS1P	chr2:73872046-73912692:+	0.63	5.88	2.5E-8	Metabolite levels	
PCPG	cis	1	rs6756987	chr2:73687077	ALMS1P	chr2:73872046-73912692:+	0.58	5.7	5.93E-8	Metabolite levels	
PCPG	cis	1	rs6759004	chr2:202004676	PPIL3	chr2:201735680-201753999:-	-0.89	-9.35	9.65E-17	Triptolide cytotoxicity	
PCPG	cis	1	rs6763088	chr3:134254989	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs6763093	chr3:134254995	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs6763829	chr3:41897046	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs6765505	chr3:134208132	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.22E-6	Height	
PCPG	cis	1	rs6766818	chr3:134226159	ANAPC13	chr3:134196547-134204865:-	0.36	4.91	2.3E-6	Height	
PCPG	cis	1	rs6768128	chr3:41865080	ULK4	chr3:41288091-42003660:-	0.81	11.25	8.48E-22	Diastolic blood pressure	
PCPG	cis	1	rs6768542	chr3:41865474	ULK4	chr3:41288091-42003660:-	0.81	11.18	1.29E-21	Diastolic blood pressure	
PCPG	cis	1	rs6768563	chr3:41865541	ULK4	chr3:41288091-42003660:-	0.81	11.08	2.38E-21	Diastolic blood pressure	
PCPG	cis	1	rs6769885	chr3:134286913	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.45E-6	Height	
PCPG	cis	1	rs6770470	chr3:48435123	TREX1	chr3:48501186-48509043:+	-0.28	-4.31	2.86E-5	Longevity	
PCPG	cis	1	rs6772896	chr3:134203347	ANAPC13	chr3:134196547-134204865:-	0.33	4.49	1.36E-5	Height	
PCPG	cis	1	rs6781326	chr3:41777028	ULK4	chr3:41288091-42003660:-	0.68	9.71	1.12E-17	Diastolic blood pressure	
PCPG	cis	1	rs6782563	chr3:134295959	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.81E-6	Height	
PCPG	cis	1	rs6783001	chr3:41862232	ULK4	chr3:41288091-42003660:-	0.77	10.83	1.15E-20	Diastolic blood pressure	
PCPG	cis	1	rs6785027	chr3:134211649	ANAPC13	chr3:134196547-134204865:-	-0.33	-4.47	1.5E-5	Height	
PCPG	cis	1	rs6787371	chr3:134254991	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs6787952	chr3:156609375	LEKR1	chr3:156544076-156763918:+	-0.47	-4.25	3.65E-5	Bone mineral density	
PCPG	cis	1	rs6789260	chr3:41776350	ULK4	chr3:41288091-42003660:-	0.61	7.2	2.55E-11	Diastolic blood pressure	
PCPG	cis	1	rs6790466	chr3:134197740	ANAPC13	chr3:134196547-134204865:-	0.34	4.72	5.33E-6	Height	
PCPG	cis	1	rs6790732	chr3:41864872	ULK4	chr3:41288091-42003660:-	0.78	11.01	3.71E-21	Diastolic blood pressure	
PCPG	cis	1	rs6791806	chr3:41889995	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs6793487	chr3:134299426	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.81E-6	Height	
PCPG	cis	1	rs6796210	chr3:41851718	ULK4	chr3:41288091-42003660:-	0.74	10.74	1.98E-20	Diastolic blood pressure	
PCPG	cis	1	rs6796491	chr3:48430465	TREX1	chr3:48501186-48509043:+	-0.28	-4.12	6.11E-5	Longevity	
PCPG	cis	1	rs6797165	chr3:41887777	ULK4	chr3:41288091-42003660:-	0.78	11.3	6.13E-22	Diastolic blood pressure	
PCPG	cis	1	rs6800862	chr3:134228628	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs6801343	chr3:41767234	ULK4	chr3:41288091-42003660:-	0.72	10.06	1.27E-18	Diastolic blood pressure	
PCPG	cis	1	rs6801596	chr3:134252114	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs6802340	chr3:41894034	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs6802654	chr3:134217072	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs6803560	chr3:41824480	ULK4	chr3:41288091-42003660:-	0.7	10.27	3.5E-19	Diastolic blood pressure	
PCPG	cis	1	rs6803652	chr3:41824556	ULK4	chr3:41288091-42003660:-	0.7	10.27	3.5E-19	Diastolic blood pressure	
PCPG	cis	1	rs6804770	chr3:134230234	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs6804774	chr3:48430617	TREX1	chr3:48501186-48509043:+	-0.28	-4.12	6.11E-5	Longevity	
PCPG	cis	1	rs6805880	chr3:41865397	ULK4	chr3:41288091-42003660:-	0.81	11.18	1.29E-21	Diastolic blood pressure	
PCPG	cis	1	rs6806417	chr3:134211446	ANAPC13	chr3:134196547-134204865:-	-0.37	-5.74	4.98E-8	Height	
PCPG	cis	1	rs6807015	chr3:41754514	ULK4	chr3:41288091-42003660:-	0.72	9.75	8.37E-18	Diastolic blood pressure	
PCPG	cis	1	rs6810060	chr3:48434748	TREX1	chr3:48501186-48509043:+	-0.27	-4.2	4.43E-5	Longevity	
PCPG	cis	1	rs68141011	chr6:28217797	ZNF187	chr6:28234788-28245978:+	-0.35	-4.58	9.52E-6	Depression	
PCPG	cis	1	rs68171315	chr6:86707400	SNHG5	chr6:86386726-86388451:-	-0.51	-6.36	2.16E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs6832503	chr4:48028442	CNGA1	chr4:47937996-48018610:-	-0.47	-5.48	1.71E-7	Renal underexcretion gout;Gout	
PCPG	cis	1	rs6856137	chr4:142160161	ZNF330	chr4:142142049-142155848:+	0.33	4.07	7.52E-5	Conduct disorder	
PCPG	cis	1	rs6874560	chr5:150182713	LOC134466	chr5:150310000-150326146:-	0.75	4.13	6.04E-5	Crohn's disease	
PCPG	cis	1	rs687672	chr11:65649984	CTSW	chr11:65647284-65651212:+	0.55	5.66	7.23E-8	Crohn's disease	
PCPG	cis	1	rs687672	chr11:65649984	SNX32	chr11:65601410-65621170:+	-0.49	-4.83	3.3E-6	Crohn's disease	
PCPG	cis	1	rs6885541	chr5:56110857	C5orf35	chr5:56205103-56213010:+	1	9.54	3.06E-17	Type 2 diabetes	
PCPG	cis	1	rs6901575	chr6:28250984	ZNF187	chr6:28234788-28245978:+	-0.34	-4.61	8.23E-6	Depression	
PCPG	cis	1	rs6904601	chr6:170131905	WDR27	chr6:169857307-170102159:-	-0.44	-4.46	1.6E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs6905391	chr6:28262686	ZNF187	chr6:28234788-28245978:+	-0.31	-4.58	9.34E-6	Depression	
PCPG	cis	1	rs6905391	chr6:28262686	ZSCAN23	chr6:28393287-28411279:-	0.24	4.02	9.07E-5	Depression	
PCPG	cis	1	rs6908866	chr6:112118505	FYN	chr6:111982487-112194627:-	-0.33	-4.2	4.46E-5	Anger	
PCPG	cis	1	rs6912959	chr6:170126224	WDR27	chr6:169857307-170102159:-	-0.5	-5.38	2.75E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs6914463	chr6:86653415	SNHG5	chr6:86386726-86388451:-	-0.47	-6.12	7.36E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs6919306	chr6:112119619	FYN	chr6:111982487-112194627:-	-0.32	-4.27	3.47E-5	Anger	
PCPG	cis	1	rs6923148	chr6:86767786	SNHG5	chr6:86386726-86388451:-	0.46	5.86	2.67E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs6923339	chr6:170128033	WDR27	chr6:169857307-170102159:-	-0.44	-4.3	3.0E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs6927188	chr6:42912589	GNMT	chr6:42928500-42931617:+	0.53	5.43	2.19E-7	Diabetic kidney disease	
PCPG	cis	1	rs6927188	chr6:42912589	PEX6	chr6:42931613-42946981:-	-0.7	-6.22	4.59E-9	Diabetic kidney disease	
PCPG	cis	1	rs6930076	chr6:88088654	C6orf162	chr6:88032306-88052043:+	-0.48	-5.47	1.81E-7	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs6933377	chr6:86705255	SNHG5	chr6:86386726-86388451:-	0.46	6.08	8.91E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs6936048	chr6:86702608	SNHG5	chr6:86386726-86388451:-	-0.5	-6.33	2.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs693824	chr11:65654783	CTSW	chr11:65647284-65651212:+	-0.55	-5.66	7.23E-8	Crohn's disease	
PCPG	cis	1	rs693824	chr11:65654783	SNX32	chr11:65601410-65621170:+	0.49	4.83	3.3E-6	Crohn's disease	
PCPG	cis	1	rs6939727	chr6:112116451	FYN	chr6:111982487-112194627:-	-0.33	-4.2	4.46E-5	Anger	
PCPG	cis	1	rs6940458	chr6:86644992	SNHG5	chr6:86386726-86388451:-	-0.5	-6.31	2.85E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs6941766	chr6:170131653	WDR27	chr6:169857307-170102159:-	-0.44	-4.46	1.6E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs6942332	chr6:170131934	WDR27	chr6:169857307-170102159:-	-0.43	-4.33	2.63E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs694994	chr11:65653309	CTSW	chr11:65647284-65651212:+	-0.57	-5.96	1.69E-8	Crohn's disease	
PCPG	cis	1	rs694994	chr11:65653309	SNX32	chr11:65601410-65621170:+	0.47	4.63	7.69E-6	Crohn's disease	
PCPG	cis	1	rs6963495	chr7:105166853	EFCAB10	chr7:105205581-105221976:-	0.53	4.26	3.54E-5	Bipolar disorder (body mass index interaction)	
PCPG	cis	1	rs7007450	chr8:71640269	XKR9	chr8:71581600-71648176:+	0.95	16.95	4.93E-37	Bone mineral density	
PCPG	cis	1	rs7017914	chr8:71591203	XKR9	chr8:71581600-71648176:+	0.96	17.1	2.03E-37	Bone mineral density	
PCPG	cis	1	rs7018	chr20:25278261	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.3	3.04E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7018	chr20:25278261	FAM182A	chr20:26035250-26067552:+	-0.47	-5.71	5.57E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7019	chr20:25278278	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.2	4.44E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7019	chr20:25278278	FAM182A	chr20:26035250-26067552:+	-0.5	-5.92	2.06E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7020	chr20:25278600	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.24	3.87E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7020	chr20:25278600	FAM182A	chr20:26035250-26067552:+	-0.47	-5.69	6.34E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7022397	chr9:116007677	CDC26	chr9:116029290-116037869:-	-0.47	-6.19	5.27E-9	Hematology traits	
PCPG	cis	1	rs7037140	chr9:123656327	LOC253039	chr9:123605320-123616644:+	-0.58	-5.48	1.7E-7	Rheumatoid arthritis	
PCPG	cis	1	rs703842	chr12:58162739	FAM119B	chr12:58166383-58176323:+	-0.51	-5.05	1.24E-6	Multiple sclerosis	
PCPG	cis	1	rs703842	chr12:58162739	TSFM	chr12:58176536-58191367:+	0.54	6.86	1.59E-10	Multiple sclerosis	
PCPG	cis	1	rs7038769	chr9:116007583	CDC26	chr9:116029290-116037869:-	-0.47	-6.19	5.27E-9	Hematology traits	
PCPG	cis	1	rs7045881	chr9:26935996	LRRC19	chr9:26993143-27005691:-	-0.64	-4.08	7.24E-5	Schizophrenia	
PCPG	cis	1	rs705696	chr12:56480648	RPS26	chr12:56435686-56438005:+	0.59	6.18	5.49E-9	Cognitive function	
PCPG	cis	1	rs7072204	chr10:124195485	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.41	1.96E-5	Height	
PCPG	cis	1	rs7072216	chr10:100156853	PYROXD2	chr10:100143323-100174978:-	0.58	7.56	3.48E-12	Metabolite levels	
PCPG	cis	1	rs7079976	chr10:124172108	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.38	2.17E-5	Height	
PCPG	cis	1	rs709592	chr17:38175553	GSDMA	chr17:38119226-38134019:+	-0.68	-8.41	2.56E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs7097701	chr10:124171857	PLEKHA1	chr10:124134220-124191866:+	-0.31	-4.38	2.17E-5	Height	
PCPG	cis	1	rs7115737	chr11:43681249	HSD17B12	chr11:43702143-43878160:+	-0.44	-5.01	1.45E-6	Forced vital capacity	
PCPG	cis	1	rs7124676	chr11:64313291	RTN3	chr11:63448922-63527357:+	-0.28	-4.31	2.92E-5	Obesity-related traits	
PCPG	cis	1	rs71327718	chr3:125592857	LOC100125556	chr3:125635444-125648865:+	0.54	4.25	3.65E-5	Metabolite levels (HVA/5-HIAA ratio)	
PCPG	cis	1	rs7153160	chr14:74509377	LIN52	chr14:74551656-74667117:+	0.33	6.44	1.46E-9	Common traits (Other)	
PCPG	cis	1	rs7153587	chr14:74509660	LIN52	chr14:74551656-74667117:+	0.3	5.7	6.02E-8	Common traits (Other)	
PCPG	cis	1	rs7157566	chr14:74649129	LIN52	chr14:74551656-74667117:+	-0.29	-5.42	2.27E-7	Common traits (Other)	
PCPG	cis	1	rs7163482	chr15:65739683	DPP8	chr15:65737999-65810035:-	-0.18	-4.33	2.71E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs7163730	chr15:78814681	CHRNA5	chr15:78857906-78886458:+	0.35	4.41	1.95E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs7164132	chr15:40675155	C15orf23	chr15:40674922-40686488:+	1.08	10.57	5.79E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs7164594	chr15:78803057	CHRNA5	chr15:78857906-78886458:+	0.34	4.1	6.79E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs7165102	chr15:65888359	DPP8	chr15:65737999-65810035:-	-0.19	-4.47	1.48E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs7166453	chr15:66013143	DPP8	chr15:65737999-65810035:-	-0.19	-4.65	7.18E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs7166991	chr15:40671957	C15orf23	chr15:40674922-40686488:+	1.07	10.54	6.73E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs7167138	chr15:50958998	SPPL2A	chr15:50999739-51057910:-	0.33	4.84	3.07E-6	QT interval	
PCPG	cis	1	rs7169404	chr15:40675443	C15orf23	chr15:40674922-40686488:+	1.06	10.4	1.57E-19	Heschl's gyrus morphology	
PCPG	cis	1	rs7171869	chr15:78900909	CHRNA5	chr15:78857906-78886458:+	-0.31	-4.15	5.58E-5	Post bronchodilator FEV1	
PCPG	cis	1	rs7172335	chr15:65977204	DPP8	chr15:65737999-65810035:-	-0.19	-4.71	5.38E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs7178584	chr15:65795200	DPP8	chr15:65737999-65810035:-	0.18	4.29	3.1E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs7181245	chr15:78814389	CHRNA5	chr15:78857906-78886458:+	0.37	4.61	8.39E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs7181333	chr15:66039826	DPP8	chr15:65737999-65810035:-	0.19	4.79	3.95E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs7181447	chr15:78814567	CHRNA5	chr15:78857906-78886458:+	0.37	4.61	8.39E-6	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs7201498	chr16:20449449	ACSM5	chr16:20420856-20452278:+	-0.35	-4.31	2.92E-5	Blood metabolite levels	
PCPG	cis	1	rs7207021	chr17:28400516	EFCAB5	chr17:28256874-28435469:+	-0.44	-4.28	3.32E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs7209180	chr17:79581519	TSPAN10	chr17:79609349-79615778:+	0.62	8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs7210738	chr17:45757598	C17orf57	chr17:45401142-45518675:+	-0.38	-4.38	2.23E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs7212497	chr17:28335949	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs7213129	chr17:79581573	TSPAN10	chr17:79609349-79615778:+	0.62	8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs7214085	chr17:38169095	GSDMA	chr17:38119226-38134019:+	-0.67	-8.35	3.61E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs7215147	chr17:30266711	LRRC37B	chr17:30335037-30380517:+	0.39	4.06	7.64E-5	Height	
PCPG	cis	1	rs7215564	chr17:78737287	NPTX1	chr17:78440633-78450404:-	-0.56	-4.03	8.66E-5	Myopia (pathological)	
PCPG	cis	1	rs7222241	chr17:79574714	TSPAN10	chr17:79609349-79615778:+	0.61	8.3	4.93E-14	Eye color traits	
PCPG	cis	1	rs7222308	chr17:28277041	EFCAB5	chr17:28256874-28435469:+	0.41	4.06	7.74E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs7223613	chr17:79574803	TSPAN10	chr17:79609349-79615778:+	-0.62	-8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs7223786	chr17:28332107	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs725309	chr3:48418708	TREX1	chr3:48501186-48509043:+	0.29	4.34	2.6E-5	Longevity	
PCPG	cis	1	rs725310	chr3:48418571	TREX1	chr3:48501186-48509043:+	0.31	4.76	4.36E-6	Longevity	
PCPG	cis	1	rs7254758	chr19:33608047	GPATCH1	chr19:33571786-33621318:+	0.39	5.14	8.25E-7	Bone properties (heel)	
PCPG	cis	1	rs7255679	chr19:42063981	CEACAM21	chr19:42055886-42093196:+	0.61	8.88	1.66E-15	Schizophrenia	
PCPG	cis	1	rs7255968	chr19:33601902	GPATCH1	chr19:33571786-33621318:+	0.45	5.62	8.56E-8	Bone properties (heel)	
PCPG	cis	1	rs725908	chr20:33968067	UQCC	chr20:33890383-33999833:-	0.44	5.68	6.55E-8	Height	
PCPG	cis	1	rs72644211	chr10:81781695	LOC219347	chr10:81805991-81838949:-	1.05	8.19	9.53E-14	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs72644213	chr10:81783660	LOC219347	chr10:81805991-81838949:-	1.05	8.02	2.48E-13	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs7267979	chr20:25298087	ENTPD6	chr20:25176339-25207360:+	-0.33	-4.19	4.63E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7267979	chr20:25298087	FAM182A	chr20:26035250-26067552:+	-0.48	-5.86	2.76E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7268053	chr20:25328286	FAM182A	chr20:26035250-26067552:+	0.52	6.5	1.05E-9	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs72768397	chr1:247219411	ZNF670	chr1:247200087-247242069:-	-0.44	-5.57	1.08E-7	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs72782294	chr2:28953390	TRMT61B	chr2:29072690-29093175:-	0.5	4.84	3.17E-6	Body mass index	
PCPG	cis	1	rs72819593	chr17:2199489	SRR	chr17:2207248-2228553:+	-0.59	-6.42	1.59E-9	Esophageal cancer (squamous cell)	
PCPG	cis	1	rs72830699	chr6:20704424	CDKAL1	chr6:20534688-21232632:+	-0.44	-4.47	1.53E-5	Type 2 diabetes	
PCPG	cis	1	rs72843784	chr6:26498758	BTN3A2	chr6:26365398-26378546:+	-0.84	-5.14	8.41E-7	Schizophrenia	
PCPG	cis	1	rs7285549	chr22:25874580	CRYBB2	chr22:25615612-25627836:+	0.73	6.34	2.4E-9	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs728615	chr10:81848089	MBL1P	chr10:81664654-81710783:+	0.62	4.45	1.61E-5	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs728616	chr10:81847914	MBL1P	chr10:81664654-81710783:+	0.66	4.7	5.69E-6	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs728616	chr10:81847914	PLAC9	chr10:81892258-81904784:+	-0.26	-4.03	8.82E-5	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs7290298	chr22:40453964	XPNPEP3	chr22:41253094-41363888:+	0.54	5.04	1.3E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs7291691	chr22:40454069	XPNPEP3	chr22:41253094-41363888:+	0.54	5.04	1.3E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs72934944	chr2:202190610	PPIL3	chr2:201735680-201753999:-	-0.66	-5.3	3.91E-7	Rheumatoid arthritis	
PCPG	cis	1	rs72934960	chr2:202204749	PPIL3	chr2:201735680-201753999:-	-0.74	-5.22	5.72E-7	Rheumatoid arthritis	
PCPG	cis	1	rs72934973	chr2:202213934	PPIL3	chr2:201735680-201753999:-	-0.66	-4.83	3.27E-6	Rheumatoid arthritis	
PCPG	cis	1	rs72934999	chr2:202223524	PPIL3	chr2:201735680-201753999:-	-0.66	-4.83	3.27E-6	Rheumatoid arthritis	
PCPG	cis	1	rs72937106	chr2:202225520	PPIL3	chr2:201735680-201753999:-	-0.61	-4.4	2.05E-5	Rheumatoid arthritis	
PCPG	cis	1	rs72937118	chr2:202229527	PPIL3	chr2:201735680-201753999:-	-0.62	-4.37	2.25E-5	Rheumatoid arthritis	
PCPG	cis	1	rs72937120	chr2:202232611	PPIL3	chr2:201735680-201753999:-	-0.6	-4.22	4.21E-5	Rheumatoid arthritis	
PCPG	cis	1	rs73004382	chr2:242382192	ANO7	chr2:242127924-242164791:+	0.39	4.04	8.43E-5	Prostate cancer	
PCPG	cis	1	rs73069392	chr3:41787009	ULK4	chr3:41288091-42003660:-	0.67	8.61	8.08E-15	Diastolic blood pressure	
PCPG	cis	1	rs73069394	chr3:41787233	ULK4	chr3:41288091-42003660:-	0.72	10.27	3.58E-19	Diastolic blood pressure	
PCPG	cis	1	rs73069396	chr3:41787236	ULK4	chr3:41288091-42003660:-	0.72	10.27	3.58E-19	Diastolic blood pressure	
PCPG	cis	1	rs73071329	chr3:41810539	ULK4	chr3:41288091-42003660:-	0.71	10.62	4.15E-20	Diastolic blood pressure	
PCPG	cis	1	rs73074358	chr3:48427247	TREX1	chr3:48501186-48509043:+	-0.28	-4.12	6.11E-5	Longevity	
PCPG	cis	1	rs73077367	chr3:41851959	ULK4	chr3:41288091-42003660:-	0.74	10.66	3.17E-20	Diastolic blood pressure	
PCPG	cis	1	rs73079316	chr3:41863859	ULK4	chr3:41288091-42003660:-	0.7	8.03	2.35E-13	Diastolic blood pressure	
PCPG	cis	1	rs73079321	chr3:41863910	ULK4	chr3:41288091-42003660:-	0.81	11.25	8.48E-22	Diastolic blood pressure	
PCPG	cis	1	rs73081353	chr3:41906448	ULK4	chr3:41288091-42003660:-	0.7	8.34	3.9E-14	Diastolic blood pressure	
PCPG	cis	1	rs73081364	chr3:41913616	ULK4	chr3:41288091-42003660:-	0.7	8.34	3.9E-14	Diastolic blood pressure	
PCPG	cis	1	rs7309927	chr12:1000185	RAD52	chr12:1021255-1099219:-	-0.45	-4.92	2.17E-6	Colorectal cancer	
PCPG	cis	1	rs7314056	chr12:122342964	PSMD9	chr12:122326646-122355770:+	-0.46	-4.48	1.47E-5	Urinary metabolites	
PCPG	cis	1	rs7320397	chr13:26730629	CDK8	chr13:26828756-26978569:+	0.28	4.15	5.46E-5	Response to Homoharringtonine (cytotoxicity)	
PCPG	cis	1	rs7324154	chr13:47891364	SUCLA2	chr13:48516792-48612125:-	0.52	4.28	3.23E-5	Cannabis use (initiation)	
PCPG	cis	1	rs73242910	chr6:170114670	WDR27	chr6:169857307-170102159:-	-0.5	-5.36	2.96E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs73242927	chr6:170129573	WDR27	chr6:169857307-170102159:-	-0.44	-4.3	3.0E-5	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs7332725	chr13:26732262	CDK8	chr13:26828756-26978569:+	0.3	4.5	1.33E-5	Response to Homoharringtonine (cytotoxicity)	
PCPG	cis	1	rs73348070	chr5:127893533	FBN2	chr5:127593602-127873916:-	0.47	4.97	1.79E-6	Multiple system atrophy	
PCPG	cis	1	rs7343481	chr20:25300113	ENTPD6	chr20:25176339-25207360:+	0.34	4.28	3.29E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7343481	chr20:25300113	FAM182A	chr20:26035250-26067552:+	0.48	5.97	1.6E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs73509996	chr19:17393449	MRPL34	chr19:17416477-17417652:+	-0.44	-4.65	7.11E-6	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PCPG	cis	1	rs735531	chr20:33947730	CPNE1	chr20:34213968-34262539:-	0.3	4.14	5.59E-5	Height	
PCPG	cis	1	rs735531	chr20:33947730	UQCC	chr20:33890383-33999833:-	0.44	5.71	5.65E-8	Height	
PCPG	cis	1	rs7356093	chr3:134238753	ANAPC13	chr3:134196547-134204865:-	0.37	5.14	8.41E-7	Height	
PCPG	cis	1	rs7371896	chr3:134249769	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs7372217	chr3:41990122	ULK4	chr3:41288091-42003660:-	-0.78	-11.43	2.66E-22	Diastolic blood pressure	
PCPG	cis	1	rs7374158	chr3:134270156	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs7374325	chr3:134275601	ANAPC13	chr3:134196547-134204865:-	0.37	5	1.56E-6	Height	
PCPG	cis	1	rs739954	chr5:139701920	SLC35A4	chr5:139944420-139948683:+	0.3	4.31	2.89E-5	Alzheimer's disease in APOE e4- carriers	
PCPG	cis	1	rs74003347	chr15:24058419	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs74003350	chr15:24058541	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs74003352	chr15:24058840	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs74003353	chr15:24059444	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs7406003	chr17:79597597	TSPAN10	chr17:79609349-79615778:+	0.61	8.04	2.22E-13	Eye color traits	
PCPG	cis	1	rs7425670	chr2:88522028	THNSL2	chr2:88469835-88486145:+	-0.69	-4.31	2.92E-5	Plasma clusterin levels	
PCPG	cis	1	rs7426847	chr3:134267519	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.9E-6	Height	
PCPG	cis	1	rs7427165	chr3:121364624	IQCB1	chr3:121488610-121553926:-	0.47	5.65	7.5E-8	Cognitive performance	
PCPG	cis	1	rs7427492	chr3:134261654	ANAPC13	chr3:134196547-134204865:-	0.37	5	1.56E-6	Height	
PCPG	cis	1	rs7428326	chr3:134251184	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs7429866	chr3:134236306	ANAPC13	chr3:134196547-134204865:-	-0.35	-4.61	8.34E-6	Height	
PCPG	cis	1	rs7432268	chr3:134242051	ANAPC13	chr3:134196547-134204865:-	0.37	5.14	8.41E-7	Height	
PCPG	cis	1	rs7433663	chr3:134235790	ANAPC13	chr3:134196547-134204865:-	0.34	4.69	6.07E-6	Height	
PCPG	cis	1	rs7433991	chr3:134312292	ANAPC13	chr3:134196547-134204865:-	0.35	4.81	3.5E-6	Height	
PCPG	cis	1	rs74372131	chr10:81787214	LOC219347	chr10:81805991-81838949:-	1.05	8.07	1.84E-13	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs7475154	chr10:131440584	MGMT	chr10:131265454-131565783:+	-0.37	-4.74	4.87E-6	Response to temozolomide	
PCPG	cis	1	rs74771370	chr15:24056589	WHAMML1	chr15:23187731-23208357:-	0.7	4.1	6.65E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs74823197	chr7:108709903	PNPLA8	chr7:108112071-108168605:-	-0.61	-4.05	8.12E-5	Smoking behavior	
PCPG	cis	1	rs74900588	chr6:170102180	WDR27	chr6:169857307-170102159:-	-0.51	-5.43	2.12E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs7496335	chr15:65758868	DPP8	chr15:65737999-65810035:-	-0.17	-4.13	5.83E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs7503679	chr17:79583843	TSPAN10	chr17:79609349-79615778:+	0.62	8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs7511962	chr1:247212122	ZNF670	chr1:247200087-247242069:-	-0.47	-5.93	1.96E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs7512150	chr1:247212326	ZNF670	chr1:247200087-247242069:-	-0.47	-6.01	1.28E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs7515491	chr1:46355079	CCDC163P	chr1:45960581-45965646:-	-0.36	-5.49	1.66E-7	Body mass index	
PCPG	cis	1	rs75159543	chr15:40665228	C15orf23	chr15:40674922-40686488:+	1.08	10.55	6.29E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs75181745	chr2:88520408	THNSL2	chr2:88469835-88486145:+	-0.75	-4.65	7.06E-6	Plasma clusterin levels	
PCPG	cis	1	rs7519795	chr1:247212126	ZNF670	chr1:247200087-247242069:-	-0.47	-5.93	1.96E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs7522601	chr1:46419021	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.7	5.81E-8	Body mass index	
PCPG	cis	1	rs7522705	chr1:45992300	CCDC163P	chr1:45960581-45965646:-	0.51	6.71	3.53E-10	Homocysteine levels	
PCPG	cis	1	rs7524495	chr1:46266932	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.92E-7	Body mass index	
PCPG	cis	1	rs75278386	chr15:40678312	C15orf23	chr15:40674922-40686488:+	1.08	10.57	5.79E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs75309929	chr2:88524377	THNSL2	chr2:88469835-88486145:+	-0.72	-4.34	2.6E-5	Plasma clusterin levels	
PCPG	cis	1	rs7534467	chr1:45988691	CCDC163P	chr1:45960581-45965646:-	-0.6	-9.63	1.84E-17	Homocysteine levels	
PCPG	cis	1	rs7536557	chr1:45992114	CCDC163P	chr1:45960581-45965646:-	-0.56	-8.66	5.83E-15	Homocysteine levels	
PCPG	cis	1	rs7539932	chr1:46292354	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.49	1.61E-7	Body mass index	
PCPG	cis	1	rs7540325	chr1:46338217	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.45	1.97E-7	Body mass index	
PCPG	cis	1	rs7546342	chr1:247213292	ZNF670	chr1:247200087-247242069:-	-0.47	-6.01	1.28E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs7549410	chr1:247214167	ZNF670	chr1:247200087-247242069:-	-0.45	-5.92	2.05E-8	Response to taxane treatment (docetaxel)	
PCPG	cis	1	rs7550746	chr1:46351719	CCDC163P	chr1:45960581-45965646:-	-0.38	-5.52	1.4E-7	Body mass index	
PCPG	cis	1	rs7556436	chr1:46363880	CCDC163P	chr1:45960581-45965646:-	0.38	5.41	2.37E-7	Body mass index	
PCPG	cis	1	rs7556615	chr1:46461369	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.82	3.28E-8	Body mass index	
PCPG	cis	1	rs7558944	chr2:73810909	ALMS1P	chr2:73872046-73912692:+	0.61	5.93	1.93E-8	Metabolite levels	
PCPG	cis	1	rs7560328	chr2:202164837	ALS2CR12	chr2:202153148-202222101:-	-0.41	-4.87	2.8E-6	Melanoma;Esophageal squamous cell carcinoma	
PCPG	cis	1	rs7562170	chr2:28943516	TRMT61B	chr2:29072690-29093175:-	0.51	5	1.57E-6	Body mass index	
PCPG	cis	1	rs7564890	chr2:73641853	ALMS1P	chr2:73872046-73912692:+	0.61	5.77	4.28E-8	Metabolite levels	
PCPG	cis	1	rs7572722	chr2:73724675	ALMS1P	chr2:73872046-73912692:+	0.59	5.66	7.36E-8	Metabolite levels	
PCPG	cis	1	rs7576245	chr2:73829678	ALMS1P	chr2:73872046-73912692:+	0.6	5.81	3.48E-8	Metabolite levels	
PCPG	cis	1	rs7579277	chr2:28996295	TRMT61B	chr2:29072690-29093175:-	-0.52	-5.28	4.38E-7	Body mass index	
PCPG	cis	1	rs757978	chr2:242371101	SEPT2	chr2:242254723-242293439:+	0.52	4.11	6.36E-5	Chronic lymphocytic leukemia	
PCPG	cis	1	rs7580240	chr2:29114372	TRMT61B	chr2:29072690-29093175:-	0.44	4.24	3.8E-5	Breast cancer (estrogen-receptor negative);Breast cancer	
PCPG	cis	1	rs7580825	chr2:73635148	ALMS1P	chr2:73872046-73912692:+	0.62	5.85	2.79E-8	Metabolite levels	
PCPG	cis	1	rs75824542	chr14:74523047	LIN52	chr14:74551656-74667117:+	0.3	5.65	7.54E-8	Common traits (Other)	
PCPG	cis	1	rs7582606	chr2:73813945	ALMS1P	chr2:73872046-73912692:+	0.6	5.9	2.27E-8	Metabolite levels	
PCPG	cis	1	rs7583255	chr2:73797996	ALMS1P	chr2:73872046-73912692:+	0.61	5.82	3.31E-8	Metabolite levels	
PCPG	cis	1	rs7584575	chr2:73666402	ALMS1P	chr2:73872046-73912692:+	0.58	5.86	2.76E-8	Metabolite levels	
PCPG	cis	1	rs7585004	chr2:73666645	ALMS1P	chr2:73872046-73912692:+	0.6	6	1.33E-8	Metabolite levels	
PCPG	cis	1	rs7586463	chr2:73798476	ALMS1P	chr2:73872046-73912692:+	0.61	5.82	3.31E-8	Metabolite levels	
PCPG	cis	1	rs7587476	chr2:215653887	BARD1	chr2:215593275-215674428:-	0.32	4.47	1.49E-5	Neuroblastoma	
PCPG	cis	1	rs7589728	chr2:88518440	THNSL2	chr2:88469835-88486145:+	-0.76	-4.7	5.62E-6	Plasma clusterin levels	
PCPG	cis	1	rs75913297	chr10:81789845	LOC219347	chr10:81805991-81838949:-	0.99	8.09	1.65E-13	Chronic obstructive pulmonary disease-related biomarkers	
PCPG	cis	1	rs7591472	chr2:201889751	PPIL3	chr2:201735680-201753999:-	-0.96	-9.9	3.38E-18	Triptolide cytotoxicity	
PCPG	cis	1	rs7594511	chr2:73681639	ALMS1P	chr2:73872046-73912692:+	0.59	5.63	8.21E-8	Metabolite levels	
PCPG	cis	1	rs7598396	chr2:73652628	ALMS1P	chr2:73872046-73912692:+	0.59	5.76	4.36E-8	Metabolite levels	
PCPG	cis	1	rs7598419	chr2:73798223	ALMS1P	chr2:73872046-73912692:+	0.63	5.67	6.81E-8	Metabolite levels	
PCPG	cis	1	rs7598876	chr2:28974466	TRMT61B	chr2:29072690-29093175:-	-0.5	-4.83	3.34E-6	Body mass index	
PCPG	cis	1	rs7604682	chr2:73788026	ALMS1P	chr2:73872046-73912692:+	0.61	6.05	1.05E-8	Metabolite levels	
PCPG	cis	1	rs760555	chr22:25872837	CRYBB2	chr22:25615612-25627836:+	0.68	6.05	1.08E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs7607014	chr2:73730174	ALMS1P	chr2:73872046-73912692:+	-0.57	-5.64	7.87E-8	Metabolite levels	
PCPG	cis	1	rs7609851	chr3:156638503	LEKR1	chr3:156544076-156763918:+	-0.52	-5.09	1.04E-6	Bone mineral density	
PCPG	cis	1	rs761025	chr20:25426968	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.32	2.81E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs761025	chr20:25426968	FAM182A	chr20:26035250-26067552:+	-0.46	-5.57	1.09E-7	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs7611611	chr3:134307877	ANAPC13	chr3:134196547-134204865:-	0.35	4.81	3.5E-6	Height	
PCPG	cis	1	rs7611828	chr3:134250325	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs7616844	chr3:41874343	ULK4	chr3:41288091-42003660:-	0.78	10.98	4.48E-21	Diastolic blood pressure	
PCPG	cis	1	rs7617397	chr3:41959037	ULK4	chr3:41288091-42003660:-	-0.78	-11.6	9.07E-23	Diastolic blood pressure	
PCPG	cis	1	rs7617912	chr3:156576412	LEKR1	chr3:156544076-156763918:+	-0.5	-4.68	6.35E-6	Bone mineral density	
PCPG	cis	1	rs7619451	chr3:134233238	ANAPC13	chr3:134196547-134204865:-	0.34	4.62	8.05E-6	Height	
PCPG	cis	1	rs7620458	chr3:156576850	LEKR1	chr3:156544076-156763918:+	-0.48	-4.49	1.41E-5	Bone mineral density	
PCPG	cis	1	rs7622259	chr3:41881351	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs76233091	chr15:24054578	WHAMML1	chr15:23187731-23208357:-	0.7	4.12	6.18E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs7624372	chr3:41881107	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs76277863	chr15:40649863	C15orf23	chr15:40674922-40686488:+	1.13	11.2	1.15E-21	Heschl's gyrus morphology	
PCPG	cis	1	rs7630874	chr3:134293291	ANAPC13	chr3:134196547-134204865:-	-0.36	-4.86	2.85E-6	Height	
PCPG	cis	1	rs7631057	chr3:41817951	ULK4	chr3:41288091-42003660:-	0.72	10.73	2.12E-20	Diastolic blood pressure	
PCPG	cis	1	rs7632387	chr3:41853161	ULK4	chr3:41288091-42003660:-	0.66	8.19	9.46E-14	Diastolic blood pressure	
PCPG	cis	1	rs7636782	chr3:48421387	TREX1	chr3:48501186-48509043:+	-0.26	-4.04	8.3E-5	Longevity	
PCPG	cis	1	rs7637227	chr3:134244155	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs7639514	chr3:156576067	LEKR1	chr3:156544076-156763918:+	-0.5	-4.94	2.03E-6	Bone mineral density	
PCPG	cis	1	rs7646144	chr3:41853125	ULK4	chr3:41288091-42003660:-	0.65	8.05	2.13E-13	Diastolic blood pressure	
PCPG	cis	1	rs76471037	chr3:41799414	ULK4	chr3:41288091-42003660:-	0.73	10.41	1.52E-19	Diastolic blood pressure	
PCPG	cis	1	rs7648357	chr3:41849670	ULK4	chr3:41288091-42003660:-	0.74	10.79	1.44E-20	Diastolic blood pressure	
PCPG	cis	1	rs7648578	chr3:41858731	ULK4	chr3:41288091-42003660:-	0.74	10.69	2.71E-20	Diastolic blood pressure	
PCPG	cis	1	rs7648990	chr3:134244390	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs7650227	chr3:41794937	ULK4	chr3:41288091-42003660:-	0.72	10.53	7.06E-20	Diastolic blood pressure	
PCPG	cis	1	rs7651407	chr3:48443816	TREX1	chr3:48501186-48509043:+	-0.28	-4.21	4.38E-5	Longevity	
PCPG	cis	1	rs7653691	chr3:48419689	TREX1	chr3:48501186-48509043:+	0.29	4.21	4.28E-5	Longevity	
PCPG	cis	1	rs76542740	chr15:43891512	ADAL	chr15:43622872-43646094:+	-0.52	-5.01	1.49E-6	Tumor biomarkers	
PCPG	cis	1	rs765527	chr19:22129555	ZNF257	chr19:22235266-22273901:+	-0.49	-4.86	2.87E-6	Chagas cardiomyopathy in Tripanosoma cruzi seropositivity	
PCPG	cis	1	rs7656037	chr4:39717965	RPL9	chr4:39455747-39460568:-	-0.51	-5.19	6.43E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
PCPG	cis	1	rs7661070	chr4:39724365	RPL9	chr4:39455747-39460568:-	-0.53	-5.41	2.39E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
PCPG	cis	1	rs7663811	chr4:142154614	ZNF330	chr4:142142049-142155848:+	-0.35	-4.33	2.69E-5	Conduct disorder	
PCPG	cis	1	rs7667	chr1:19718824	ALDH4A1	chr1:19197926-19229293:-	0.3	4.08	7.12E-5	Crohn's disease and psoriasis	
PCPG	cis	1	rs7679975	chr4:142154551	ZNF330	chr4:142142049-142155848:+	-0.35	-4.29	3.12E-5	Conduct disorder	
PCPG	cis	1	rs76812330	chr19:50531860	SIGLEC16	chr19:50472912-50479075:+	0.77	5.1	9.92E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs7684664	chr4:142150860	ZNF330	chr4:142142049-142155848:+	-0.34	-4.05	7.96E-5	Conduct disorder	
PCPG	cis	1	rs7687557	chr4:39769260	RPL9	chr4:39455747-39460568:-	-0.52	-5.38	2.68E-7	Plasma amyloid beta peptide concentrations (ABx-40)	
PCPG	cis	1	rs76955643	chr15:24054859	WHAMML1	chr15:23187731-23208357:-	0.7	4.12	6.18E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs76994419	chr15:40714150	C15orf23	chr15:40674922-40686488:+	1.2	10.71	2.32E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs7705093	chr5:96290647	ERAP2	chr5:96211644-96255398:+	1.16	22.74	4.28E-51	Birdshot chorioretinopathy	
PCPG	cis	1	rs77187281	chr19:50507667	SIGLEC16	chr19:50472912-50479075:+	0.77	5.1	9.92E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs7740487	chr6:28216486	ZNF187	chr6:28234788-28245978:+	-0.35	-4.61	8.53E-6	Depression	
PCPG	cis	1	rs7743393	chr6:127396215	THEMIS	chr6:128029346-128239742:-	0.27	4.18	4.78E-5	Iron status biomarkers	
PCPG	cis	1	rs7746598	chr6:170084933	WDR27	chr6:169857307-170102159:-	-0.54	-5.64	7.98E-8	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs7747645	chr6:170070291	WDR27	chr6:169857307-170102159:-	-0.57	-6.26	3.71E-9	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs7747824	chr6:86647106	SNHG5	chr6:86386726-86388451:-	-0.47	-6.15	6.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs7750918	chr6:49430082	MUT	chr6:49398994-49431031:-	0.26	4.18	4.81E-5	Folate pathway vitamin levels	
PCPG	cis	1	rs77531164	chr15:40673466	C15orf23	chr15:40674922-40686488:+	1.05	10.26	3.75E-19	Heschl's gyrus morphology	
PCPG	cis	1	rs7756203	chr6:86627707	SNHG5	chr6:86386726-86388451:-	-0.49	-6.23	4.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs7757969	chr6:112132032	FYN	chr6:111982487-112194627:-	-0.33	-4.26	3.54E-5	Anger	
PCPG	cis	1	rs7758660	chr6:112128947	FYN	chr6:111982487-112194627:-	-0.32	-4.12	6.14E-5	Anger	
PCPG	cis	1	rs7760207	chr6:86721700	SNHG5	chr6:86386726-86388451:-	-0.5	-6.32	2.67E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs7762018	chr6:170113244	WDR27	chr6:169857307-170102159:-	-0.5	-5.12	8.99E-7	Thiazide-induced adverse metabolic effects in hypertensive patients	
PCPG	cis	1	rs7766645	chr6:86622238	SNHG5	chr6:86386726-86388451:-	-0.47	-6.15	6.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs7771342	chr6:86631936	SNHG5	chr6:86386726-86388451:-	-0.49	-6.23	4.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs77828254	chr14:32225501	NUBPL	chr14:32030591-32330417:+	0.33	4.23	4.06E-5	Polychlorinated biphenyl levels	
PCPG	cis	1	rs778758	chr2:61782161	AHSA2	chr2:61404553-61414058:+	-0.36	-5.31	3.75E-7	Tuberculosis	
PCPG	cis	1	rs778758	chr2:61782161	C2orf74	chr2:61372243-61391964:+	0.34	4.5	1.32E-5	Tuberculosis	
PCPG	cis	1	rs778762	chr2:61782921	AHSA2	chr2:61404553-61414058:+	-0.36	-5.37	2.87E-7	Tuberculosis	
PCPG	cis	1	rs778762	chr2:61782921	C2orf74	chr2:61372243-61391964:+	0.34	4.52	1.21E-5	Tuberculosis	
PCPG	cis	1	rs778763	chr2:61785639	AHSA2	chr2:61404553-61414058:+	-0.36	-5.31	3.75E-7	Tuberculosis	
PCPG	cis	1	rs778763	chr2:61785639	C2orf74	chr2:61372243-61391964:+	0.34	4.5	1.32E-5	Tuberculosis	
PCPG	cis	1	rs7792262	chr7:23915743	C7orf46	chr7:23719749-23742268:+	-0.44	-5.76	4.37E-8	Schizophrenia	
PCPG	cis	1	rs78153629	chr15:40673465	C15orf23	chr15:40674922-40686488:+	1.05	10.34	2.38E-19	Heschl's gyrus morphology	
PCPG	cis	1	rs785464	chr1:46523089	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.92	2.01E-8	Body mass index	
PCPG	cis	1	rs785471	chr1:46518677	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.46	1.89E-7	Body mass index	
PCPG	cis	1	rs785479	chr1:46492144	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.71	5.55E-8	Body mass index	
PCPG	cis	1	rs785481	chr1:46554518	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.88	2.45E-8	Body mass index	
PCPG	cis	1	rs785485	chr1:46574424	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.74	4.95E-8	Body mass index	
PCPG	cis	1	rs785488	chr1:46576095	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.94	1.8E-8	Body mass index	
PCPG	cis	1	rs785489	chr1:46576390	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.94	1.8E-8	Body mass index	
PCPG	cis	1	rs785491	chr1:46583418	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.16	5.93E-9	Body mass index	
PCPG	cis	1	rs785492	chr1:46583607	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.92	2.01E-8	Body mass index	
PCPG	cis	1	rs785494	chr1:46586626	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.15	6.41E-9	Body mass index	
PCPG	cis	1	rs785495	chr1:46587887	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.25	3.8E-9	Body mass index	
PCPG	cis	1	rs785503	chr1:46595868	CCDC163P	chr1:45960581-45965646:-	-0.41	-6.15	6.41E-9	Body mass index	
PCPG	cis	1	rs785520	chr1:46568836	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.88	2.45E-8	Body mass index	
PCPG	cis	1	rs789859	chr3:194405888	LSG1	chr3:194361518-194393206:-	-0.26	-4.07	7.58E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs789860	chr3:194405630	LSG1	chr3:194361518-194393206:-	-0.27	-4.07	7.43E-5	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs79044944	chr15:40676285	C15orf23	chr15:40674922-40686488:+	1.08	10.57	5.79E-20	Heschl's gyrus morphology	
PCPG	cis	1	rs79099212	chr15:24054856	WHAMML1	chr15:23187731-23208357:-	0.7	4.12	6.18E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs791856	chr6:86681841	SNHG5	chr6:86386726-86388451:-	0.46	5.94	1.82E-8	Response to antipsychotic treatment	
PCPG	cis	1	rs79548696	chr3:41803385	ULK4	chr3:41288091-42003660:-	0.71	10.15	7.6E-19	Diastolic blood pressure	
PCPG	cis	1	rs79602855	chr19:50525725	SIGLEC16	chr19:50472912-50479075:+	0.77	5.1	9.92E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs79633979	chr19:50488612	SIGLEC16	chr19:50472912-50479075:+	0.77	5.08	1.07E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs7975389	chr12:79899702	PAWR	chr12:79985747-80084790:-	0.35	4.63	7.66E-6	Classic bladder exstrophy	
PCPG	cis	1	rs798741	chr4:1712413	FGFR3	chr4:1795039-1810599:+	-0.37	-4.2	4.58E-5	Urinary bladder cancer;Bladder cancer	
PCPG	cis	1	rs8000149	chr13:50090025	SETDB2	chr13:50018429-50069138:+	-0.33	-4.05	8.24E-5	Cardiac hypertrophy	
PCPG	cis	1	rs8010715	chr14:24609147	FAM158A	chr14:24608175-24610797:-	-0.29	-4.41	1.92E-5	IgG glycosylation	
PCPG	cis	1	rs80135780	chr15:24054600	WHAMML1	chr15:23187731-23208357:-	0.7	4.12	6.18E-5	Attention deficit hyperactivity disorder (hyperactivity-impulsivity symptoms)	
PCPG	cis	1	rs8014374	chr14:75322914	DLST	chr14:75348594-75370450:+	-0.27	-4.04	8.5E-5	Caffeine consumption	
PCPG	cis	1	rs80202648	chr19:50494386	SIGLEC16	chr19:50472912-50479075:+	0.77	5.1	9.92E-7	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs8023644	chr15:50937123	SPPL2A	chr15:50999739-51057910:-	0.31	4.4	2.01E-5	QT interval	
PCPG	cis	1	rs8023716	chr15:65744861	DPP8	chr15:65737999-65810035:-	-0.19	-4.59	9.21E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs8027260	chr15:65955172	DPP8	chr15:65737999-65810035:-	0.18	4.39	2.11E-5	Mean corpuscular hemoglobin	
PCPG	cis	1	rs80285556	chr19:50540170	SIGLEC16	chr19:50472912-50479075:+	0.76	4.89	2.48E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs8031179	chr15:65952034	DPP8	chr15:65737999-65810035:-	-0.19	-4.64	7.26E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs80314222	chr19:50525514	SIGLEC16	chr19:50472912-50479075:+	0.78	5.08	1.09E-6	antipsychotic drug dosage in schizophrenia or schizoaffective disorder	
PCPG	cis	1	rs8033938	chr15:40703114	C15orf23	chr15:40674922-40686488:+	1.13	11.35	4.58E-22	Heschl's gyrus morphology	
PCPG	cis	1	rs8035639	chr15:65944548	DPP8	chr15:65737999-65810035:-	-0.19	-4.72	5.17E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs8036588	chr15:50956834	SPPL2A	chr15:50999739-51057910:-	0.32	4.72	5.21E-6	QT interval	
PCPG	cis	1	rs8042366	chr15:66012443	DPP8	chr15:65737999-65810035:-	-0.19	-4.71	5.38E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs8042807	chr15:66012444	DPP8	chr15:65737999-65810035:-	-0.19	-4.71	5.38E-6	Mean corpuscular hemoglobin	
PCPG	cis	1	rs804280	chr8:11612698	C8orf12	chr8:11225911-11296166:+	0.46	5.32	3.64E-7	Myopia (pathological)	
PCPG	cis	1	rs804280	chr8:11612698	FAM167A	chr8:11278973-11324276:-	0.49	5.53	1.34E-7	Myopia (pathological)	
PCPG	cis	1	rs804281	chr8:11611865	C8orf12	chr8:11225911-11296166:+	0.43	4.72	5.29E-6	Myopia (pathological)	
PCPG	cis	1	rs804281	chr8:11611865	FAM167A	chr8:11278973-11324276:-	0.52	5.71	5.66E-8	Myopia (pathological)	
PCPG	cis	1	rs8056893	chr16:68304392	NFATC3	chr16:68118654-68260837:+	0.56	5.52	1.4E-7	Blood metabolite levels;Blood metabolite ratios;Glomerular filtration rate (creatinine)	
PCPG	cis	1	rs8065059	chr17:28417376	EFCAB5	chr17:28256874-28435469:+	-0.42	-4.04	8.36E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs8065437	chr17:45721653	C17orf57	chr17:45401142-45518675:+	0.39	4.57	9.87E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs8065669	chr17:45724996	C17orf57	chr17:45401142-45518675:+	0.39	4.55	1.07E-5	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs8070454	chr17:38160754	GSDMA	chr17:38119226-38134019:+	-0.67	-8.22	7.91E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs8072100	chr17:45674687	C17orf57	chr17:45401142-45518675:+	-0.41	-4.76	4.36E-6	Very long-chain saturated fatty acid levels (fatty acid 20:0)	
PCPG	cis	1	rs8078723	chr17:38166879	GSDMA	chr17:38119226-38134019:+	-0.66	-8.2	8.91E-14	Neutrophil count;White blood cell count;C-reactive protein and white blood cell count	
PCPG	cis	1	rs809775	chr1:46538040	CCDC163P	chr1:45960581-45965646:-	-0.4	-5.73	5.15E-8	Body mass index	
PCPG	cis	1	rs8100392	chr19:33605933	GPATCH1	chr19:33571786-33621318:+	0.39	5.14	8.25E-7	Bone properties (heel)	
PCPG	cis	1	rs8105994	chr19:18593553	ELL	chr19:18553475-18632937:-	-0.38	-4.2	4.48E-5	Breast cancer	
PCPG	cis	1	rs8110181	chr19:33605939	GPATCH1	chr19:33571786-33621318:+	0.39	5.14	8.25E-7	Bone properties (heel)	
PCPG	cis	1	rs8111746	chr19:39212859	LGALS7	chr19:39261608-39264157:-	-0.34	-4.09	6.82E-5	Heart rate	
PCPG	cis	1	rs8125868	chr20:25324410	ENTPD6	chr20:25176339-25207360:+	0.33	4.19	4.63E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs8125868	chr20:25324410	FAM182A	chr20:26035250-26067552:+	0.48	5.86	2.76E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs8136657	chr22:40516522	XPNPEP3	chr22:41253094-41363888:+	0.5	4.71	5.53E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs8138799	chr22:24556902	SUSD2	chr22:24577444-24585074:+	0.71	4.81	3.55E-6	Amyotrophic lateral sclerosis	
PCPG	cis	1	rs8141797	chr22:24582041	SUSD2	chr22:24577444-24585074:+	-0.68	-4.67	6.62E-6	Amyotrophic lateral sclerosis	
PCPG	cis	1	rs8170	chr19:17389704	MRPL34	chr19:17416477-17417652:+	-0.42	-4.46	1.6E-5	Breast cancer (estrogen-receptor negative);Breast Cancer in BRCA1 mutation carriers;Epithelial ovarian cancer;Ovarian cancer;Breast cancer	
PCPG	cis	1	rs8181644	chr12:58173466	FAM119B	chr12:58166383-58176323:+	0.57	5.61	9.1E-8	Multiple sclerosis	
PCPG	cis	1	rs8181644	chr12:58173466	TSFM	chr12:58176536-58191367:+	-0.54	-6.77	2.56E-10	Multiple sclerosis	
PCPG	cis	1	rs823144	chr1:205744546	RAB7L1	chr1:205737115-205744610:-	0.37	4.49	1.38E-5	Parkinson's disease	
PCPG	cis	1	rs832551	chr5:56180112	C5orf35	chr5:56205103-56213010:+	1.09	10.55	6.23E-20	Type 2 diabetes	
PCPG	cis	1	rs832553	chr5:56114786	C5orf35	chr5:56205103-56213010:+	0.95	9.52	3.46E-17	Type 2 diabetes	
PCPG	cis	1	rs832554	chr5:56115036	C5orf35	chr5:56205103-56213010:+	0.97	9.78	7.3E-18	Type 2 diabetes	
PCPG	cis	1	rs832565	chr5:56150803	C5orf35	chr5:56205103-56213010:+	1.05	9.86	4.35E-18	Type 2 diabetes	
PCPG	cis	1	rs832568	chr5:56153776	C5orf35	chr5:56205103-56213010:+	1.05	9.86	4.35E-18	Type 2 diabetes	
PCPG	cis	1	rs832569	chr5:56154584	C5orf35	chr5:56205103-56213010:+	1.05	9.86	4.35E-18	Type 2 diabetes	
PCPG	cis	1	rs832578	chr5:56164223	C5orf35	chr5:56205103-56213010:+	1.05	10.56	6.12E-20	Type 2 diabetes	
PCPG	cis	1	rs832582	chr5:56177743	C5orf35	chr5:56205103-56213010:+	1.09	10.55	6.23E-20	Type 2 diabetes	
PCPG	cis	1	rs832583	chr5:56178217	C5orf35	chr5:56205103-56213010:+	1.09	10.55	6.23E-20	Type 2 diabetes	
PCPG	cis	1	rs832584	chr5:56179212	C5orf35	chr5:56205103-56213010:+	-1.09	-10.55	6.23E-20	Type 2 diabetes	
PCPG	cis	1	rs853676	chr6:28299687	ZNF187	chr6:28234788-28245978:+	-0.3	-4.4	2.0E-5	Depression	
PCPG	cis	1	rs853678	chr6:28297313	ZNF187	chr6:28234788-28245978:+	-0.28	-4.15	5.51E-5	Depression	
PCPG	cis	1	rs853679	chr6:28296863	ZNF187	chr6:28234788-28245978:+	-0.28	-4.15	5.51E-5	Depression	
PCPG	cis	1	rs853685	chr6:28288785	ZNF187	chr6:28234788-28245978:+	-0.3	-4.4	1.98E-5	Depression	
PCPG	cis	1	rs853685	chr6:28288785	ZSCAN23	chr6:28393287-28411279:-	0.24	4.15	5.52E-5	Depression	
PCPG	cis	1	rs853694	chr6:28279100	ZNF187	chr6:28234788-28245978:+	-0.3	-4.4	1.98E-5	Depression	
PCPG	cis	1	rs853694	chr6:28279100	ZSCAN23	chr6:28393287-28411279:-	0.24	4.15	5.52E-5	Depression	
PCPG	cis	1	rs853758	chr12:122408855	PSMD9	chr12:122326646-122355770:+	-0.45	-4.1	6.64E-5	Urinary metabolites	
PCPG	cis	1	rs854572	chr7:94954696	PON1	chr7:94927671-95025687:-	0.45	5.23	5.37E-7	Paraoxonase activity	
PCPG	cis	1	rs860580	chr5:56149429	C5orf35	chr5:56205103-56213010:+	-1.02	-10.27	3.48E-19	Type 2 diabetes	
PCPG	cis	1	rs861283	chr5:56184610	C5orf35	chr5:56205103-56213010:+	1.09	10.55	6.23E-20	Type 2 diabetes	
PCPG	cis	1	rs863840	chr5:56128999	C5orf35	chr5:56205103-56213010:+	1.01	8.57	1.0E-14	Type 2 diabetes	
PCPG	cis	1	rs866222	chr5:56184444	C5orf35	chr5:56205103-56213010:+	1.09	10.55	6.23E-20	Type 2 diabetes	
PCPG	cis	1	rs877636	chr12:56480583	RPS26	chr12:56435686-56438005:+	-0.69	-7.88	5.4E-13	Cognitive function	
PCPG	cis	1	rs881375	chr9:123652898	LOC253039	chr9:123605320-123616644:+	-0.56	-5.43	2.15E-7	Rheumatoid arthritis	
PCPG	cis	1	rs882803	chr1:45976147	CCDC163P	chr1:45960581-45965646:-	-0.54	-8.59	9.29E-15	Homocysteine levels	
PCPG	cis	1	rs884613	chr20:25288505	ENTPD6	chr20:25176339-25207360:+	0.34	4.14	5.64E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs884613	chr20:25288505	FAM182A	chr20:26035250-26067552:+	0.55	6.56	7.68E-10	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs884841	chr6:86680300	SNHG5	chr6:86386726-86388451:-	-0.51	-6.28	3.28E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs891386	chr18:21103971	NPC1	chr18:21108363-21166581:-	0.33	5.12	8.94E-7	Body mass index	
PCPG	cis	1	rs892864	chr5:127835859	FBN2	chr5:127593602-127873916:-	0.43	4.09	6.92E-5	Multiple system atrophy	
PCPG	cis	1	rs895958	chr12:122378206	PSMD9	chr12:122326646-122355770:+	-0.44	-4.03	8.59E-5	Urinary metabolites	
PCPG	cis	1	rs895959	chr12:122320352	PSMD9	chr12:122326646-122355770:+	-0.43	-4.27	3.37E-5	Urinary metabolites	
PCPG	cis	1	rs898225	chr3:48413179	TREX1	chr3:48501186-48509043:+	0.29	4.16	5.37E-5	Longevity	
PCPG	cis	1	rs904251	chr6:37451696	C6orf129	chr6:37450699-37467700:-	0.3	4.49	1.41E-5	Cognitive performance	
PCPG	cis	1	rs910997	chr20:25267301	ENTPD6	chr20:25176339-25207360:+	-0.34	-4.27	3.34E-5	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs910997	chr20:25267301	FAM182A	chr20:26035250-26067552:+	-0.48	-5.97	1.61E-8	Liver enzyme levels (alkaline phosphatase)	
PCPG	cis	1	rs917911	chr12:9905851	CLECL1	chr12:9868457-9885860:-	0.4	4.93	2.1E-6	Type 1 diabetes	
PCPG	cis	1	rs922075	chr3:48489398	TREX1	chr3:48501186-48509043:+	0.28	4.29	3.17E-5	Longevity	
PCPG	cis	1	rs922483	chr8:11351912	TDH	chr8:11197146-11225961:+	0.39	4.25	3.74E-5	Systemic lupus erythematosus	
PCPG	cis	1	rs9283717	chr5:56078659	C5orf35	chr5:56205103-56213010:+	0.91	8.24	6.86E-14	Type 2 diabetes	
PCPG	cis	1	rs9288316	chr2:202163483	ALS2CR12	chr2:202153148-202222101:-	0.43	5.13	8.72E-7	Melanoma;Esophageal squamous cell carcinoma	
PCPG	cis	1	rs9289471	chr3:134230811	ANAPC13	chr3:134196547-134204865:-	0.36	5.23	5.41E-7	Height	
PCPG	cis	1	rs9289475	chr3:134236459	ANAPC13	chr3:134196547-134204865:-	0.34	4.69	6.07E-6	Height	
PCPG	cis	1	rs9289476	chr3:134237103	ANAPC13	chr3:134196547-134204865:-	0.34	4.69	6.07E-6	Height	
PCPG	cis	1	rs9289478	chr3:134268619	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs9291683	chr4:10324160	SLC2A9	chr4:9827850-10041872:-	-0.33	-4.23	4.05E-5	Bone mineral density	
PCPG	cis	1	rs9294377	chr6:88084839	C6orf162	chr6:88032306-88052043:+	-0.49	-5.61	8.95E-8	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs9296404	chr6:42925803	GNMT	chr6:42928500-42931617:+	-0.68	-8.56	1.05E-14	Plasma homocysteine levels (post-methionine load test)	
PCPG	cis	1	rs9296404	chr6:42925803	PEX6	chr6:42931613-42946981:-	0.9	10.05	1.35E-18	Plasma homocysteine levels (post-methionine load test)	
PCPG	cis	1	rs9296504	chr6:46629505	TDRD6	chr6:46655866-46670149:+	-0.28	-4.04	8.45E-5	QRS complex (Sokolow-Lyon)	
PCPG	cis	1	rs9296832	chr6:56100909	COL21A1	chr6:55921389-56258892:-	0.73	11.65	6.81E-23	Pulse pressure	
PCPG	cis	1	rs929843	chr16:70045748	CLEC18A	chr16:69984626-69997887:+	-0.51	-5.6	9.49E-8	Menarche (age at onset)	
PCPG	cis	1	rs929843	chr16:70045748	PDXDC2	chr16:70010210-70099851:-	-0.44	-6.74	3.06E-10	Menarche (age at onset)	
PCPG	cis	1	rs9303029	chr17:80408815	C17orf62	chr17:80400520-80408694:-	-0.45	-4.12	6.21E-5	Protein quantitative trait loci	
PCPG	cis	1	rs9304578	chr19:39250337	LGALS7	chr19:39261608-39264157:-	0.35	4.27	3.43E-5	Heart rate	
PCPG	cis	1	rs9309473	chr2:73743982	ALMS1P	chr2:73872046-73912692:+	0.6	5.78	3.96E-8	Metabolite levels	
PCPG	cis	1	rs9311288	chr3:41804581	ULK4	chr3:41288091-42003660:-	0.71	10.49	9.38E-20	Diastolic blood pressure	
PCPG	cis	1	rs9318086	chr13:24432467	PCOTH	chr13:24463028-24466241:+	0.41	4.54	1.14E-5	Myopia (pathological)	
PCPG	cis	1	rs934093	chr3:134195885	ANAPC13	chr3:134196547-134204865:-	0.36	4.9	2.43E-6	Height	
PCPG	cis	1	rs9344759	chr6:88903937	AKIRIN2	chr6:88384579-88411985:-	-0.36	-4.25	3.7E-5	Gut microbiota (functional units)	
PCPG	cis	1	rs934624	chr15:50968906	SPPL2A	chr15:50999739-51057910:-	0.33	4.84	3.07E-6	QT interval	
PCPG	cis	1	rs934625	chr15:50968756	SPPL2A	chr15:50999739-51057910:-	0.32	4.72	5.21E-6	QT interval	
PCPG	cis	1	rs9348968	chr6:35117251	UHRF1BP1	chr6:34759794-34853117:+	-0.31	-4.5	1.35E-5	Airway responsiveness in chronic obstructive pulmonary disease	
PCPG	cis	1	rs9349804	chr6:56098876	COL21A1	chr6:55921389-56258892:-	0.75	11.9	1.44E-23	Pulse pressure	
PCPG	cis	1	rs9350272	chr6:20720818	CDKAL1	chr6:20534688-21232632:+	-0.41	-4.35	2.44E-5	Type 2 diabetes	
PCPG	cis	1	rs9354951	chr6:71707973	C6orf155	chr6:72124149-72130448:-	0.38	4.08	7.12E-5	Daytime sleep phenotypes	
PCPG	cis	1	rs9358357	chr6:20719145	CDKAL1	chr6:20534688-21232632:+	-0.41	-4.34	2.6E-5	Type 2 diabetes	
PCPG	cis	1	rs9362426	chr6:88089874	C6orf162	chr6:88032306-88052043:+	-0.43	-5	1.56E-6	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs9368219	chr6:20674691	CDKAL1	chr6:20534688-21232632:+	-0.53	-5.36	3.01E-7	Type 2 diabetes	
PCPG	cis	1	rs9368224	chr6:20719232	CDKAL1	chr6:20534688-21232632:+	-0.41	-4.34	2.6E-5	Type 2 diabetes	
PCPG	cis	1	rs9368849	chr6:35118236	UHRF1BP1	chr6:34759794-34853117:+	-0.32	-4.6	8.86E-6	Airway responsiveness in chronic obstructive pulmonary disease	
PCPG	cis	1	rs9372857	chr6:127393207	THEMIS	chr6:128029346-128239742:-	0.29	4.39	2.06E-5	Iron status biomarkers	
PCPG	cis	1	rs9374291	chr6:112114791	FYN	chr6:111982487-112194627:-	-0.34	-4.3	3.03E-5	Anger	
PCPG	cis	1	rs9375487	chr6:127397240	THEMIS	chr6:128029346-128239742:-	-0.27	-4.12	6.16E-5	Iron status biomarkers	
PCPG	cis	1	rs9387038	chr6:112125335	FYN	chr6:111982487-112194627:-	-0.33	-4.3	3.03E-5	Anger	
PCPG	cis	1	rs9387040	chr6:112131578	FYN	chr6:111982487-112194627:-	-0.33	-4.26	3.54E-5	Anger	
PCPG	cis	1	rs9388451	chr6:126090377	HEY2	chr6:126068780-126082414:+	-0.22	-4.03	8.66E-5	Brugada syndrome	
PCPG	cis	1	rs9394931	chr6:42873245	GNMT	chr6:42928500-42931617:+	0.37	4.36	2.36E-5	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
PCPG	cis	1	rs9394931	chr6:42873245	PEX6	chr6:42931613-42946981:-	-0.58	-6.08	9.17E-9	Plasma omega-6 polyunsaturated fatty acid levels (arachidonic acid)	
PCPG	cis	1	rs939558	chr3:41976040	ULK4	chr3:41288091-42003660:-	-0.78	-11.6	9.07E-23	Diastolic blood pressure	
PCPG	cis	1	rs9401938	chr6:127390719	THEMIS	chr6:128029346-128239742:-	0.27	4.07	7.56E-5	Iron status biomarkers	
PCPG	cis	1	rs9425766	chr1:173853127	SERPINC1	chr1:173872943-173886516:-	0.43	4.31	2.86E-5	Life satisfaction	
PCPG	cis	1	rs9429183	chr1:46524582	CCDC163P	chr1:45960581-45965646:-	-0.41	-5.98	1.47E-8	Body mass index	
PCPG	cis	1	rs9450662	chr6:88088593	C6orf162	chr6:88032306-88052043:+	-0.48	-5.47	1.81E-7	Depressive episodes in bipolar disorder	
PCPG	cis	1	rs9460550	chr6:20719561	CDKAL1	chr6:20534688-21232632:+	-0.41	-4.34	2.6E-5	Type 2 diabetes	
PCPG	cis	1	rs946529	chr1:46485548	CCDC163P	chr1:45960581-45965646:-	-0.39	-5.58	1.05E-7	Body mass index	
PCPG	cis	1	rs947211	chr1:205752665	RAB7L1	chr1:205737115-205744610:-	0.34	4.35	2.46E-5	Parkinson's disease	
PCPG	cis	1	rs9475752	chr6:56780741	BEND6	chr6:56819773-56892138:+	-0.35	-4.05	8.16E-5	Menarche (age at onset)	
PCPG	cis	1	rs9481189	chr6:112113938	FYN	chr6:111982487-112194627:-	-0.33	-4.28	3.31E-5	Anger	
PCPG	cis	1	rs9481192	chr6:112130478	FYN	chr6:111982487-112194627:-	-0.33	-4.26	3.54E-5	Anger	
PCPG	cis	1	rs9487722	chr6:112121766	FYN	chr6:111982487-112194627:-	-0.34	-4.47	1.52E-5	Anger	
PCPG	cis	1	rs951366	chr1:205685352	RAB7L1	chr1:205737115-205744610:-	0.4	5.36	3.04E-7	Menarche (age at onset)	
PCPG	cis	1	rs9527	chr10:104623578	AS3MT	chr10:104613967-104661653:+	-0.29	-4.54	1.11E-5	Arsenic metabolism	
PCPG	cis	1	rs9527	chr10:104623578	C10orf32	chr10:104613967-104624718:+	-0.61	-7.27	1.68E-11	Arsenic metabolism	
PCPG	cis	1	rs955196	chr6:86729951	SNHG5	chr6:86386726-86388451:-	0.52	6.55	7.94E-10	Response to antipsychotic treatment	
PCPG	cis	1	rs955197	chr6:86729675	SNHG5	chr6:86386726-86388451:-	-0.5	-6.29	3.17E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs955227	chr6:86651032	SNHG5	chr6:86386726-86388451:-	-0.52	-6.31	2.76E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs9591032	chr13:47900420	SUCLA2	chr13:48516792-48612125:-	0.55	4.31	2.91E-5	Cannabis use (initiation)	
PCPG	cis	1	rs9623117	chr22:40452119	XPNPEP3	chr22:41253094-41363888:+	0.54	5.04	1.3E-6	Prostate cancer (gene x gene interaction);Prostate cancer	
PCPG	cis	1	rs9624834	chr22:25846015	CRYBB2	chr22:25615612-25627836:+	0.67	5.7	5.9E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs9624835	chr22:25846021	CRYBB2	chr22:25615612-25627836:+	0.67	5.7	5.9E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs9624836	chr22:25846087	CRYBB2	chr22:25615612-25627836:+	0.67	5.7	5.9E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs9647603	chr6:86639341	SNHG5	chr6:86386726-86388451:-	-0.47	-6.15	6.52E-9	Response to antipsychotic treatment	
PCPG	cis	1	rs9653557	chr2:73795962	ALMS1P	chr2:73872046-73912692:+	0.59	5.67	6.98E-8	Metabolite levels	
PCPG	cis	1	rs965469	chr20:3381549	ITPA	chr20:3190056-3204504:+	-0.3	-4.11	6.31E-5	IFN-related cytopenia	
PCPG	cis	1	rs9673404	chr16:31347592	ITGAX	chr16:31366509-31394318:+	0.22	4.59	8.98E-6	IgA nephropathy	
PCPG	cis	1	rs9673405	chr16:31347599	ITGAX	chr16:31366509-31394318:+	0.22	4.59	8.98E-6	IgA nephropathy	
PCPG	cis	1	rs9674009	chr16:31347541	ITGAX	chr16:31366509-31394318:+	0.22	4.59	8.98E-6	IgA nephropathy	
PCPG	cis	1	rs9674872	chr17:79581931	TSPAN10	chr17:79609349-79615778:+	0.62	8.21	8.26E-14	Eye color traits	
PCPG	cis	1	rs972275	chr6:127391844	THEMIS	chr6:128029346-128239742:-	0.27	4.07	7.56E-5	Iron status biomarkers	
PCPG	cis	1	rs9747349	chr17:79584297	TSPAN10	chr17:79609349-79615778:+	0.62	8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs9748176	chr17:79584043	TSPAN10	chr17:79609349-79615778:+	0.62	8.28	5.46E-14	Eye color traits	
PCPG	cis	1	rs9769098	chr7:23916732	C7orf46	chr7:23719749-23742268:+	0.44	5.59	9.95E-8	Schizophrenia	
PCPG	cis	1	rs9783304	chr11:43660255	HSD17B12	chr11:43702143-43878160:+	0.38	4.35	2.47E-5	Forced vital capacity	
PCPG	cis	1	rs9788682	chr15:78802586	CHRNA5	chr15:78857906-78886458:+	-0.34	-4.14	5.73E-5	Post bronchodilator FEV1;Post bronchodilator FEV1/FVC ratio	
PCPG	cis	1	rs979972	chr19:39144167	LGALS7	chr19:39261608-39264157:-	-0.35	-4.13	5.91E-5	Heart rate	
PCPG	cis	1	rs9804992	chr12:988894	RAD52	chr12:1021255-1099219:-	0.44	4.89	2.46E-6	Colorectal cancer	
PCPG	cis	1	rs9809619	chr3:134280948	ANAPC13	chr3:134196547-134204865:-	0.35	4.93	2.1E-6	Height	
PCPG	cis	1	rs9809843	chr3:48434398	TREX1	chr3:48501186-48509043:+	-0.28	-4.21	4.4E-5	Longevity	
PCPG	cis	1	rs9812647	chr3:48448914	TREX1	chr3:48501186-48509043:+	0.28	4.23	4.0E-5	Longevity	
PCPG	cis	1	rs9813774	chr3:134227100	ANAPC13	chr3:134196547-134204865:-	0.35	4.85	2.98E-6	Height	
PCPG	cis	1	rs9814567	chr3:134218557	ANAPC13	chr3:134196547-134204865:-	-0.34	-4.81	3.53E-6	Height	
PCPG	cis	1	rs9815354	chr3:41912651	ULK4	chr3:41288091-42003660:-	0.7	8.34	3.9E-14	Diastolic blood pressure	
PCPG	cis	1	rs9818169	chr3:41860599	ULK4	chr3:41288091-42003660:-	0.79	10.69	2.65E-20	Diastolic blood pressure	
PCPG	cis	1	rs9819532	chr3:134288644	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.45E-6	Height	
PCPG	cis	1	rs9820192	chr3:41889281	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs9823254	chr3:41894768	ULK4	chr3:41288091-42003660:-	0.71	8.41	2.67E-14	Diastolic blood pressure	
PCPG	cis	1	rs9824731	chr3:41889698	ULK4	chr3:41288091-42003660:-	0.71	8.51	1.45E-14	Diastolic blood pressure	
PCPG	cis	1	rs9825741	chr3:41761828	ULK4	chr3:41288091-42003660:-	-0.72	-10.2	5.62E-19	Diastolic blood pressure	
PCPG	cis	1	rs9826058	chr3:41762062	ULK4	chr3:41288091-42003660:-	0.72	10.19	5.75E-19	Diastolic blood pressure	
PCPG	cis	1	rs9826195	chr3:48433635	TREX1	chr3:48501186-48509043:+	-0.28	-4.21	4.4E-5	Longevity	
PCPG	cis	1	rs9826496	chr3:134224437	ANAPC13	chr3:134196547-134204865:-	0.34	4.81	3.58E-6	Height	
PCPG	cis	1	rs9827987	chr3:134272621	ANAPC13	chr3:134196547-134204865:-	0.37	5	1.56E-6	Height	
PCPG	cis	1	rs9828398	chr3:41895893	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs9828815	chr3:134265749	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs9829092	chr3:134229866	ANAPC13	chr3:134196547-134204865:-	0.35	4.77	4.16E-6	Height	
PCPG	cis	1	rs9830064	chr3:41881801	ULK4	chr3:41288091-42003660:-	0.79	11.22	9.97E-22	Diastolic blood pressure	
PCPG	cis	1	rs9830469	chr3:41762535	ULK4	chr3:41288091-42003660:-	0.72	10.19	5.75E-19	Diastolic blood pressure	
PCPG	cis	1	rs9832785	chr3:134213070	ANAPC13	chr3:134196547-134204865:-	0.36	4.91	2.3E-6	Height	
PCPG	cis	1	rs9834098	chr3:41833493	ULK4	chr3:41288091-42003660:-	0.74	10.51	8.12E-20	Diastolic blood pressure	
PCPG	cis	1	rs9834755	chr3:134206845	ANAPC13	chr3:134196547-134204865:-	0.35	4.67	6.4E-6	Height	
PCPG	cis	1	rs9835204	chr3:134261342	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs9838618	chr3:48487353	TREX1	chr3:48501186-48509043:+	-0.28	-4.2	4.47E-5	Longevity	
PCPG	cis	1	rs9838965	chr3:41927938	ULK4	chr3:41288091-42003660:-	-0.78	-11.07	2.59E-21	Diastolic blood pressure	
PCPG	cis	1	rs9839399	chr3:41928044	ULK4	chr3:41288091-42003660:-	-0.78	-11.07	2.59E-21	Diastolic blood pressure	
PCPG	cis	1	rs9840037	chr3:41827522	ULK4	chr3:41288091-42003660:-	0.7	9.97	2.25E-18	Diastolic blood pressure	
PCPG	cis	1	rs9840532	chr3:41885697	ULK4	chr3:41288091-42003660:-	0.79	11.08	2.43E-21	Diastolic blood pressure	
PCPG	cis	1	rs9841212	chr3:134191938	ANAPC13	chr3:134196547-134204865:-	0.38	5.64	8.1E-8	Height	
PCPG	cis	1	rs984222	chr1:119503843	WARS2	chr1:119573841-119683295:-	-0.39	-5.24	5.25E-7	Waist-to-hip ratio adjusted for body mass index;Waist-hip ratio	
PCPG	cis	1	rs9842261	chr3:41822708	ULK4	chr3:41288091-42003660:-	-0.66	-9.76	8.29E-18	Diastolic blood pressure	
PCPG	cis	1	rs9842305	chr3:41998412	ULK4	chr3:41288091-42003660:-	-0.78	-11.43	2.66E-22	Diastolic blood pressure	
PCPG	cis	1	rs9846634	chr3:41894049	ULK4	chr3:41288091-42003660:-	0.71	8.51	1.45E-14	Diastolic blood pressure	
PCPG	cis	1	rs9847006	chr3:41755359	ULK4	chr3:41288091-42003660:-	0.72	10.45	1.18E-19	Diastolic blood pressure	
PCPG	cis	1	rs9847975	chr3:41786904	ULK4	chr3:41288091-42003660:-	0.63	7.79	9.42E-13	Diastolic blood pressure	
PCPG	cis	1	rs9848754	chr3:41753647	ULK4	chr3:41288091-42003660:-	0.62	7.43	6.92E-12	Diastolic blood pressure	
PCPG	cis	1	rs9850015	chr3:134269541	ANAPC13	chr3:134196547-134204865:-	0.37	5	1.56E-6	Height	
PCPG	cis	1	rs9851441	chr3:134315091	ANAPC13	chr3:134196547-134204865:-	0.35	4.86	2.87E-6	Height	
PCPG	cis	1	rs9852303	chr3:41759525	ULK4	chr3:41288091-42003660:-	0.72	10.39	1.75E-19	Diastolic blood pressure	
PCPG	cis	1	rs9854299	chr3:134206728	ANAPC13	chr3:134196547-134204865:-	0.33	4.57	9.76E-6	Height	
PCPG	cis	1	rs9854833	chr3:41775577	ULK4	chr3:41288091-42003660:-	0.61	7.2	2.55E-11	Diastolic blood pressure	
PCPG	cis	1	rs9854838	chr3:41805670	ULK4	chr3:41288091-42003660:-	0.71	10.49	9.38E-20	Diastolic blood pressure	
PCPG	cis	1	rs9855965	chr3:41860508	ULK4	chr3:41288091-42003660:-	0.79	10.69	2.65E-20	Diastolic blood pressure	
PCPG	cis	1	rs9856088	chr3:41860482	ULK4	chr3:41288091-42003660:-	0.79	10.69	2.65E-20	Diastolic blood pressure	
PCPG	cis	1	rs9856633	chr3:42013850	ULK4	chr3:41288091-42003660:-	0.72	10.54	6.84E-20	Diastolic blood pressure	
PCPG	cis	1	rs9856693	chr3:134306913	ANAPC13	chr3:134196547-134204865:-	0.35	4.81	3.5E-6	Height	
PCPG	cis	1	rs9857175	chr3:41822054	ULK4	chr3:41288091-42003660:-	0.7	10.22	4.72E-19	Diastolic blood pressure	
PCPG	cis	1	rs9863786	chr3:134247203	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs9863915	chr3:41762002	ULK4	chr3:41288091-42003660:-	0.72	10.39	1.75E-19	Diastolic blood pressure	
PCPG	cis	1	rs9864217	chr3:41762206	ULK4	chr3:41288091-42003660:-	0.62	7.36	1.05E-11	Diastolic blood pressure	
PCPG	cis	1	rs9864346	chr3:134312352	ANAPC13	chr3:134196547-134204865:-	0.36	4.97	1.78E-6	Height	
PCPG	cis	1	rs9864371	chr3:48426766	TREX1	chr3:48501186-48509043:+	-0.28	-4.12	6.11E-5	Longevity	
PCPG	cis	1	rs9864439	chr3:134298671	ANAPC13	chr3:134196547-134204865:-	0.36	4.86	2.81E-6	Height	
PCPG	cis	1	rs9864582	chr3:129970462	COL6A4P2	chr3:129931663-129992648:+	0.4	4.22	4.18E-5	Response to amphetamines	
PCPG	cis	1	rs9865127	chr3:41807448	ULK4	chr3:41288091-42003660:-	0.71	10.54	6.93E-20	Diastolic blood pressure	
PCPG	cis	1	rs9865780	chr3:41895802	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs9866092	chr3:41895967	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs9866759	chr3:41758418	ULK4	chr3:41288091-42003660:-	0.72	10.45	1.18E-19	Diastolic blood pressure	
PCPG	cis	1	rs9867627	chr3:41795841	ULK4	chr3:41288091-42003660:-	-0.64	-7.96	3.46E-13	Diastolic blood pressure	
PCPG	cis	1	rs9869207	chr3:41878661	ULK4	chr3:41288091-42003660:-	0.79	11.24	8.88E-22	Diastolic blood pressure	
PCPG	cis	1	rs9869282	chr3:41756064	ULK4	chr3:41288091-42003660:-	0.72	10.45	1.18E-19	Diastolic blood pressure	
PCPG	cis	1	rs9869440	chr3:41763155	ULK4	chr3:41288091-42003660:-	0.72	10.19	5.75E-19	Diastolic blood pressure	
PCPG	cis	1	rs9869981	chr3:134248801	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs9871305	chr3:134213538	ANAPC13	chr3:134196547-134204865:-	0.35	4.76	4.46E-6	Height	
PCPG	cis	1	rs9873207	chr3:41884750	ULK4	chr3:41288091-42003660:-	0.71	8.51	1.45E-14	Diastolic blood pressure	
PCPG	cis	1	rs9874513	chr3:41909508	ULK4	chr3:41288091-42003660:-	0.7	8.34	3.9E-14	Diastolic blood pressure	
PCPG	cis	1	rs9874975	chr3:41764300	ULK4	chr3:41288091-42003660:-	0.72	10.26	3.85E-19	Diastolic blood pressure	
PCPG	cis	1	rs9875083	chr3:41775786	ULK4	chr3:41288091-42003660:-	0.61	7.2	2.55E-11	Diastolic blood pressure	
PCPG	cis	1	rs9875107	chr3:41822313	ULK4	chr3:41288091-42003660:-	0.69	10.1	1.04E-18	Diastolic blood pressure	
PCPG	cis	1	rs9876658	chr3:134179453	ANAPC13	chr3:134196547-134204865:-	-0.34	-4.66	6.92E-6	Height	
PCPG	cis	1	rs9876781	chr3:48487338	TREX1	chr3:48501186-48509043:+	-0.27	-4.18	4.92E-5	Longevity	
PCPG	cis	1	rs9876960	chr3:41985812	ULK4	chr3:41288091-42003660:-	-0.78	-11.43	2.66E-22	Diastolic blood pressure	
PCPG	cis	1	rs9882329	chr3:41767154	ULK4	chr3:41288091-42003660:-	0.72	10.26	3.85E-19	Diastolic blood pressure	
PCPG	cis	1	rs9883753	chr3:134247231	ANAPC13	chr3:134196547-134204865:-	0.36	5.01	1.46E-6	Height	
PCPG	cis	1	rs9884031	chr3:134256500	ANAPC13	chr3:134196547-134204865:-	0.35	4.92	2.17E-6	Height	
PCPG	cis	1	rs9890205	chr17:28382704	EFCAB5	chr17:28256874-28435469:+	-0.44	-4.33	2.7E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs9890886	chr17:28391076	EFCAB5	chr17:28256874-28435469:+	-0.44	-4.33	2.7E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs9891871	chr17:28370191	EFCAB5	chr17:28256874-28435469:+	-0.44	-4.33	2.7E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs9894429	chr17:79596811	TSPAN10	chr17:79609349-79615778:+	0.61	8.04	2.22E-13	Eye color traits	
PCPG	cis	1	rs9896062	chr17:28357047	EFCAB5	chr17:28256874-28435469:+	-0.45	-4.36	2.39E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs9897206	chr17:28406108	EFCAB5	chr17:28256874-28435469:+	-0.44	-4.28	3.32E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs9902453	chr17:28349095	EFCAB5	chr17:28256874-28435469:+	-0.46	-4.39	2.12E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs9905565	chr17:18758641	FOXO3B	chr17:18569236-18576494:-	-0.4	-4.44	1.71E-5	Pancreatic cancer	
PCPG	cis	1	rs9906340	chr17:28398977	EFCAB5	chr17:28256874-28435469:+	-0.43	-4.14	5.72E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs9909940	chr17:80689036	FN3KRP	chr17:80674582-80685889:+	-0.52	-5.2	6.14E-7	Glycated hemoglobin levels	
PCPG	cis	1	rs9911854	chr17:80408348	C17orf62	chr17:80400520-80408694:-	-0.45	-4.16	5.36E-5	Protein quantitative trait loci	
PCPG	cis	1	rs9912741	chr17:28359511	EFCAB5	chr17:28256874-28435469:+	-0.44	-4.33	2.7E-5	Coffee consumption (cups per day)	
PCPG	cis	1	rs9918016	chr4:159621997	ETFDH	chr4:159593277-159629839:+	0.34	4.29	3.14E-5	Blood metabolite levels;Metabolite levels;Metabolic traits;Acylcarnitine levels	
PCPG	cis	1	rs9925964	chr16:31129895	ZNF668	chr16:31072172-31085504:-	0.27	4.41	1.95E-5	Body mass index	
PCPG	cis	1	rs9940665	chr16:67289841	CMTM4	chr16:66648654-66730610:-	-0.45	-4.42	1.84E-5	HDL cholesterol	
PCPG	cis	1	rs9968172	chr3:134231251	ANAPC13	chr3:134196547-134204865:-	-0.36	-5.11	9.55E-7	Height	
PCPG	cis	1	rs9975639	chr21:34736479	IFNGR2	chr21:34775202-34809827:+	-0.44	-5.2	6.32E-7	Cognitive decline (age-related)	
PCPG	cis	1	rs9978280	chr21:34736946	IFNGR2	chr21:34775202-34809827:+	-0.45	-5.36	3.04E-7	Cognitive decline (age-related)	
PCPG	cis	1	rs9978569	chr21:34737271	IFNGR2	chr21:34775202-34809827:+	-0.46	-5.47	1.77E-7	Cognitive decline (age-related)	
PCPG	cis	1	rs997872	chr22:25878614	CRYBB2	chr22:25615612-25627836:+	0.66	5.96	1.7E-8	Bipolar disorder with mood-incongruent psychosis	
PCPG	cis	1	rs9978964	chr21:34736952	IFNGR2	chr21:34775202-34809827:+	-0.45	-5.36	3.04E-7	Cognitive decline (age-related)	
PCPG	cis	1	rs9980664	chr21:34734510	IFNGR2	chr21:34775202-34809827:+	-0.43	-5.43	2.12E-7	Cognitive decline (age-related)	
PCPG	cis	1	rs9984973	chr21:34739174	IFNGR2	chr21:34775202-34809827:+	-0.43	-4.89	2.52E-6	Cognitive decline (age-related)	
PCPG	cis	1	rs9985356	chr3:134232920	ANAPC13	chr3:134196547-134204865:-	-0.36	-5.18	6.87E-7	Height	
PCPG	cis	1	rs9986596	chr6:28219661	ZNF187	chr6:28234788-28245978:+	-0.34	-4.47	1.53E-5	Depression	
PCPG	cis	1	rs9989967	chr3:134238964	ANAPC13	chr3:134196547-134204865:-	0.36	5.06	1.2E-6	Height	
PCPG	cis	1	rs9990351	chr3:134239191	ANAPC13	chr3:134196547-134204865:-	-0.34	-4.85	2.98E-6	Height	
PCPG	trans	1	rs10214634	chr6:26564582	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.21E-14	Educational attainment	
PCPG	trans	1	rs10484442	chr6:26555879	ZNF322B	chr9:99957633-99961910:-	0.64	8.41	2.67E-14	Educational attainment	
PCPG	trans	1	rs1056667	chr6:26510564	ZNF322B	chr9:99957633-99961910:-	0.62	8.2	8.99E-14	Educational attainment	
PCPG	trans	1	rs10769371	chr11:48531184	FOLH1B	chr11:89392465-89431885:+	-0.51	-6.98	8.17E-11	HDL cholesterol	
PCPG	trans	1	rs10769390	chr11:48618222	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.65	4.75E-10	HDL cholesterol	
PCPG	trans	1	rs1078679	chr6:26568741	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs10838912	chr11:48496477	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.71	3.47E-10	HDL cholesterol	
PCPG	trans	1	rs10838917	chr11:48503127	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.7	3.78E-10	HDL cholesterol	
PCPG	trans	1	rs10838931	chr11:48540973	FOLH1B	chr11:89392465-89431885:+	-0.5	-6.96	9.09E-11	HDL cholesterol	
PCPG	trans	1	rs10838943	chr11:48557442	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.13	3.74E-11	HDL cholesterol	
PCPG	trans	1	rs10838944	chr11:48559571	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.13	3.74E-11	HDL cholesterol	
PCPG	trans	1	rs10838954	chr11:48579323	FOLH1B	chr11:89392465-89431885:+	-0.52	-7.25	1.88E-11	HDL cholesterol	
PCPG	trans	1	rs10838966	chr11:48589723	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs10838975	chr11:48617615	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.61	6.06E-10	HDL cholesterol	
PCPG	trans	1	rs10946834	chr6:26533664	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs10946835	chr6:26533757	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs11039745	chr11:48463811	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.66	4.47E-10	HDL cholesterol	
PCPG	trans	1	rs11039777	chr11:48517049	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.68	4.19E-10	HDL cholesterol	
PCPG	trans	1	rs11039779	chr11:48517895	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.69	3.89E-10	HDL cholesterol	
PCPG	trans	1	rs11039817	chr11:48561480	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.13	3.74E-11	HDL cholesterol	
PCPG	trans	1	rs11039819	chr11:48562181	FOLH1B	chr11:89392465-89431885:+	-0.52	-7.41	7.98E-12	HDL cholesterol	
PCPG	trans	1	rs11039820	chr11:48562252	FOLH1B	chr11:89392465-89431885:+	-0.52	-7.29	1.49E-11	HDL cholesterol	
PCPG	trans	1	rs11039821	chr11:48562875	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.16	3.02E-11	HDL cholesterol	
PCPG	trans	1	rs11039851	chr11:48600839	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.81	2.08E-10	HDL cholesterol	
PCPG	trans	1	rs11039854	chr11:48607688	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.6	6.33E-10	HDL cholesterol	
PCPG	trans	1	rs11039859	chr11:48611988	FOLH1B	chr11:89392465-89431885:+	-0.47	-6.59	6.46E-10	HDL cholesterol	
PCPG	trans	1	rs11039868	chr11:48622146	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.65	4.75E-10	HDL cholesterol	
PCPG	trans	1	rs11756120	chr6:26529808	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs12361812	chr11:48563104	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.16	3.02E-11	HDL cholesterol	
PCPG	trans	1	rs12365220	chr11:48555957	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.13	3.74E-11	HDL cholesterol	
PCPG	trans	1	rs12366208	chr11:48563128	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.14	3.43E-11	HDL cholesterol	
PCPG	trans	1	rs12419576	chr11:48581644	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs12421159	chr11:48624841	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.65	4.75E-10	HDL cholesterol	
PCPG	trans	1	rs12526680	chr6:26550954	ZNF322B	chr9:99957633-99961910:-	0.59	7.46	5.84E-12	Educational attainment	
PCPG	trans	1	rs1321479	chr6:26501897	ZNF322B	chr9:99957633-99961910:-	-0.63	-8.07	1.86E-13	Educational attainment	
PCPG	trans	1	rs1321480	chr6:26532742	ZNF322B	chr9:99957633-99961910:-	0.62	8.16	1.11E-13	Educational attainment	
PCPG	trans	1	rs1321481	chr6:26538210	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs1535277	chr6:26567802	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs1884946	chr6:26545308	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs1884948	chr6:26567988	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs1884949	chr6:26568067	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs2208331	chr6:26507319	ZNF322B	chr9:99957633-99961910:-	0.62	8.2	8.99E-14	Educational attainment	
PCPG	trans	1	rs2224380	chr6:26553943	ZNF322B	chr9:99957633-99961910:-	0.65	8.89	1.56E-15	Educational attainment	
PCPG	trans	1	rs2255070	chr6:26501777	ZNF322B	chr9:99957633-99961910:-	0.63	8.16	1.08E-13	Educational attainment	
PCPG	trans	1	rs2393670	chr6:26535541	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs28558133	chr6:26531433	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs34636547	chr11:48590103	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs3736781	chr6:26505362	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.2E-14	Educational attainment	
PCPG	trans	1	rs3736782	chr6:26505403	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.2E-14	Educational attainment	
PCPG	trans	1	rs4713006	chr6:26519872	ZNF322B	chr9:99957633-99961910:-	0.62	8.21	8.23E-14	Educational attainment	
PCPG	trans	1	rs4713008	chr6:26538268	ZNF322B	chr9:99957633-99961910:-	0.64	8.43	2.32E-14	Educational attainment	
PCPG	trans	1	rs4871	chr6:26545632	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs4881994	chr11:48498139	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.69	3.91E-10	HDL cholesterol	
PCPG	trans	1	rs4882010	chr11:48559173	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.13	3.74E-11	HDL cholesterol	
PCPG	trans	1	rs4882015	chr11:48565573	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.14	3.43E-11	HDL cholesterol	
PCPG	trans	1	rs4882016	chr11:48570125	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.16	3.02E-11	HDL cholesterol	
PCPG	trans	1	rs4882017	chr11:48570182	FOLH1B	chr11:89392465-89431885:+	0.48	6.84	1.74E-10	HDL cholesterol	
PCPG	trans	1	rs4882019	chr11:48598748	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.79	2.32E-10	HDL cholesterol	
PCPG	trans	1	rs4882021	chr11:48615966	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.61	6.06E-10	HDL cholesterol	
PCPG	trans	1	rs4882096	chr11:48534102	FOLH1B	chr11:89392465-89431885:+	-0.51	-6.98	8.17E-11	HDL cholesterol	
PCPG	trans	1	rs4882111	chr11:48558447	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.13	3.74E-11	HDL cholesterol	
PCPG	trans	1	rs4882117	chr11:48565468	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.14	3.43E-11	HDL cholesterol	
PCPG	trans	1	rs4882120	chr11:48573529	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.06	5.4E-11	HDL cholesterol	
PCPG	trans	1	rs4882123	chr11:48575739	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.06	5.4E-11	HDL cholesterol	
PCPG	trans	1	rs4882129	chr11:48588774	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs4882130	chr11:48588954	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs4882134	chr11:48598795	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.79	2.32E-10	HDL cholesterol	
PCPG	trans	1	rs4882136	chr11:48615311	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.63	5.36E-10	HDL cholesterol	
PCPG	trans	1	rs55834832	chr11:48562583	FOLH1B	chr11:89392465-89431885:+	-0.51	-7.16	3.02E-11	HDL cholesterol	
PCPG	trans	1	rs6456733	chr6:26566804	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs6456734	chr6:26566965	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs6485872	chr11:48579710	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.93	1.08E-10	HDL cholesterol	
PCPG	trans	1	rs6485875	chr11:48581034	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs6903973	chr6:26499942	ZNF322B	chr9:99957633-99961910:-	0.62	8.15	1.16E-13	Educational attainment	
PCPG	trans	1	rs6910899	chr6:26524339	ZNF322B	chr9:99957633-99961910:-	0.62	8.21	8.23E-14	Educational attainment	
PCPG	trans	1	rs6922824	chr6:26553815	ZNF322B	chr9:99957633-99961910:-	-0.61	-8.13	1.32E-13	Educational attainment	
PCPG	trans	1	rs6924838	chr6:26571756	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs6925703	chr6:26521589	ZNF322B	chr9:99957633-99961910:-	0.62	8.21	8.23E-14	Educational attainment	
PCPG	trans	1	rs6925895	chr6:26572165	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs6926629	chr6:26499903	ZNF322B	chr9:99957633-99961910:-	0.62	8.15	1.16E-13	Educational attainment	
PCPG	trans	1	rs6930120	chr6:26555484	ZNF322B	chr9:99957633-99961910:-	0.64	8.53	1.29E-14	Educational attainment	
PCPG	trans	1	rs6932156	chr6:26571506	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs6933176	chr6:26540178	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs6940053	chr6:26562122	ZNF322B	chr9:99957633-99961910:-	0.64	8.53	1.29E-14	Educational attainment	
PCPG	trans	1	rs6940188	chr6:26562029	ZNF322B	chr9:99957633-99961910:-	0.64	8.53	1.29E-14	Educational attainment	
PCPG	trans	1	rs7107184	chr11:48577069	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.04	6.02E-11	HDL cholesterol	
PCPG	trans	1	rs7121460	chr11:48545232	FOLH1B	chr11:89392465-89431885:+	-0.5	-6.94	1.01E-10	HDL cholesterol	
PCPG	trans	1	rs7121992	chr11:48592582	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.81	2.08E-10	HDL cholesterol	
PCPG	trans	1	rs7129386	chr11:48616694	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.61	6.06E-10	HDL cholesterol	
PCPG	trans	1	rs7478900	chr11:48544003	FOLH1B	chr11:89392465-89431885:+	-0.5	-6.96	9.2E-11	HDL cholesterol	
PCPG	trans	1	rs7481308	chr11:48600067	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.81	2.08E-10	HDL cholesterol	
PCPG	trans	1	rs7481880	chr11:48609347	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.6	6.33E-10	HDL cholesterol	
PCPG	trans	1	rs7482176	chr11:48604620	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.6	6.33E-10	HDL cholesterol	
PCPG	trans	1	rs7482528	chr11:48640052	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.88	1.39E-10	HDL cholesterol	
PCPG	trans	1	rs7483920	chr11:48599969	FOLH1B	chr11:89392465-89431885:+	-0.48	-6.79	2.32E-10	HDL cholesterol	
PCPG	trans	1	rs767471	chr6:26557854	ZNF322B	chr9:99957633-99961910:-	0.64	8.53	1.29E-14	Educational attainment	
PCPG	trans	1	rs7928083	chr11:48613148	FOLH1B	chr11:89392465-89431885:+	-0.47	-6.59	6.46E-10	HDL cholesterol	
PCPG	trans	1	rs7931984	chr11:48580835	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs7945192	chr11:48580737	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs7949348	chr11:48493801	FOLH1B	chr11:89392465-89431885:+	-0.49	-6.71	3.47E-10	HDL cholesterol	
PCPG	trans	1	rs7949554	chr11:48581992	FOLH1B	chr11:89392465-89431885:+	-0.5	-7.07	4.95E-11	HDL cholesterol	
PCPG	trans	1	rs9295695	chr6:26528250	ZNF322B	chr9:99957633-99961910:-	-0.63	-8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs9357010	chr6:26527945	ZNF322B	chr9:99957633-99961910:-	0.58	7.55	3.66E-12	Educational attainment	
PCPG	trans	1	rs9393728	chr6:26509330	ZNF322B	chr9:99957633-99961910:-	0.62	8.2	8.99E-14	Educational attainment	
PCPG	trans	1	rs9393729	chr6:26514166	ZNF322B	chr9:99957633-99961910:-	0.62	8.21	8.23E-14	Educational attainment	
PCPG	trans	1	rs9393731	chr6:26529374	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs9393732	chr6:26530898	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs9461259	chr6:26504835	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.2E-14	Educational attainment	
PCPG	trans	1	rs9461271	chr6:26554968	ZNF322B	chr9:99957633-99961910:-	0.64	8.53	1.29E-14	Educational attainment	
PCPG	trans	1	rs9467773	chr6:26498426	ZNF322B	chr9:99957633-99961910:-	0.62	8.15	1.16E-13	Educational attainment	
PCPG	trans	1	rs9467774	chr6:26505036	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.2E-14	Educational attainment	
PCPG	trans	1	rs9467778	chr6:26534743	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs9467779	chr6:26536687	ZNF322B	chr9:99957633-99961910:-	-0.63	-8.39	2.88E-14	Educational attainment	
PCPG	trans	1	rs9467782	chr6:26542773	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs9467783	chr6:26542894	ZNF322B	chr9:99957633-99961910:-	0.63	8.36	3.54E-14	Educational attainment	
PCPG	trans	1	rs9467787	chr6:26556769	ZNF322B	chr9:99957633-99961910:-	0.64	8.53	1.3E-14	Educational attainment	
PCPG	trans	1	rs9467791	chr6:26562486	ZNF322B	chr9:99957633-99961910:-	-0.64	-8.54	1.21E-14	Educational attainment	
PCPG	trans	1	rs9467796	chr6:26568411	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs9467797	chr6:26568473	ZNF322B	chr9:99957633-99961910:-	0.64	8.54	1.19E-14	Educational attainment	
PCPG	trans	1	rs9986382	chr6:26550619	ZNF322B	chr9:99957633-99961910:-	0.63	8.34	4.02E-14	Educational attainment	
